<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1310211165
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2004
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        CIPROPHARM 250MG TABLET
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CIPROFLOXACIN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        250
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        9.75
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Pharma International Co." />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Pharma International Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 513]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SAUDI ARABIAN DRUG STORE COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Pharma International Co.
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01MA02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="text-align:left">&nbsp;</p><p style="margin-left:32.2pt; margin-right:0cm; text-align:left">Ciprofloxacin, the active ingredient of <strong>Cipropharm</strong><strong>&reg;</strong>, belongs to a group of medicines known as the quinolone antibacterials, fluoroquinolones. It has high anti-bacterial activity against a wide range of organisms.</p><p style="margin-left:32.2pt; text-align:left"><strong>Cipropharm</strong><strong>&reg; </strong>works by killing bacteria that cause infections. It only works with specific strains of bacteria.</p><p style="text-align:left">Adults:</p><p style="margin-left:32.2pt; text-align:left"><strong>Cipropharm</strong><strong>&reg; </strong>is used to treat the following bacterial infections:</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Respiratory tract infections(e.g. certain types of pneumonia)</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Long lasting or recurring ear or sinus infections</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Urinary tract infections (bladder and kidneys infection)</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Infections of the testicles</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Genital organ infections in women(e.g. gonorrhoea, a sexually transmitted disease)</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Gastro-intestinal tract infections (e.g. severe gastro-enteritis) and intra-abdominal infections</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Skin and soft tissue infections</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Bone and joint infections</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->To treat infections in patients with a very low white blood cell count (neutropenia)</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->To prevent infections in patients with a very low white blood cell count (neutropenia)</p><p style="margin-right:8.15pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]-->To prevent infections due to the bacteria Neisseria meningitides which causes meningitis (brain and spinal cord inflammation)</p><p style="margin-left:32.2pt; margin-right:0.7pt; text-align:left; text-indent:2.8pt"><!--[if !supportLists]-->&middot; <!--[endif]-->Anthrax inhalation exposure (infection that occurs when the spores from bacteria Bacillus anthracis enters the body) <strong>Cipropharm</strong><strong>&reg; </strong>may be used in the management of patients with low white blood cell counts (neutropenia) who have a fever that is suspected to be due to a bacterial infection.</p><p style="margin-left:32.2pt; text-align:left">If you have a severe infection or one that is caused by more than one type of bacteria, you may be given additional antibiotic treatment in addition to <strong>Cipropharm</strong><strong>&reg;</strong>.</p><p style="text-align:left">Children and adolescents:</p><p style="margin-left:32.2pt; margin-right:7.55pt; text-align:left"><strong>Cipropharm</strong><strong>&reg; </strong>should be used under specialist medical supervision, to treat the following bacterial infections for children and adolescents:</p><p style="margin-right:2.8pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]-->Lung and bronchial infections in children and adolescents suffering from cystic fibrosis (genetic disorder known to be an inherited disease of the secretory glands, including the glands that make mucus and sweat).</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Complicated urinary tract infections, including infections that have reached the kidneys (pyelonephritis).</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Anthrax inhalation exposure (infection that occurs when the spores from bacteria Bacillus anthracis enters the body).</p><p style="text-align:left">&nbsp;</p><p style="margin-left:32.2pt; text-align:left"><strong>Cipropharm</strong><strong>&reg; </strong>may also be used to treat other specific severe infections in children and adolescents when your doctor considers this as necessary.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="text-align:left">&nbsp;</p><p style="margin-left:32.2pt; text-align:left"><strong>Do not take Cipropharm</strong><strong>&reg; </strong><strong>if you:</strong></p><p style="margin-left:37.9pt; text-align:left; text-indent:-2.95pt"><!--[if !supportLists]-->&middot; <!--[endif]-->Are allergic (hypersensitive) to the Ciprofloxacin, to any other quinolone drugs or to any of the other ingredients of</p><p style="margin-left:37.85pt; text-align:left"><strong>Cipropharm</strong><strong>&reg; </strong>tablets (Listed in section 6: Further information).</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Are taking tizanidine (see Section 2: Taking other medicines).</p><p style="text-align:left">Take special care with Cipropharm&reg; tablets:</p><p style="margin-left:32.2pt; text-align:left"><strong>Before taking Cipropharm</strong><strong>&reg; </strong><strong>tablets, tell your doctor:</strong></p><p style="margin-left:37.2pt; text-align:left; text-indent:-2.25pt"><!--[if !supportLists]-->- <!--[endif]-->If You suffer from &lsquo;fits&rsquo; or epilepsy or any other neurological conditions.</p><p style="margin-left:37.2pt; text-align:left; text-indent:-2.25pt"><!--[if !supportLists]-->- <!--[endif]-->If You have ever had kidney problems because your treatment may need to be adjusted.</p><p style="margin-left:37.2pt; text-align:left; text-indent:-2.25pt"><!--[if !supportLists]-->- <!--[endif]-->If You have a history of tendon problems during previous treatment with antibiotics such as <strong>Cipropharm</strong><strong>&reg;</strong>.</p><p style="margin-left:37.2pt; text-align:left; text-indent:-2.25pt"><!--[if !supportLists]-->- <!--[endif]-->If You have myasthenia gravis (a type of muscle weakness).</p><p style="margin-left:37.2pt; text-align:left; text-indent:-2.25pt"><!--[if !supportLists]-->- <!--[endif]-->If You have a history of abnormal heart rhythms (arrhythmias).</p><p style="margin-left:37.85pt; margin-right:3pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->- <!--[endif]-->If you have been diagnosed with an enlargement or &ldquo;bulge&rdquo; of a large blood vessel (aortic aneurysm or large vessel peripheral aneurysm).</p><p style="margin-left:37.2pt; text-align:left; text-indent:-2.25pt"><!--[if !supportLists]-->- <!--[endif]-->If you have experienced a previous episode of aortic dissection (a tear in the aorta wall).</p><p style="margin-left:37.85pt; margin-right:6.35pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->- <!--[endif]-->If you have a family history of aortic aneurysm or aortic dissection or other risk factors or predisposing conditions (e.g. connective tissue disorders such as Marfan syndrome, or vascular Ehlers-Danlos syndrome, or vascular disorders such as Takayasu arteritis, giant cell arteritis, Behcet&rsquo;s disease, high blood pressure, or known atherosclerosis).</p><p style="margin-left:35pt; text-align:left">If you feel sudden, severe pain in your abdomen, chest or back, go immediately to an emergency room.</p><p style="text-align:left">Heart problems</p><p style="margin-right:0.3pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]-->Caution should be taken when using this kind of medicine, if you were born with or have family history of&nbsp; prolonged QT interval (seen on ECG, electrical recording of the heart), have salt imbalance in the blood (especially low level of potassium or magnesium in the blood), have a very slow heart rhythm (called &lsquo;bradycardia&rsquo;), have a weak heart (heart failure), have a history of heart attack (myocardial infarction), you are female or elderly or you are taking other medicines that result in abnormal ECG changes (see section Taking other medicines).</p><p style="text-align:left">Psychiatric Adverse Reactions</p><p style="margin-left:32.2pt; margin-right:7.55pt; text-align:left">Fluoroquinolones, including <strong>Cipropharm</strong><strong>&reg;</strong>, have been associated with an increased risk of psychiatric adverse reactions, including: toxic psychosis, psychotic reactions progressing to suicidal ideations/thoughts, hallucinations, or paranoia; depression, or self-injurious behavior such as attempted or completed suicide; anxiety, agitation, or nervousness; confusion, delirium, disorientation, or disturbances in attention; insomnia or nightmares; memory</p><p style="margin-left:32.2pt; text-align:left">impairment. These reactions may occur following the first dose. Advise patients receiving <strong>Cipropharm</strong><strong>&reg; </strong>to inform their healthcare provider immediately if these reactions occur, discontinue the drug, and institute appropriate care.</p><p style="text-align:left">Tendon Rupture, Peripheral Neuropathy, and Central Nervous System Effects</p><p style="margin-left:32.2pt; margin-right:5.7pt; text-align:left">Fluoroquinolones, including <strong>Cipropharm</strong><strong>&reg;</strong>, have been associated with disabling and potentially irreversible serious adverse reactions from different body systems that can occur together in the same patient. Commonly seen adverse reactions include tendinitis, tendon rupture, arthralgia, myalgia, peripheral neuropathy, and central nervous system effects (hallucinations, anxiety, depression, insomnia, severe headaches, and confusion). These reactions can occur within hours to weeks after starting <strong>Cipropharm</strong><strong>&reg;</strong>. Patients of any age or without pre-existing risk factors have experienced these adverse reactions</p><p style="margin-left:32.2pt; margin-right:7.55pt; text-align:left">Discontinue <strong>Cipropharm</strong><strong>&reg;</strong>, immediately at the first signs or symptoms of any serious adverse reaction. In addition, avoid the use of fluoroquinolones, including cipropharm&reg;, in patients who have experienced any of these serious adverse reactions associated with fluoroquinolones.</p><p style="text-align:left">Aortic aneurysm</p><p style="margin-left:32.2pt; margin-right:0cm; text-align:left">Inform your doctor before starting an antibiotic prescription, if you have a history of aneurysms, blockages or hardening of the arteries, high blood pressure, or genetic conditions such as Marfan syndrome or Ehlers-Danlos syndrome.</p><p style="margin-left:32.2pt; margin-right:5.7pt; text-align:left">Be aware that symptoms of an aortic aneurysm often do not show up until the aneurysm becomes large or bursts, so report any unusual side effects from taking fluoroquinolones to your doctor immediately.</p><p style="margin-left:32.2pt; text-align:left">Seek medical attention immediately by going to an emergency room if you experience sudden, severe, and constant pain in the stomach, chest or back. Do not stop the antibiotic without first talking to your doctor.</p><p style="text-align:left">Blood Glucose Disturbances</p><p style="margin-left:32.2pt; margin-right:1.6pt; text-align:left">Fluoroquinolones, including <strong>Cipropharm</strong><strong>&reg;</strong>, have been associated with disturbances of blood glucose, including symptomatic hyperglycemia and hypoglycemia, usually in diabetic patients receiving concomitant treatment with an oral hypoglycemic agent (for example, glyburide) or with insulin. In these patients, careful monitoring of blood glucose is recommended. Severe cases of hypoglycemia resulting in coma or death have been reported. If a hypoglycemic reaction occurs in a patient being treated with <strong>Cipropharm</strong><strong>&reg;</strong>, discontinue <strong>Cipropharm</strong><strong>&reg; </strong>and initiate appropriate&nbsp; therapy immediately.</p><p style="margin-left:32.2pt; margin-right:10.15pt; text-align:left">Because fluoroquinolones have been associated with serious adverse reactions reserve fluoroquinolones for use in patients who have no alternative treatment options for the following indications:</p><p style="margin-left:34.2pt; text-align:left; text-indent:-2.05pt"><!--[if !supportLists]-->&bull; <!--[endif]-->Acute bacterial exacerbation of chronic bronchitis</p><p style="margin-left:34.4pt; text-align:left; text-indent:-2.25pt"><!--[if !supportLists]-->&bull; <!--[endif]-->uncomplicated urinary tract infection</p><p style="margin-left:34.2pt; text-align:left; text-indent:-2.05pt"><!--[if !supportLists]-->&bull; <!--[endif]-->Acute bacterial sinusitis</p><p style="margin-left:32.2pt; margin-right:5.7pt; text-align:left">For the treatment of some genital tract infections, your doctor can prescribe another antibiotic in addition to <strong>Cipropharm</strong><strong>&reg;</strong>. If there is no improvement in symptoms after 3 days of treatment, please consult your doctor.&nbsp; Contact your doctor immediately, if any of the following occurs while taking <strong>Cipropharm</strong><strong>&reg;</strong>. Your doctor will decide whether treatment with <strong>Cipropharm</strong><strong>&reg; </strong>needs to be stopped.</p><p style="margin-left:37.85pt; margin-right:0.45pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]-->Severe, sudden allergic reaction (an anaphylactic reaction/shock, angio-oedema). Even with the first dose, there is a small chance that you may experience a severe allergic reaction with the following symptoms: tightness in the chest, feeling dizzy, sick or faint, or experiencing dizziness when standing up. If this happens, stop taking <strong>Cipropharm</strong><strong>&reg;</strong><strong>&nbsp;</strong>tablets and contact your doctor immediately.</p><p style="margin-right:0.8pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]-->Pain and swelling in the joints and tendinitis may occur occasionally, particularly if you are elderly and are also being treated with corticosteroids. Inflammation and ruptures of tendons may occur even within the first 48 hours of treatment or up to several months after discontinuation of <strong>Cipropharm</strong><strong>&reg; </strong>tablets therapy. At the first sign of any pain or inflammation stop taking <strong>Cipropharm</strong><strong>&reg; </strong>tablets and rest the painful area. Avoid any unnecessary exercise, as this might increase the risk of a tendon rupture.</p><p style="margin-right:0.45pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]-->If you suffer from epilepsy or other neurological conditions such as cerebral ischemia or stroke, you may experience side effects associated with the central nervous system. If this happens, stop taking <strong>Cipropharm</strong><strong>&reg; </strong>tablets and&nbsp; contact your doctor immediately.</p><p style="text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]-->You may experience psychiatric reactions the first time you take <strong>Cipropharm</strong><strong>&reg; </strong>tablets. If you suffer from depression or psychosis, your symptoms may become worse under treatment with <strong>Cipropharm</strong><strong>&reg; </strong>tablets. In rare cases, depression or psychosis can progress to thoughts of suicide, suicide attempts, or completed suicide. If this happens, stop taking <strong>Cipropharm</strong><strong>&reg; </strong>tablets and contact your doctor immediately.</p><p style="margin-right:6.4pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]-->You may experience symptoms of neuropathy such as pain, burning, tingling, numbness and/or weakness. If this happens, stop taking <strong>Cipropharm</strong><strong>&reg; </strong>tablets and contact your doctor immediately.</p><p style="margin-right:1.8pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]-->Diarrhoea may develop while you are taking antibiotics, including <strong>Cipropharm</strong><strong>&reg; </strong>tablets, or even several weeks after you have stopped taking them. If it becomes severe or persistent or you notice that your stool contains blood&nbsp; or mucus, stop taking <strong>Cipropharm</strong><strong>&reg; </strong>tablets immediately, as this can be life-threatening. Do not take medicines that stop or slow down bowel movements and contact your doctor.</p><p style="margin-right:12.65pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]-->Tell the doctor or laboratory staff that you are taking <strong>Cipropharm</strong><strong>&reg; </strong>tablets if you have to provide a blood or urine sample.</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->If you suffer from kidney problems, tell the doctor because your dose may need to be adjusted.</p><p style="margin-right:8.3pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]--><strong>Cipropharm</strong><strong>&reg; </strong>tablets may cause liver damage. If you notice any symptoms such as loss of appetite, jaundice (yellowing of the skin), dark urine, itching, or tenderness of the stomach, stop taking <strong>Cipropharm</strong><strong>&reg; </strong>tablets and contact your doctor immediately.</p><p style="margin-right:2.45pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]--><strong>Cipropharm</strong><strong>&reg; </strong>tablets may cause a reduction in the number of white blood cells and your resistance to infection may be decreased. If you experience an infection with symptoms such as fever and serious deterioration of your general condition, or fever with local infection symptoms such as sore throat/pharynx/mouth or urinary problems you should see your doctor immediately. A blood test will be taken to check possible reduction of white blood cells (agranulocytosis). It is important to inform your doctor about your medicine.</p><p style="margin-right:17.3pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]-->Tell your doctor if you or a member of your family is known to have a deficiency in glucose-6-phosphate dehydrogenase (G6PD), since you may experience a risk of anemia with <strong>Cipropharm</strong><strong>&reg;</strong>.</p><p style="margin-right:6.25pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]-->Your skin becomes more sensitive to sunlight or ultraviolet (UV) light when taking <strong>Cipropharm</strong><strong>&reg; </strong>tablets. Avoid exposure to strong sunlight, or artificial UV light such as sunbeds.</p><p style="text-align:left">Taking other medicines</p><p style="margin-left:32.2pt; margin-right:0cm; text-align:left">Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including those medicines obtained without a prescription.</p><p style="margin-left:32.2pt; margin-right:2.45pt; text-align:left">You must tell your doctor if you are taking other medicines that can alter your heart rhythm: medicines that belong to the group of anti-arrhythmics (e.g. quinidine, hydroquinidine, disopyramide, amiodarone, sotalol, dofetilide, ibutilide), tricyclic antidepressants, some antimicrobials (that belong to the group of macrolides), some antipsychotics.</p><p style="margin-left:32.2pt; text-align:left">Do not take <strong>Cipropharm</strong><strong>&reg; </strong>together with tizanidine, because this may cause side effects such as low blood pressure and sleepiness (see Section 2: &laquo;Do not take <strong>Cipropharm</strong><strong>&reg;</strong>&raquo;).</p><p style="margin-left:32.2pt; margin-right:8.15pt; text-align:left">The following medicines are known to interact with <strong>Cipropharm</strong><strong>&reg; </strong>in your body. Taking <strong>Cipropharm</strong><strong>&reg; </strong>together with these medicines can influence the therapeutic effect of those medicines. It can also increase the probability of experiencing side effects.</p><p style="text-align:left">Tell your doctor if you are taking:</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Xanthine derivatives such as theophylline (used to treat asthma).</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Phenytoin (used to treat epilepsy).</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Any drugs which thin the blood (known as anti-coagulants e.g. warfarin).</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Cyclosporine (used to treat psoriasis, dermatitis, rheumatoid arthritis and in organ transplantation).</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Glibenclamide (an oral drug used to treat diabetes).</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Probenecid (used to prevent gout).</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Metoclopramide (used to treat nausea and vomiting (feeling/being sick) and migraine).</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Mexiletine (used to treat abnormal heart beats) .</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Ropinirole (used to treat Parkinson&rsquo;s disease).</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Methotrexate (for certain types of cancer, psoriasis, rheumatoid arthritis).</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Tizanidine (for muscle spasticity in multiple sclerosis).</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Clozapine (an antipsychotic) .</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Olanzapine (an antipsychotic).</p><p style="margin-right:2.7pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]-->Other medicines that can alter your heart rhythm: medicines that belong to the group of anti-arrhythmics (e.g. quinidine, hydroquinidine, disopyramide, amiodarone, sotalol, dofetilide, ibutilide), tricyclic antidepressants, some antimicrobials (that belong to the group of macrolides), some antipsychotics.</p><p style="margin-left:32.2pt; text-align:left"><strong>Cipropharm</strong><strong>&reg; </strong>may increase the levels of the following medicines in your blood:</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Pentoxifylline (for circulatory disorders).</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Caffeine.</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Duloxetine (for depression, diabetic nerve damage or incontinence).</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Lidocaine (for heart conditions or anesthetic use).</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Sildenafil (e.g. for erectile dysfunction)</p><p style="margin-left:32.2pt; text-align:left">Some medicines <strong>reduce </strong>the effect of <strong>Cipropharm</strong><strong>&reg;</strong>. Tell your doctor if you take or wish to take:</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Antacids.</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Omeprazole.</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Mineral supplements.</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Sucralfate.</p><p style="text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->A polymeric phosphate binder (e.g. sevelamer).</p><p style="margin-left:32.2pt; margin-right:7.55pt; text-align:left">Medicines or supplements containing calcium, magnesium, aluminum or iron (e.g. didanosine tablets (an antiviral drug used to treat HIV))</p><p style="text-align:left">&nbsp;</p><p style="text-align:left">&nbsp;</p><p style="margin-left:9.3pt; text-align:left">If these preparations are essential, take <strong>Cipropharm</strong><strong>&reg; </strong>about two hours before or no sooner than four hours after them.</p><p style="text-align:left">Taking Cipropharm&reg; with food and drink</p><p style="margin-left:9.3pt; margin-right:20.85pt; text-align:left">Unless you take <strong>Cipropharm</strong><strong>&reg; </strong>during meals, do not eat or drink any dairy products (e.g. milk or yogurt) or drinks with added calcium. These can affect the absorption of <strong>Cipropharm</strong><strong>&reg; </strong>and so you should take your tablets either 1 to 2 hours before or at least 4 hours after you have such products.</p><p style="text-align:left">Pregnancy and breast-feeding</p><p style="margin-left:9.3pt; margin-right:25.6pt; text-align:left">It is preferable to avoid the use of <strong>Cipropharm</strong><strong>&reg; </strong>during pregnancy. Tell your doctor if you are pregnant or planning to become pregnant.</p><p style="margin-left:9.3pt; margin-right:20.4pt; text-align:left">Do not take <strong>Cipropharm</strong><strong>&reg; </strong>tablets during breast feeding because <strong>Cipropharm</strong><strong>&reg; </strong>is excreted in breast milk and can be harmful for your child.</p><p style="margin-left:9.3pt; text-align:left">Ask your doctor or pharmacist for advice before taking any other medicine.</p><p style="text-align:left">Driving and using machines</p><p style="margin-left:9.3pt; margin-right:20.4pt; text-align:left"><strong>Cipropharm</strong><strong>&reg; </strong>may make you feel less alert. Some neurological adverse events can occur. Therefore, make sure you know how you react to <strong>Cipropharm</strong><strong>&reg; </strong>before driving a vehicle or operating machinery. If in doubt, talk to your doctor.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="text-align:left">&nbsp;</p><p style="margin-left:9.3pt; margin-right:18.75pt; text-align:left">Always take <strong>Cipropharm</strong><strong>&reg; </strong>tablets exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.</p><p style="margin-left:9.3pt; margin-right:19.65pt; text-align:left">Take the tablets exactly as your doctor has told you. The tablets should always be taken with plenty of water, as this will help to prevent the formation of tiny crystals in your urine (crystalluria).</p><p style="margin-left:9.3pt; margin-right:20.4pt; text-align:left">You can take the tablets at meal times or between meals. Any calcium you take as a part of a meal will not seriously affect uptake. However, do not take <strong>Cipropharm</strong><strong>&reg; </strong>tablets with dairy products such as milk or yogurt or with fortified fruit juices (eg. Calcium-fortified orange juice).</p><p style="margin-left:9.3pt; text-align:left">Tell your doctor if you suffer from kidney problems because your dose may need to be adjusted.</p><p style="margin-left:9.3pt; margin-right:26.8pt; text-align:left">Your dose will be dependent on the type and severity of your infection, your age, weight and kidney function. Your doctor will choose the best dose for you.</p><p style="text-align:left">Adults</p><p style="margin-left:9.3pt; margin-right:20.4pt; text-align:left">The usual adult dose is between 100 &ndash; 750mg twice daily. In Respiratory infections the usual dose is 500mg-750mg twice daily. In infections of the bladder and kidneys, the usual dose is 250 - 500mg twice daily. In gonorrhoea, the&nbsp; usual dose is 250 - 500mg as a single dose. In gastro-intestinal infections, the usual dose is 500 mg twice daily. In intra- abdominal infections, skin and soft tissue infections, bone and joint infections, and in neutropenic patients the usual</p><p style="margin-left:9.3pt; margin-right:18.6pt; text-align:left">dose is 500-750mg twice daily. In infections due to Bacterium Neisseria meningitidis the usual dose is 500mg as a single dose. Inhalation anthrax exposure the usual dose is 500mg twice daily.</p><p style="text-align:left">Elderly Patients</p><p style="margin-left:9.3pt; margin-right:19.35pt; text-align:left">Your doctor will decide what dose to give you. This may be lower than the usual adult dose depending on the severity of your infection and your kidney function.</p><p style="text-align:left">Kidney/Liver problems</p><p style="margin-left:9.3pt; margin-right:20.75pt; text-align:left">Your doctor will decide what dose to give you depending on your kidney and liver function. Special dosing instructions are needed if you are on hemodialysis or having CAPD (continuous ambulatory peritoneal dialysis).</p><p style="text-align:left">Children and adolescents</p><p style="margin-left:9.3pt; margin-right:25.6pt; text-align:left">The use of <strong>Cipropharm</strong><strong>&reg; </strong>tablets is not generally recommended in children. However in some cases treatment with these tablets is of benefit and your doctor may decide to treat your child with this drug particularly for the below mentioned infections.</p><p style="margin-left:9.3pt; margin-right:22.95pt; text-align:left">Cystic fibrosis the usual dose is 20mg/kg body weight twice daily with a maximum daily dose of 750 mg. Complicated urinary tract infections and pyelonephritis the usual dose is 10 to 20 mg/kg body weight twice daily with a maximum of 750 mg per dose.</p><p style="margin-left:9.3pt; margin-right:27.45pt; text-align:left">Inhalation anthrax exposure the usual dose is 10 to 15 mg/kg body weight twice daily with a maximum of 500mg per dose.</p><p style="margin-left:9.3pt; text-align:left">Other severe infections the usual dose is 20mg /kg body weight twice daily with a maximum of 750mg per dose.</p><p style="margin-left:9.3pt; margin-right:18.6pt; text-align:left">It is very important that you follow your doctor&rsquo;s instructions as to how many <strong>Cipropharm</strong><strong>&reg;&nbsp; </strong>tablets to take, how often&nbsp; to take them and for how long you should continue to take your tablets. The normal duration of treatment is between 5 to 21 days (although this may be longer), depending on the type and severity of infection.</p><p style="text-align:left">If you take more Cipropharm&reg; tablets than you should</p><p style="margin-left:9.3pt; margin-right:22.85pt; text-align:left">If you or someone else swallows several of these tablets all together, or you think a child has swallowed any of these tablets, contact your doctor or pharmacist or hospital emergency department immediately. Always take any tablets left over with you, also the box and leaflet as this will allow easier identification of the tablets.</p><p style="text-align:left">If you forget to take Cipropharm&reg; tablets</p><p style="margin-left:9.3pt; margin-right:20.4pt; text-align:left">If you forget to take a dose, take it as soon as you remember. If it is almost time for your next dose, do not take the missed dose and just carry on as before. Do not take a double dose to make up for a forgotten dose. Be sure to complete your course of treatment.</p><p style="text-align:left">If you stop taking Cipropharm&reg; tablets</p><p style="margin-left:9.3pt; margin-right:19.95pt; text-align:left">It is important that you <strong>finish the course of treatment </strong>even if you begin to feel better after a few days. If you stop taking this medicine too soon your infection may not be completely cured and the symptoms of the infection may return or get worse. You might also develop resistance to the antibiotic. If you have any further questions on the use of this product, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="text-align:left">&nbsp;</p><p style="margin-left:9.3pt; text-align:left">Like all medicines, Ciprofloxacin can cause side-effects, although not everybody gets them.</p><p style="margin-left:9.3pt; margin-right:22.35pt; text-align:left">About 5 &ndash;14% of patients have side-effects and the most common side-effects involve the gut and the nervous system. If any of the following symptoms occur soon after taking your tablets, stop taking the tablets and tell your doctor immediately. This kind of reaction is rare and may mean you are suffering from an allergic reaction to the tablets:</p><p style="margin-left:14.95pt; margin-right:20.1pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]-->Rash, itching, a lumpy skin rash (hives), fever, small red spots on the body, increased sensitivity to sunlight or very rarely severe skin reactions such as large fluid filled blisters, peeling, sores and ulceration. Ulceration can also occur in the mouth and throat, around the anus and genital region and on the surface of the eyes.</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Sudden wheeziness or tightness of the chest.</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Swelling of the eyelids, face, lips or blood vessels in the skin.</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Sickness and headache.</p><p style="margin-left:9.3pt; text-align:left">You should also tell your doctor immediately and stop taking your tablets if you notice:</p><p style="margin-left:14.95pt; margin-right:26.15pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]-->Pain or inflammation in the tendons. This effect occurs in isolated cases. If these symptoms are experienced you should stop taking your tablet, rest the affected limb and consult your doctor immediately.</p><p style="margin-left:14.95pt; margin-right:23.4pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]-->Severe diarrhea with bleeding or mucus. This effect occurs in less than one in a thousand but more than one in ten thousand people.</p><p style="margin-left:9.3pt; margin-right:63.4pt; text-align:left; text-indent:2.8pt"><!--[if !supportLists]-->&middot; <!--[endif]-->A feeling that you want to physically harm yourself. This only occurs in isolated cases. Other possible side-effects, which may occur, are listed below:</p><p style="margin-left:9.3pt; text-align:left"><strong>Common side effects </strong>(between 1 and 10 in every 100 people):</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Nausea, diarrhea.</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Joint pains in children.</p><p style="margin-left:9.3pt; text-align:left"><strong>Uncommon side effects </strong>(between 1 and 10 in every 1,000 people):</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Fungal super infections.</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->A high concentration of eosinophils, a type of white blood cell.</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Loss of appetite (anorexia).</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Hyperactivity or agitation 0</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Headache, dizziness, sleeping problems, or taste disorders.</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Vomiting, abdominal pain, digestive problems such as stomach upset (indigestion/ heartburn), or wind 0</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Increased amounts of certain substances in the blood (transaminases and/or bilirubin).</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Rash, itching, or hives.</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Poor kidney function.</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Pains in your muscles and bones, feeling unwell (asthenia), or fever</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Increase in blood alkaline phosphatase (a certain substance in the blood).</p><p style="margin-left:9.3pt; text-align:left"><strong>Rare side effects </strong>(between 1 and 10 in every 10,000 people):</p><p style="margin-left:14.95pt; margin-right:27.6pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]-->Inflammation of the bowel (colitis) linked to antibiotic use (can be fatal in very rare cases) (see Section 2: Take special care with <strong>Cipropharm</strong><strong>&reg;</strong>).</p><p style="margin-left:14.95pt; margin-right:22.6pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]-->Changes to the blood count (leukopenia, leukocytosis, neutropenia, anaemia), increased or decreased amounts of a blood clotting factor (thrombocytes).</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Allergic reaction, swelling (oedema), or rapid swelling of the skin and mucous membranes (angioedema).</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Increased blood sugar (hyperglycemia).</p><p style="margin-left:14.95pt; margin-right:21.9pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]-->Confusion, disorientation, anxiety reactions, strange dreams, depression (potentially leading to thoughts of suicide, suicide attempts, or completed suicide), or hallucinations.</p><p style="margin-left:14.95pt; margin-right:29.8pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]-->Pins and needles, unusual sensitivity to stimuli of the senses, decreased skin sensitivity, tremors, seizures (see Section 2: Take special care with <strong>Cipropharm</strong><strong>&reg;</strong>), or giddiness.</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Eyesight problems including double vision.</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Tinnitus, loss of hearing, impaired hearing.</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Rapid heartbeat (tachycardia).</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Expansion of blood vessels (vasodilation), low blood pressure, or fainting..</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Shortness of breath, including asthmatic symptoms.</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Liver disorders, jaundice (cholestatic icterus), or hepatitis.</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Sensitivity to light (see Section 2: Take special care with <strong>Cipropharm</strong><strong>&reg;</strong>).</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Muscle pain, inflammation of the joints, increased muscle tone, or cramp.</p><p style="margin-left:14.95pt; margin-right:27pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]-->Kidney failure, blood or crystals in the urine (see Section 2: Take special care with <strong>Cipropharm</strong><strong>&reg;</strong>),urinary tract inflammation 0</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Fluid retention or excessive sweating.</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Increased levels of the enzyme amylase.</p><p style="margin-left:9.3pt; text-align:left"><strong>Very rare side effects </strong>(less than 1 in every 10,000 people):</p><p style="margin-left:14.95pt; margin-right:21.15pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]-->Migraine, disturbed coordination, unsteady walk (gait disturbance), disorder of sense of smell (olfactory disorders), pressure on the brain (intracranial pressure).</p><p style="margin-left:14.95pt; margin-right:21pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]-->A special type of reduced blood cell count ((haemolytic anaemia)-a form of anemia due to the breaking down of&nbsp; red blood cells,) may occur with jaundice), a dangerous drop in a type of white blood cells (agranulocytosis); a&nbsp; drop in the number of red and white blood cells and platelets (pancytopenia), which may be fatal; and bone marrow depression, which may also be fatal (see Section 2: Take special care with <strong>Cipropharm</strong><strong>&reg;</strong>).</p><p style="margin-left:14.95pt; margin-right:26.5pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]-->Severe allergic reactions (anaphylactic reaction or anaphylactic shock, which can be fatal - serum sickness) (see Section 2: Take special care with <strong>Cipropharm</strong><strong>&reg;</strong>).</p><p style="margin-left:14.95pt; margin-right:22.95pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]-->Mental disturbances (psychotic reactions potentially leading to thoughts of suicide, suicide attempts, or completed suicide) (see Section 2: Take special care with <strong>Cipropharm</strong><strong>&reg;</strong>).</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Visual colour distortions.</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Inflammation of the wall of the blood vessels (vasculitis).</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Pancreatitis.</p><p style="margin-left:14.95pt; margin-right:21.55pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]-->Small, pin-point bleeding under the skin (petechiaae); various skin eruptions or rashes (for example, the potentially fatal Stevens-Johnson syndrome or toxic epidermal necrolysis).</p><p style="margin-left:14.95pt; margin-right:21.35pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]-->Muscle weakness, tendon inflammation, tendon rupture &ndash; especially of the large tendon at the back of the ankle (Achilles tendon) (see Section 2: Take special care with <strong>Cipropharm</strong><strong>&reg;</strong>); worsening of the symptoms of myasthenia gravis (see Section 2: Take special care with <strong>Cipropharm</strong><strong>&reg;</strong>).</p><p style="margin-left:9.3pt; text-align:left"><strong>Frequency not known </strong>(cannot be estimated from the available data)</p><p style="margin-left:14.95pt; margin-right:34.4pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]-->Troubles associated with the nervous system such as pain, burning, tingling, numbness and/or weakness in extremities.</p><p style="margin-left:14.95pt; margin-right:36.3pt; text-align:left; text-indent:-2.85pt"><!--[if !supportLists]-->&middot; <!--[endif]-->Abnormal fast heart rhythm, life-threatening irregular heart rhythm, alteration of the heart rhythm (called &lsquo;prolongation of QT interval&rsquo;, seen on ECG, electrical activity of the heart) .</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Pustular rash.</p><p style="margin-left:14.95pt; text-align:left"><!--[if !supportLists]-->&middot; <!--[endif]-->Influence on blood clotting (in patients treated with Vitamin K antagonists).</p><p style="margin-left:9.3pt; margin-right:25.6pt; text-align:left">If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="text-align:left">&nbsp;</p><p style="margin-left:9.3pt; text-align:left">Keep out of the reach and sight of children.</p><p style="margin-left:9.3pt; margin-right:38.55pt; text-align:left">Do not use <strong>Cipropharm</strong><strong>&reg; </strong>tablets after the expiry date (EXP) which is stated on the blister and the carton. The expiry date refers to the last day of that month.</p><p style="margin-left:9.3pt; text-align:left"><strong>Cipropharm</strong><strong>&reg; </strong>tablets: Store below 30&deg;C.</p><p style="margin-left:9.3pt; margin-right:25.6pt; text-align:left">Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-left:9.3pt"><strong>&nbsp;</strong></p><p style="margin-left:9.3pt; text-align:left">The active substance is Ciprofloxacin hydrochloride.</p><p style="margin-left:9.3pt; margin-right:20.25pt; text-align:left">The other ingredients are Sodium starch glycolate, Povidone K, Microcrystalline cellulose Avicel PH, Talc, Magnesium stearate, Opadry O-YL White, Polyethylene glycol</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                
White, round, shallow convex film coated tablets, scored on one face and engraved with PhI on the other, presented in PVDC /Alu blisters, intended for oral use.
Pack size: 10 tablets

(Not all pack sizes may be marketed in your country)


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-left:9.3pt; margin-right:150.7pt; text-align:left">Pharma International Company Amman - Jordan</p><p style="margin-left:9.3pt; text-align:left">Tel: 00962-6-5158890 / 5157893</p><p style="margin-left:9.3pt; text-align:left">Fax: 00962-6-5154753</p><p style="text-align:left">Email: marketing@pic-jo.com</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                
This leaflet was last revised in 01/2019

            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p style="margin-left:0px; margin-right:0px">سيبروفلوكساسين،&nbsp;المادة&nbsp;الفعالة&nbsp;ل&nbsp;سيبروفارم&nbsp;ينتمي&nbsp;إلى&nbsp;مجموعة&nbsp;من&nbsp;الأدوية&nbsp;المعروفة&nbsp;باسم&nbsp;مضادات&nbsp;الجراثيم&nbsp;الكينولون،&nbsp;الفلوروكينولونات.&nbsp;له&nbsp;نشاط</p><p style="margin-left:0px; margin-right:0px">عالي&nbsp;مضاد&nbsp;للبكتيريا&nbsp;ضد&nbsp;طائفة&nbsp;واسعة&nbsp;من&nbsp;الكائنات&nbsp;الحية</p><p style="margin-left:0px; margin-right:0px">يعمل&nbsp;سيبروفارم&nbsp;على&nbsp;قتل&nbsp;البكتيريا&nbsp;التي&nbsp;تسبب&nbsp;الالتهابات.&nbsp;و&nbsp;لا&nbsp;يعمل&nbsp;إلا&nbsp;مع&nbsp;سلالات&nbsp;معينة&nbsp;من&nbsp;البكتيريا.</p><p style="margin-left:0px; margin-right:0px">البالغين:</p><p style="margin-left:0px; margin-right:0px">يستخدم&nbsp;سيبروفارم&nbsp;لعلاج&nbsp;الالتهابات&nbsp;البكتيرية&nbsp;التالية</p><p style="margin-left:0px; margin-right:0px">&nbsp;</p><p style="margin-left:0px; margin-right:0px">&bull;&nbsp;التهابات&nbsp;المسالك&nbsp;التنفسية&nbsp;(مثل&nbsp;أنواع&nbsp;معينة&nbsp;من&nbsp;الالتهاب&nbsp;الرئوي)</p><p style="margin-left:0px; margin-right:0px">&bull;&nbsp;التهابات&nbsp;الجيوب&nbsp;الأنفية&nbsp;أو&nbsp;الأذن&nbsp;طويلة&nbsp;الأمد&nbsp;أو&nbsp;المتكررة</p><p style="margin-left:0px; margin-right:0px">&bull;&nbsp;التهابات&nbsp;المسالك&nbsp;البولية&nbsp;(التهاب&nbsp;المثانة&nbsp;والكلى)</p><p style="margin-left:0px; margin-right:0px">&bull;&nbsp;التهابات&nbsp;الخصيتين</p><p style="margin-left:0px; margin-right:0px">و&nbsp;التهابات&nbsp;الجهاز&nbsp;التناسلي&nbsp;عند&nbsp;النساء&nbsp;(مثل&nbsp;السيلان&nbsp;والأمراض&nbsp;المنقولة&nbsp;جنسيا)</p><p style="margin-left:0px; margin-right:0px">&bull;&nbsp;التهابات&nbsp;الجهاز&nbsp;المعدي&nbsp;المعوي&nbsp;(مثل&nbsp;التهاب&nbsp;المعدة&nbsp;والأمعاء&nbsp;الحاد)&nbsp;و&nbsp;التهابات&nbsp;داخل&nbsp;البطن</p><p style="margin-left:0px; margin-right:0px">&bull;&nbsp;التهابات&nbsp;الجلد&nbsp;والأنسجة&nbsp;اللينة</p><p style="margin-left:0px; margin-right:0px">&bull;&nbsp;التهابات&nbsp;العظام&nbsp;و&nbsp;المفاصل</p><p style="margin-left:0px; margin-right:0px">&bull;&nbsp;العلاج&nbsp;الالتهابات&nbsp;عند&nbsp;المرضى&nbsp;الذين&nbsp;يعانون&nbsp;من&nbsp;انخفاض&nbsp;شديد&nbsp;في&nbsp;عدد&nbsp;خلايا&nbsp;الدم&nbsp;البيضاء&nbsp;(العدلات)</p><p style="margin-left:0px; margin-right:0px">:&nbsp;لمنع&nbsp;الالتهابات&nbsp;عند&nbsp;المرضى&nbsp;الذين&nbsp;يعانون&nbsp;من&nbsp;انخفاض&nbsp;شديد&nbsp;في&nbsp;عدد&nbsp;خلايا&nbsp;الدم&nbsp;البيضاء&nbsp;(العدلات)</p><p style="margin-left:0px; margin-right:0px">&bull;&nbsp;لمنع&nbsp;الالتهابات&nbsp;الحاصلة&nbsp;بسبب&nbsp;بكتيريا&nbsp;السحايا&nbsp;النيسرية&nbsp;الذي&nbsp;يسبب&nbsp;التهاب&nbsp;السحايا&nbsp;(التهاب&nbsp;الدماغ&nbsp;والنخاع&nbsp;الشوكي)</p><p style="margin-left:0px; margin-right:0px">&nbsp;</p><p style="margin-left:0px; margin-right:0px">:&nbsp;التعرض&nbsp;لاستنشاق&nbsp;الجمرة&nbsp;الخبيثة&nbsp;(الالتهاب&nbsp;الذي&nbsp;يحدث&nbsp;عند&nbsp;دخول&nbsp;بذور&nbsp;البكتيريا&nbsp;الجمرة&nbsp;الخبيثة&nbsp;للجسم)</p><p style="margin-left:0px; margin-right:0px">يمكن&nbsp;استخدام&nbsp;سيبروفارم&quot;&nbsp;في&nbsp;تدبير&nbsp;وضع&nbsp;المرضى&nbsp;الذين&nbsp;يعانون&nbsp;من&nbsp;انخفاض&nbsp;عدد&nbsp;الخلايا&nbsp;البيضاء&nbsp;في&nbsp;الدم&nbsp;(العدلات)&nbsp;الذين&nbsp;يعانون&nbsp;منحسی&nbsp;بشتبه&nbsp;بأن</p><p style="margin-left:0px; margin-right:0px">يكون&nbsp;سببها&nbsp;عدوى&nbsp;بكتيرية</p><p style="margin-left:0px; margin-right:0px">إذا&nbsp;كانت&nbsp;تعاني&nbsp;من&nbsp;التهاب&nbsp;شديد&nbsp;أو&nbsp;من&nbsp;التهاب&nbsp;سببه&nbsp;أكثر&nbsp;من&nbsp;نوع&nbsp;واحد&nbsp;من&nbsp;البكتيريا،&nbsp;قد&nbsp;يتم&nbsp;إضافة&nbsp;مضادات&nbsp;حيوية&nbsp;للعلاج&nbsp;بالإضافة&nbsp;للسيبروفارم</p><p style="margin-left:0px; margin-right:0px">الأطفال&nbsp;والمراهقين:</p><p style="margin-left:0px; margin-right:0px">&nbsp;</p><p style="margin-left:0px; margin-right:0px">استخدام&nbsp;سيبروفارم&nbsp;تحت&nbsp;إشراف&nbsp;طبي&nbsp;متخصص،&nbsp;لعلاج&nbsp;الالتهابات&nbsp;البكتيرية&nbsp;التالية&nbsp;للأطفال&nbsp;والمراهقين</p><p style="margin-left:0px; margin-right:0px">&bull;&nbsp;الرنة&nbsp;و&nbsp;التهابات&nbsp;الشعب&nbsp;الهوائية&nbsp;لدى&nbsp;الأطفال&nbsp;والمراهقين&nbsp;الذين&nbsp;يعانون&nbsp;من&nbsp;التليف&nbsp;الكبسي&nbsp;(اضطراب&nbsp;جيني&nbsp;يعرف&nbsp;بأنه&nbsp;مرض&nbsp;وراثي&nbsp;فيالغدد</p><p style="margin-left:0px; margin-right:0px">الإفرازية،&nbsp;بما&nbsp;في&nbsp;ذلك&nbsp;الغدد&nbsp;التي&nbsp;تفرز&nbsp;المخاط&nbsp;و&nbsp;العرق)</p><p style="margin-left:0px; margin-right:0px">.&nbsp;التهابات&nbsp;المسالك&nbsp;البولية&nbsp;المعقدة،&nbsp;بما&nbsp;في&nbsp;ذلك&nbsp;الإصابات&nbsp;التي&nbsp;وصلت&nbsp;إلى&nbsp;الكلى&nbsp;(التهاب&nbsp;الحو&nbsp;بحياة&nbsp;و&nbsp;الكلية)</p><p style="margin-left:0px; margin-right:0px">&nbsp;</p><p style="margin-left:0px; margin-right:0px">:&nbsp;التعرض&nbsp;لاستنشاق&nbsp;الجمرة&nbsp;الخبيثة&nbsp;(الالتهاب&nbsp;الذي&nbsp;يحدث&nbsp;عند&nbsp;دخول&nbsp;بذور&nbsp;البكتيريا&nbsp;الجمرة&nbsp;الخبيثة&nbsp;للجسم)</p><p style="margin-left:0px; margin-right:0px">ويمكن&nbsp;أيضا&nbsp;استخدام&nbsp;ال&nbsp;سيبروفارم&nbsp;لعلاج&nbsp;التهابات&nbsp;شديدة&nbsp;أخرى&nbsp;تصيب&nbsp;الأطفال&nbsp;و المراهقين عندما&nbsp;يرى&nbsp;الطبيب&nbsp;الضرورة&nbsp;لذلك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">لا&nbsp;تأخذ&nbsp;سيبروفارم&nbsp;أقراص&nbsp;إذا&nbsp;كنت:</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&nbsp;</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">تعاني&nbsp;من&nbsp;حساسية&nbsp;(حساسية&nbsp;مفرطة)&nbsp;ل&nbsp;سيبروفلوكساسين&nbsp;أو&nbsp;أي&nbsp;من&nbsp;المكونات&nbsp;الأخرى&nbsp;ل&nbsp;سيبروفارم&nbsp; أقراص&nbsp;(المذكورة&nbsp;في&nbsp;البند&nbsp;6:&nbsp;للمزيدمن</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">المعلومات).</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">.&nbsp;تستخدم&nbsp;تيزانيدين&nbsp;(انظر&nbsp;البند&nbsp;2:&nbsp;تناول&nbsp;أدوية&nbsp;أخرى).</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">اتخذ&nbsp;احتياطات&nbsp;خاصة&nbsp;مع&nbsp;سيبروفارم أقراص:</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">قبل&nbsp;استخدام&nbsp;سيبروفارم&nbsp;أقراص،&nbsp;أخبر&nbsp;طبيبك&nbsp;:</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">-&nbsp;إذا&nbsp;كنت&nbsp;تعاني&nbsp;من&nbsp;&laquo;نوبات&raquo;&nbsp;أو&nbsp;صرع&nbsp;أو&nbsp;أي&nbsp;ظرف&nbsp;من&nbsp;الظروف&nbsp;العصبية&nbsp;الأخرى.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">-&nbsp;إذا&nbsp;عانيت&nbsp;من&nbsp;أي&nbsp;مشاكل&nbsp;في&nbsp;الكلى&nbsp;وذلك&nbsp;لأن&nbsp;علاجك&nbsp;قد&nbsp;يحتاج&nbsp;إلى&nbsp;تعديل.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">-&nbsp;إذا&nbsp;كان&nbsp;لديك&nbsp;تاريخ&nbsp;من&nbsp;المشاكل&nbsp;في&nbsp;الأوتار&nbsp;خلال&nbsp;فترة&nbsp;علاج&nbsp;سابقة&nbsp;مع&nbsp;المضادات&nbsp;الحيوية&nbsp;مثل&nbsp;سيبروفارم</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">-&nbsp;إذا&nbsp;لديك&nbsp;الوهن&nbsp;العضلي&nbsp;الوبيل&nbsp;(نوع&nbsp;من&nbsp;ضعف&nbsp;العضلات).</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">-&nbsp;إذا&nbsp;لديك&nbsp;تاريخ&nbsp;من&nbsp;عدم&nbsp;انتظام&nbsp;ضربات&nbsp;القلب&nbsp;(عدم&nbsp;انتظام&nbsp;ضربات&nbsp;القلب).</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">-&nbsp;إذا&nbsp;تم&nbsp;تشخيص&nbsp;إصابتك&nbsp;بتضخم&nbsp;أو&nbsp;(انتفاخ&nbsp;الأوعية&nbsp;الدموية&nbsp;الكبيرة&nbsp;(تنفخ&nbsp;الشريان&nbsp;الأورطي&nbsp;أو&nbsp;تنفخ&nbsp;الأوعية&nbsp;الدموية&nbsp;الكبيرة&nbsp;الطرفية).</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">-&nbsp;إذا&nbsp;عانيت&nbsp;سابقا&nbsp;من&nbsp;نوبات&nbsp;تمزق&nbsp;الشريان&nbsp;الأورطي&nbsp;(تمزق&nbsp;في&nbsp;جدار&nbsp;الشريان&nbsp;الأورطي).</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">-&nbsp;إذا&nbsp;كان&nbsp;لديك&nbsp;تاريخ&nbsp;عائلي&nbsp;من&nbsp;تنفخ&nbsp;الشريان&nbsp;الأورطي&nbsp;أو&nbsp;تمزق&nbsp;الشريان&nbsp;الأورطي&nbsp;أو&nbsp;عوامل&nbsp;خطورة&nbsp;أخرى&nbsp;أو&nbsp;ظروف&nbsp;مهيئة&nbsp;لذلك&nbsp;(مثل</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">اضطربات&nbsp;الأنسجة&nbsp;الضامة&nbsp;مثل&nbsp;متلازمة&nbsp;مارفان،&nbsp;أو&nbsp;متلازمة&nbsp;إهلرز&nbsp;-&nbsp;دانلوس&nbsp;(جلد&nbsp;مفرط&nbsp;المرونة)،&nbsp;أو&nbsp;اضطربات&nbsp;الأوعية&nbsp;الدموية&nbsp;مثل</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">التهاب&nbsp;الشريان&nbsp;تاکایاسو&nbsp;(التهاب&nbsp;الأورطي&nbsp;غير&nbsp;المحدد)،&nbsp;التهاب&nbsp;الشريان&nbsp;ذو&nbsp;الخلايا&nbsp;العملاقة،&nbsp;مرض&nbsp;بهجت،&nbsp;ارتفاع&nbsp;ضغط&nbsp;الدم،&nbsp;أو&nbsp;تصلب</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">شرايين&nbsp;المعروف).</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">إذا&nbsp;شعرت&nbsp;بألم&nbsp;مفاجئ&nbsp;و&nbsp;شديد&nbsp;في&nbsp;البطن&nbsp;،&nbsp;الصدر&nbsp;أو&nbsp;الظهر،&nbsp;اذهب&nbsp;الى&nbsp;الطوارئ&nbsp;مباشرة&nbsp;.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">مشاكل&nbsp;في&nbsp;القلب</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&bull;&nbsp;يجب&nbsp;أخذ&nbsp;الحذر&nbsp;عند&nbsp;استخدام&nbsp;هذا&nbsp;النوع&nbsp;من&nbsp;الأدوية،&nbsp;و&nbsp;إذا&nbsp;ولدت&nbsp;مع&nbsp;أو&nbsp;لديك&nbsp;تاريخ&nbsp;عائلي&nbsp;من&nbsp;فترات&nbsp;QT&nbsp;الممتدة&nbsp;(تظهر&nbsp;في&nbsp;تخطيط&nbsp;القلب،والتسجيل</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">الكهربائي&nbsp;للقلب)،&nbsp;تعاني&nbsp;من&nbsp;اختلال&nbsp;الأملاح&nbsp;في&nbsp;الدم&nbsp;(خاصة&nbsp;انخفاض&nbsp;مستوى&nbsp;البوتاسيوم&nbsp;أو&nbsp;المغنيسيوم&nbsp;في&nbsp;الدم)،&nbsp;تعاني&nbsp;من&nbsp;انخفاضشديد&nbsp;في&nbsp;ضربات</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">القلب&nbsp;(وتسسی&nbsp;(بطء&nbsp;ضربات&nbsp;القلب&raquo;)،&nbsp;تعاني&nbsp;من&nbsp;قلب&nbsp;ضعيف&nbsp;(قصور&nbsp;القلب)،&nbsp;عانيت&nbsp;سابقا&nbsp;من&nbsp;أزمة&nbsp;قلبية&nbsp;(احتشاء&nbsp;عضلة&nbsp;القلب)،&nbsp;كنتأنثى&nbsp;أو&nbsp;من&nbsp;كبار</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">السن&nbsp;أو&nbsp;كنت&nbsp;تأخذ&nbsp;أدوية&nbsp;أخرى&nbsp;تنتج&nbsp;عنها&nbsp;تغيرات&nbsp;غير&nbsp;طبيعية&nbsp;في&nbsp;تخطيط&nbsp;القلب&nbsp;غير&nbsp;طبيعية&nbsp;(انظر&nbsp;البند&nbsp;&laquo;تناول&nbsp;أدوية&nbsp;أخرى&raquo;).</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">الآثار&nbsp;الجانبية&nbsp;النفسية:</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">ارتبط&nbsp;استعمال&nbsp;الأدوية&nbsp;من&nbsp;مجموعة&nbsp;فلوروكوينولون،&nbsp;بما&nbsp;فيها&nbsp;سيبروفارم&nbsp;بزيادة&nbsp;خطورة&nbsp;حدوث&nbsp;الأثار&nbsp;الجانبية&nbsp;النفسية&nbsp;و&nbsp;التي&nbsp;تشمل:&nbsp;الذهانالسام،</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">التفاعلات&nbsp;الذهانية&nbsp;التي&nbsp;تتطور&nbsp;إلى&nbsp;أفكار&nbsp;انتحارية،&nbsp;هلوسات،&nbsp;أو&nbsp;جنون&nbsp;العظمة.&nbsp;الاكتئاب،&nbsp;أو&nbsp;السلوك&nbsp;المضر&nbsp;بالنفس&nbsp;مثل&nbsp;محاولة&nbsp;الانتحار&nbsp;أوالإقدام&nbsp;عليه،</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">القلق&nbsp;أو&nbsp;هياج&nbsp;أو&nbsp;العصبية،&nbsp;الارتباك،&nbsp;و&nbsp;الهذيان،&nbsp;توهان&nbsp;أو&nbsp;اضطرابات&nbsp;الانتياد،&nbsp;الأرق&nbsp;أو&nbsp;الكوابيس،&nbsp;ضعف&nbsp;الذاكرة.&nbsp;قد&nbsp;تحدث&nbsp;هذه&nbsp;الآثارالجانبية&nbsp;بعد</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">عة&nbsp;لذلك</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&nbsp;</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">ينصح&nbsp;الذين&nbsp;يتناولون&nbsp;سيبروفارم&nbsp;بإبلاغ&nbsp;مسؤول&nbsp;الرعاية&nbsp;الصحية&nbsp;فورا&nbsp;إذا&nbsp;حدثت&nbsp;هذه&nbsp;الآثار&nbsp;الجانبية،&nbsp;توقف&nbsp;عن&nbsp;استعمال</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">الدواء،&nbsp;و&nbsp;ابدأ&nbsp;اجراءات&nbsp;رعاية&nbsp;مناسبة</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">تمزق&nbsp;الوتر،&nbsp;الاعتلال&nbsp;العصبي&nbsp;الطرفي،&nbsp;واثار&nbsp;جانبية&nbsp;مرتبطة&nbsp;بالجهاز&nbsp;العصبي&nbsp;المركزي:</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">ارتبط&nbsp;استعمال&nbsp;الأدوية&nbsp;من&nbsp;مجموعة&nbsp;فلوروكوينولون،&nbsp;بما&nbsp;فيها&nbsp;سيبروفارم&nbsp;بحدوث&nbsp;آثار&nbsp;جانبية&nbsp;خطرة&nbsp;من&nbsp;المحتمل&nbsp;أن&nbsp;لا&nbsp;تعود&nbsp;إلى&nbsp;حالتها&nbsp;الطبيعيةبعد</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">التوقف&nbsp;عن&nbsp;استعمال&nbsp;الدواء&nbsp;و&nbsp;عجز&nbsp;في&nbsp;أجهزة&nbsp;الجسم&nbsp;المختلفة&nbsp;التي&nbsp;قد&nbsp;تحدث&nbsp;معها&nbsp;عند&nbsp;نفس&nbsp;المريض.&nbsp;نصن&nbsp;الأثار&nbsp;الجانبية&nbsp;الشائعة&nbsp;التي&nbsp;تماحطها</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">التهاب&nbsp;الأوتار&nbsp;،&nbsp;تمزق&nbsp;الأوتار&nbsp;،&nbsp;ألم&nbsp;مفصلي،&nbsp;ألم&nbsp;عضلي،&nbsp;اعتلال&nbsp;عصبي&nbsp;طرفي،&nbsp;و&nbsp;آثار&nbsp;جانبية&nbsp;مرتبطة&nbsp;بالجهاز&nbsp;العصبي&nbsp;المركزي&nbsp;الهلوسة،القلق،</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">الاكتئاب،&nbsp;الأرق،&nbsp;صداع&nbsp;حاد،&nbsp;والارتباك).&nbsp;قد&nbsp;تحدث&nbsp;هذه&nbsp;الأثار&nbsp;خلال&nbsp;ساعات&nbsp;إلى&nbsp;أسابيع&nbsp;بعد&nbsp;بدء&nbsp;استعمال&nbsp;سيبروفارم&nbsp;عانيالمرضى&nbsp;من&nbsp;جميعالأعمار</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">أو&nbsp;الذين&nbsp;لم&nbsp;يعانوا&nbsp;من&nbsp;عوامل&nbsp;خطورة&nbsp;مسبقة&nbsp;من&nbsp;هذه&nbsp;الآثار&nbsp;الجانبية</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&nbsp;</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">توقف&nbsp;عن&nbsp;استعمال&nbsp;سيبروفارم&nbsp;فورا&nbsp;بعد&nbsp;أول&nbsp;علامة&nbsp;أو&nbsp;عرض&nbsp;لأي&nbsp;من&nbsp;الآثار&nbsp;الجانبية&nbsp;الخطيرة.&nbsp;بالإضافة&nbsp;إلى&nbsp;ذلك&nbsp;يجب&nbsp;تجنب&nbsp;استعمال&nbsp;الأدوية</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">من&nbsp;مجموعة&nbsp;فلوروكوينولون،&nbsp;بما&nbsp;فيها&nbsp;سيبروفارم&nbsp;للمرضى&nbsp;الذين&nbsp;عانوا&nbsp;من&nbsp;أي&nbsp;من&nbsp;هذه&nbsp;الآثار&nbsp;الجانبية&nbsp;المختلفة&nbsp;باستعمال&nbsp;الأدوية&nbsp;من&nbsp;مجموععة</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">فلوروكوينولون.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">تنفخ&nbsp;الشريان&nbsp;الأورطي:</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">أخبر&nbsp;طبيبك&nbsp;قبل&nbsp;وصف&nbsp;أحد&nbsp;المضادات&nbsp;الحيوية&nbsp;لك،&nbsp;إذا&nbsp;عانيت&nbsp;في&nbsp;السابق&nbsp;من&nbsp;تنفخ&nbsp;الشريان&nbsp;الأورطي،&nbsp;انسداد&nbsp;أو&nbsp;تصلب&nbsp;الشرايين،&nbsp;ارتفاعضغط&nbsp;الدم،&nbsp;أو</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">حالات&nbsp;وراثية&nbsp;مثل&nbsp;متلازمة&nbsp;مارفان&nbsp;(خلل&nbsp;في&nbsp;النسيج&nbsp;الرابط)&nbsp;أو&nbsp;متلازمة&nbsp;إهلرز&nbsp;دانلوس&nbsp;(فرط&nbsp;مرونة&nbsp;الجلد).</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">كن&nbsp;على&nbsp;دراية&nbsp;بأن&nbsp;أعراض&nbsp;تنفخ&nbsp;الشريان&nbsp;الأورطي&nbsp;لا&nbsp;تظهر&nbsp;إلى&nbsp;أن&nbsp;يصبح&nbsp;التنفخ&nbsp;كبير&nbsp;أو&nbsp;يحدث&nbsp;انفجار&nbsp;في&nbsp;الشريان،&nbsp;لذلك&nbsp;يجب&nbsp;إبلاغ&nbsp;طبيبكفورا&nbsp;عن&nbsp;أي</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">آثار&nbsp;جانبية&nbsp;غير&nbsp;معتادة&nbsp;ظهرت&nbsp;عند&nbsp;بدء&nbsp;تناول&nbsp;الأدوية&nbsp;من&nbsp;مجموعة&nbsp;فلوكوينولون</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">اطلب&nbsp;الرعاية&nbsp;الطبية&nbsp;فورا&nbsp;وذلك&nbsp;بالذهاب&nbsp;إلى&nbsp;الطوارئ&nbsp;إذا&nbsp;عانيت&nbsp;من&nbsp;ألم&nbsp;مفاجيء،&nbsp;حاد&nbsp;و&nbsp;مستمر&nbsp;في&nbsp;المعدة،&nbsp;الصدر&nbsp;أو&nbsp;الظهر.&nbsp;لا&nbsp;تتوقف&nbsp;عناستعمال</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">المضادات&nbsp;الحيوية&nbsp;قبل&nbsp;التحدث&nbsp;مع&nbsp;طبيبك&nbsp;أولا.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">اضطربات&nbsp;مستوى&nbsp;الجلوكوز&nbsp;بالدم:</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">ارتبط&nbsp;استعمال&nbsp;الأدوية&nbsp;من&nbsp;مجموعة&nbsp;فلوروكوينولون،&nbsp;بما&nbsp;فيها&nbsp;سيبروفارم&nbsp;بحدوث&nbsp;اضطرابات&nbsp;في&nbsp;مستوى&nbsp;الجلوكوز&nbsp;في&nbsp;الدم،&nbsp;والتي&nbsp;تشملارتفاع</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">مستوى&nbsp;سكر&nbsp;الدم&nbsp;العرضي&nbsp;و&nbsp;انخفاض&nbsp;مستوى&nbsp;سكر&nbsp;الدم&nbsp;العرضي،&nbsp;عادة&nbsp;يحدث&nbsp;عند&nbsp;المرضى&nbsp;الذين&nbsp;يعانون&nbsp;من&nbsp;داء&nbsp;السكري&nbsp;و&nbsp;الذينيتناولون&nbsp;العلاج</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">بالتزامن&nbsp;مع&nbsp;عوامل&nbsp;لتخفيض&nbsp;مستوى&nbsp;سكر&nbsp;الدم&nbsp;عن&nbsp;طريق&nbsp;الفم&nbsp;(مثل&nbsp;جليبيوريد)&nbsp;أو&nbsp;مع&nbsp;الأنسولين.&nbsp;لذا&nbsp;ينصح&nbsp;بمراقبة&nbsp;جيدة&nbsp;لمستوى&nbsp;سكر&nbsp;الدمعند&nbsp;هؤلاء</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">المرضى.&nbsp;سجلت&nbsp;حالات&nbsp;حادة&nbsp;من&nbsp;انخفاض&nbsp;مستوى&nbsp;سكر&nbsp;الدم&nbsp;الذي&nbsp;يؤدي&nbsp;إلى&nbsp;غيبوبة&nbsp;أو&nbsp;الموت.&nbsp;إذا&nbsp;كان&nbsp;المريض&nbsp;يتعالج&nbsp;باستعمال&nbsp;سيبروفارمو&nbsp;عانی</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">من&nbsp;انخفاض&nbsp;مستوى&nbsp;السكر&nbsp;في&nbsp;الدم&nbsp;يجب&nbsp;التوقف&nbsp;عن&nbsp;استعمال&nbsp;سيبروفارم&nbsp;و&nbsp;بدء&nbsp;استعمال&nbsp;العلاج&nbsp;المناسب&nbsp;فورا.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">بسيب&nbsp;الآثار&nbsp;الجانبية&nbsp;الخطيرة&nbsp;المصاحبة&nbsp;للأدوية&nbsp;من&nbsp;مجموعة&nbsp;فلوروكوينولون&nbsp;يقتصر&nbsp;استعمالها&nbsp;للمرضى&nbsp;الذين&nbsp;لا&nbsp;يوجد&nbsp;لديهم&nbsp;خيارات&nbsp;علاجيةبديلة</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">أخرى&nbsp;لدواعي&nbsp;الاستعمال&nbsp;التالية</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">تفاقم&nbsp;بكتيري&nbsp;حاد&nbsp;في&nbsp;حالة&nbsp;التهاب&nbsp;القصبات&nbsp;الهوائية</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">التهاب&nbsp;الجهاز&nbsp;البولي&nbsp;غير&nbsp;المعقد.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">:&nbsp;التهاب&nbsp;بكتيري&nbsp;حاد&nbsp;في&nbsp;جيوب&nbsp;الأنفية</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">العلاج&nbsp;بعض&nbsp;التهابات&nbsp;المسالك&nbsp;التناسلية،&nbsp;يمكن&nbsp;أن&nbsp;يصف&nbsp;لك&nbsp;طبيبك&nbsp;مضادات&nbsp;حيوية&nbsp;أخرى&nbsp;بالإضافة&nbsp;إلى&nbsp;سيبروفارم.&nbsp;إذا&nbsp;لم&nbsp;تلاحظ&nbsp;أيتحسن&nbsp;في&nbsp;الأعراض</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">بعد&nbsp;3&nbsp;أيام&nbsp;من&nbsp;العلاج،&nbsp;يرجى&nbsp;مراجعة&nbsp;طبيبك.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">راجع&nbsp;طبيبك&nbsp;على&nbsp;الفور،&nbsp;إذا&nbsp;عانيت&nbsp;من&nbsp;أي&nbsp;مما&nbsp;يلي&nbsp;أثناء&nbsp;استخدامك&nbsp;ل&nbsp;سيبروفارم&quot;&nbsp;طبيبك&nbsp;سوف&nbsp;يقرر&nbsp;ما&nbsp;إذا&nbsp;كان&nbsp;العلاج&nbsp;باستخدامسيبروفارما&nbsp;يحتاج&nbsp;إلى&nbsp;وقفه</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">رد&nbsp;فعل&nbsp;تحسسي&nbsp;شديد&nbsp;و&nbsp;مفاجئ&nbsp;(وهو&nbsp;رد&nbsp;فعل&nbsp;الحساسية&nbsp;/&nbsp;الصدمة،&nbsp;وذمة&nbsp;وعائية)&nbsp;حتى&nbsp;مع&nbsp;الجرعة&nbsp;الأولى،&nbsp;هناك&nbsp;فرصة&nbsp;صغيرة&nbsp;بأن&nbsp;تواجهردود&nbsp;فعل</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">تحسسية&nbsp;حادة&nbsp;تتضمن&nbsp;الأعراض&nbsp;التالية:&nbsp;ضيق&nbsp;في&nbsp;الصدر،&nbsp;الشعور&nbsp;بالدوار&nbsp;،&nbsp;الشعور&nbsp;بالإعياء&nbsp;أو&nbsp;الشحوب،&nbsp;أو&nbsp;الإصابة&nbsp;بالدوار&nbsp;عند&nbsp;الوقوف.&nbsp;إذا&nbsp;عانيت&nbsp;من</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">ذلك،&nbsp;توقف&nbsp;عن&nbsp;تناول&nbsp;أقراص&nbsp;سيبروفارم&nbsp;واتصل&nbsp;بطبيبك&nbsp;على&nbsp;الفور.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">.&nbsp;ألم&nbsp;وتورم&nbsp;في&nbsp;المفاصل&nbsp;والأوتار&nbsp;قد&nbsp;يحدث&nbsp;في&nbsp;بعض&nbsp;الأحيان،&nbsp;خاصة&nbsp;إذا&nbsp;كنت&nbsp;من&nbsp;كبار&nbsp;السن&nbsp;ويجري&nbsp;عازحك&nbsp;أيضا&nbsp;بالستيرويدات&nbsp;القشرية.&nbsp;قد&nbsp;يحدث</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">التهاب&nbsp;وتمزق&nbsp;الأوتار&nbsp;حتى&nbsp;خلال&nbsp;ال&nbsp;48&nbsp;ساعة&nbsp;الأولى&nbsp;من&nbsp;العلاج&nbsp;أو&nbsp;ما&nbsp;يصل&nbsp;إلى&nbsp;عدة&nbsp;أشهر&nbsp;بعد&nbsp;التوقف&nbsp;عن&nbsp;العلاج&nbsp;ب&nbsp;سيبروفارم&nbsp;أقراص.&nbsp;فيأول</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">بادرة&nbsp;لأي&nbsp;ألم&nbsp;أو&nbsp;التهاب&nbsp;عليك&nbsp;التوقف&nbsp;عن&nbsp;تناول&nbsp;سيبروفارمة&nbsp;أقراص&nbsp;و&nbsp;أرح&nbsp;المنطقة&nbsp;المؤلمة.&nbsp;تجنب&nbsp;أي&nbsp;ممارسة&nbsp;أو&nbsp;حركة&nbsp;لا&nbsp;داعي&nbsp;لها،&nbsp;لأن&nbsp;ذلك&nbsp;قد</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">يزيد&nbsp;من&nbsp;خطر&nbsp;تمزق&nbsp;الوتر</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">:&nbsp;إذا&nbsp;كنت&nbsp;تعاني&nbsp;من&nbsp;الصرع&nbsp;أو&nbsp;حالات&nbsp;عصبية&nbsp;أخرى&nbsp;مثل&nbsp;نقص&nbsp;التروية&nbsp;الدماغية&nbsp;أو&nbsp;السكتة&nbsp;الدماغية،&nbsp;قد&nbsp;تواجه&nbsp;الآثار&nbsp;الجانبية&nbsp;المرتبطة&nbsp;معالجهاز</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">العصبي&nbsp;المركزي.&nbsp;إذا&nbsp;حدث&nbsp;هذا،&nbsp;توقف&nbsp;عن&nbsp;تناول&nbsp;سيبروفارم&nbsp;أقراص&nbsp;و&nbsp;اتصل&nbsp;بطبك&nbsp;على&nbsp;الفور.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">،&nbsp;قد&nbsp;تواجه&nbsp;ردود&nbsp;فعل&nbsp;نفسية&nbsp;في&nbsp;أول&nbsp;مرة&nbsp;تتناول&nbsp;فيها&nbsp;سيبروفارما&nbsp;أقراص.&nbsp;إذا&nbsp;كنت&nbsp;تعاني&nbsp;من&nbsp;الاكتئاب&nbsp;أو&nbsp;الذهان،&nbsp;قد&nbsp;تسوء&nbsp;أعراضك&nbsp;أثناءالعاج&nbsp;ب</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">سيبروفارم أفراد</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">في&nbsp;حالات&nbsp;نادرة،&nbsp;يمكن&nbsp;للاكتئاب&nbsp;أو&nbsp;الذهان&nbsp;أن&nbsp;يتطور&nbsp;إلى&nbsp;أفكار&nbsp;انتحارية،&nbsp;محاولات&nbsp;انتحار&nbsp;أو&nbsp;الانتحار&nbsp;الكامل.&nbsp;إذا&nbsp;حدث&nbsp;هذا،&nbsp;توقف&nbsp;عنتناول&nbsp;سيبروفارم&nbsp;أقراص&nbsp;واتصل&nbsp;بطبيبك&nbsp;على&nbsp;الفور.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">.&nbsp;قد&nbsp;تعاني&nbsp;من&nbsp;أعراض&nbsp;الاعتلال&nbsp;العصبي&nbsp;مثل&nbsp;الألم،&nbsp;حرق،&nbsp;وخز،&nbsp;خدران&nbsp;و&nbsp;/&nbsp;أو&nbsp;ضعف.&nbsp;إذا&nbsp;حدث&nbsp;هذا،&nbsp;توقف&nbsp;عن&nbsp;تناول&nbsp;سيبروفارمة&nbsp;أقراصواتصل</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">بطبيبك&nbsp;على&nbsp;الفور.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&bull;&nbsp;قد&nbsp;تعاني&nbsp;من&nbsp;الإسهال&nbsp;أثناء&nbsp;استخدامك&nbsp;للمضادات&nbsp;الحيوية،&nbsp;بما&nbsp;في&nbsp;ذلك&nbsp;سيبروفارم&nbsp;أقراص،&nbsp;أو&nbsp;حتى&nbsp;بعد&nbsp;عدة&nbsp;أسابيع&nbsp;من&nbsp;التوقف&nbsp;عناستخدامهم.&nbsp;إذا&nbsp;اشتد</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">الاسهال&nbsp;أو&nbsp;استمر&nbsp;طويلا&nbsp;أو&nbsp;لاحظت&nbsp;أن&nbsp;البراز&nbsp;يحتوي&nbsp;على&nbsp;دم&nbsp;أو&nbsp;مخاط&nbsp;توقف&nbsp;عن&nbsp;تناول&nbsp;سيبروفارم&nbsp;أقراص&nbsp;على&nbsp;الفور،&nbsp;حيث&nbsp;أنه&nbsp;قد&nbsp;يهددحياتك.&nbsp;لا</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">تأخذ&nbsp;الأدوية&nbsp;التي&nbsp;توقف&nbsp;أو&nbsp;تبطء&nbsp;حركة&nbsp;الأمعاء&nbsp;وراجع&nbsp;طبيبك.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&bull;&nbsp;أخبر&nbsp;الطبيب&nbsp;أو&nbsp;موظفين&nbsp;المختبر&nbsp;باستخدامك&nbsp;ل&nbsp;سيبروفارم&nbsp;أقراص&nbsp;إذا&nbsp;كنت&nbsp;ستقوم&nbsp;بتحليل&nbsp;دم&nbsp;أو&nbsp;بول</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">.&nbsp;إذا&nbsp;كنت&nbsp;تعاني&nbsp;من&nbsp;مشاكل&nbsp;في&nbsp;الكلى،&nbsp;أخبر&nbsp;الطبيب&nbsp;لأن&nbsp;الجرعة&nbsp;قد&nbsp;تحتاج&nbsp;إلى&nbsp;تعديل</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">.&nbsp;قد&nbsp;يتسبب&nbsp;سيبروفارم&nbsp;أقراص&nbsp;بتلف&nbsp;الكيد.&nbsp;إذا&nbsp;لاحظت&nbsp;أي&nbsp;أعراض&nbsp;مثل&nbsp;فقدان&nbsp;الشهية،&nbsp;واليرقان&nbsp;(اصفرار&nbsp;الجلد)&nbsp;و&nbsp;لون&nbsp;البول&nbsp;الداكن&nbsp;والحكة،أو&nbsp;الألم</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">في&nbsp;المعدة،&nbsp;توقف&nbsp;عن&nbsp;تناول&nbsp;سيبروفارم&nbsp;أقراص&nbsp;وراجع&nbsp;طبيبك&nbsp;على&nbsp;الفور.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">و&nbsp;قد&nbsp;يتسبب&nbsp;سيبروفارم&nbsp;أقراص&nbsp;بانخفاض&nbsp;عدد&nbsp;خلايا&nbsp;الدم&nbsp;البيضاء&nbsp;وانخفاض&nbsp;المقاومة&nbsp;للعدوى.&nbsp;إذا&nbsp;عانيت&nbsp;من&nbsp;عدوى&nbsp;مع&nbsp;أعراض&nbsp;مثل&nbsp;الحمىوتدهور</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">خطير&nbsp;في&nbsp;الحالة&nbsp;العامة،&nbsp;أو&nbsp;مع&nbsp;أعراض&nbsp;العدوى&nbsp;المحلية&nbsp;مثل&nbsp;التهاب&nbsp;الحلق&nbsp;/&nbsp;البلعوم&nbsp;/&nbsp;الفم&nbsp;أو&nbsp;مشاكل&nbsp;في&nbsp;المسالك&nbsp;البولية&nbsp;عليك&nbsp;أن&nbsp;تراجعطبيبك&nbsp;فورا.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">سيتم&nbsp;إجراء&nbsp;فحص&nbsp;للدم&nbsp;للتحقق&nbsp;من&nbsp;احتمالية&nbsp;انخفاض&nbsp;عدد&nbsp;خلايا&nbsp;الدم&nbsp;البيضاء&nbsp;(ندرة&nbsp;المحببات).&nbsp;و&nbsp;من&nbsp;المهم&nbsp;إبلاغ&nbsp;الطبيب&nbsp;عن&nbsp;الدواء.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&bull;&nbsp;أخبر&nbsp;طبيبك&nbsp;إذا&nbsp;كنت&nbsp;أو&nbsp;أحد&nbsp;أفراد&nbsp;عائلتك&nbsp;يعاني&nbsp;من&nbsp;نقص&nbsp;في&nbsp; G6PD glucose-6-phosphate dehydrogenase و&nbsp;ذلك&nbsp;لأنك&nbsp;قد&nbsp;تواجه خطر&nbsp;فقر&nbsp;الدم&nbsp;مع&nbsp;سيبروفارم</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">:&nbsp;يصبح&nbsp;جلدك&nbsp;أكثر&nbsp;حساسية&nbsp;الأشعة&nbsp;الشمس&nbsp;أو&nbsp;الأشعة&nbsp;فوق&nbsp;البنفسجية&nbsp;(0)&nbsp;أثناء&nbsp;استخدامك&nbsp;ل&nbsp;سيبروفارم*&nbsp;أقراص.&nbsp;تجنب&nbsp;التعرض&nbsp;لأشعةالشمس</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">القوية،&nbsp;أو&nbsp;الأشعة&nbsp;فوق&nbsp;البنفسجية&nbsp;الاصطناعية&nbsp;مثل&nbsp;أجهزة&nbsp;اسمرار&nbsp;البشرة</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">تناول&nbsp;أدوية&nbsp;أخرى</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">يرجى&nbsp;إخبار&nbsp;الطبيب&nbsp;أو&nbsp;الصيدلي&nbsp;إذا&nbsp;كنت&nbsp;تستخدم&nbsp;أو&nbsp;استخدمت&nbsp;مؤخرا&nbsp;أي&nbsp;أدوية&nbsp;أخرى،&nbsp;بما&nbsp;في&nbsp;ذلك&nbsp;الأدوية&nbsp;التي&nbsp;تم&nbsp;الحصول&nbsp;عليها&nbsp;دونوصفة&nbsp;طبية</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">عليك&nbsp;إخبار&nbsp;طبيبك&nbsp;إذا&nbsp;كنت&nbsp;تتناول&nbsp;أي&nbsp;أدوية&nbsp;أخرى&nbsp;يمكن&nbsp;أن&nbsp;تغير&nbsp;إيقاع&nbsp;قلبك:&nbsp;الأدوية&nbsp;التي&nbsp;تنتمي&nbsp;إلى&nbsp;مجموعة&nbsp;مضادات&nbsp;اضطراب&nbsp;نظامقلبك&nbsp;(مثل&nbsp;كينيدين،</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">هايدروكينيدين،&nbsp;ديسوبيراميد،&nbsp;اميودارون،&nbsp;السوتالول،&nbsp;دو&nbsp;فيتيليد،&nbsp;إبيوتبلید)،&nbsp;مضادات&nbsp;الاكتئاب&nbsp;ثلاثية&nbsp;الحلقات،&nbsp;وبعض&nbsp;مضادات&nbsp;الميكروباتالتي&nbsp;تنتمي&nbsp;إلى</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">مجموعة&nbsp;الماكروليدات)،&nbsp;وبعض&nbsp;مضادات&nbsp;الذهان.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">لا&nbsp;تأخذ&nbsp;سيبروفارم&nbsp;مع&nbsp;تيزانيدين،&nbsp;لأن&nbsp;ذلك&nbsp;قد&nbsp;يسبب&nbsp;أثار&nbsp;جانبية&nbsp;مثل&nbsp;انخفاض&nbsp;ضغط&nbsp;الدم&nbsp;و&nbsp;النعاس&nbsp;(انظر&nbsp;البند&nbsp;2: &laquo;لا&nbsp;تأخذه</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">سيبروفارم)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">ومن&nbsp;المعروف&nbsp;أن&nbsp;الأدوية&nbsp;التالية&nbsp;للتفاعل&nbsp;مع&nbsp;سيبروفارم&nbsp;داخل&nbsp;جسمك.&nbsp;استخدام&nbsp;سيبروفارم&nbsp;مع&nbsp;هذه&nbsp;الأدوية&nbsp;يؤثر&nbsp;على&nbsp;التأثير&nbsp;العلاجي&nbsp;لها.&nbsp;ويمكن</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">أيضا&nbsp;زيادة&nbsp;احتمالية&nbsp;الآثار&nbsp;جانبية</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">أخبر&nbsp;طبيبك&nbsp;إذا&nbsp;كنت&nbsp;تتناول:</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&bull;&nbsp;مشتقات&nbsp;الزنثين&nbsp;مثل&nbsp;الثيوفيلين&nbsp;(تستخدم&nbsp;لعلاج&nbsp;الربو)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">و&nbsp;الفينيتوين&nbsp;(يستخدم&nbsp;لعلاج&nbsp;الصرع)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">:&nbsp;أي&nbsp;أدوية&nbsp;مميعة&nbsp;للدم&nbsp;(المعروفة&nbsp;باسم&nbsp;مضادات&nbsp;التخثر&nbsp;مثل&nbsp;الوارفارين)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&bull;&nbsp;السيكلوسبورين&nbsp;(يستخدم&nbsp;لعلاج&nbsp;الصدفية،&nbsp;التهاب&nbsp;الجلد،&nbsp;التهاب&nbsp;المفاصل&nbsp;الروماتيزمي&nbsp;وزرع&nbsp;الأعضاء)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">:&nbsp;جلبينگاميد&nbsp;(دواء&nbsp;عن&nbsp;طريق&nbsp;الفم&nbsp;يستخدم&nbsp;لعلاج&nbsp;مرض&nbsp;السكري)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">و&nbsp;بالبروبليسيد&nbsp;(يستخدم&nbsp;لمنع&nbsp;النقرس)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">و&nbsp;ميتوكلوبراميد&nbsp;(يستخدم&nbsp;لعلاج&nbsp;الغثيان&nbsp;والقيء،&nbsp;الشعور&nbsp;بالإعياء&nbsp;و&nbsp;الشفيفة)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">:&nbsp;میكسبليتين&nbsp;(يستخدم&nbsp;لعلاج&nbsp;ضربات&nbsp;القلب&nbsp;غير&nbsp;طبيعية)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">و&nbsp;روببينيرول&nbsp;(يستخدم&nbsp;لعلاج&nbsp;مرض&nbsp;باركنسون)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">،&nbsp;الميثوتركسات&nbsp;(لأنواع&nbsp;معينة&nbsp;من&nbsp;السرطان،&nbsp;الصدفية،&nbsp;التهاب&nbsp;المفاصل&nbsp;الروماتويدي)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&bull;&nbsp;تیزانیدین&nbsp;(التشنج&nbsp;العضلات&nbsp;في&nbsp;التصلب&nbsp;المتعدد)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&bull;&nbsp;كلوزابين&nbsp;(أحد&nbsp;مضادات&nbsp;الذهان)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&bull;&nbsp;الأولانزابين&nbsp;(أحد&nbsp;مضادات&nbsp;الذهان)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&bull;&nbsp;الأدوية&nbsp;الأخرى&nbsp;التي&nbsp;يمكن&nbsp;أن&nbsp;تغير&nbsp;إيقاع&nbsp;قلبك:&nbsp;الأدوية&nbsp;التي&nbsp;تنتمي&nbsp;إلى&nbsp;مجموعة&nbsp;مضادات&nbsp;اضطراب&nbsp;نظام&nbsp;قلبك&nbsp;(مثل&nbsp;كينيدين،هايدروكينيدين،</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">ديسوبيراميد،&nbsp;اميودارون،&nbsp;السوتالول،&nbsp;دوفيتيليد،&nbsp;إبيوتيليد)،&nbsp;مضادات&nbsp;الاكتئاب&nbsp;ثلاثية&nbsp;الحلقات،&nbsp;وبعض&nbsp;مضادات&nbsp;الميكروبات&nbsp;التي&nbsp;تنتمي&nbsp;إلى مجموعة</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">الماكروليدات)،&nbsp;وبعض&nbsp;مضادات&nbsp;الذهان.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">قد&nbsp;يزيد&nbsp;سيبروفارم&quot;&nbsp;من&nbsp;مستويات&nbsp;الأدوية&nbsp;التالية&nbsp;في&nbsp;الدم</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">و&nbsp;البنتوكسيفيلين&nbsp;(الاضطرابات&nbsp;الدورة&nbsp;الدموية)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">الكافيين.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&bull;&nbsp;دولاكسيتين&nbsp;(للاكتئاب،&nbsp;تلف&nbsp;الأعصاب&nbsp;السكري&nbsp;أو&nbsp;سلس&nbsp;البول)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">-&nbsp;ليدوكائين&nbsp;(الأمراض&nbsp;القلب&nbsp;أو&nbsp;استخدام&nbsp;مخدر)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">.&nbsp;فياغرا&nbsp;(على&nbsp;سبيل&nbsp;المثال&nbsp;لعدم&nbsp;القدرة&nbsp;على&nbsp;الانتصاب)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">بعض&nbsp;الأدوية&nbsp;تقلل&nbsp;من&nbsp;تأثير&nbsp;سيبروفارم&quot;.&nbsp;أخبر&nbsp;طبيبك&nbsp;إذا&nbsp;كنت&nbsp;تستخدمها&nbsp;أو&nbsp;ترغب&nbsp;باستخدامها</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">:&nbsp;مضادات&nbsp;الحموضة.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">:&nbsp;أوميبرازول.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">.&nbsp;المكملات&nbsp;المعدنية</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&bull;&nbsp;سوكر&nbsp;الفيت</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&bull;&nbsp;سوق&nbsp;الفوسفات&nbsp;البوليمرية&nbsp;(مثل:&nbsp;سيفيليمير)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">الأدوية&nbsp;أو&nbsp;المكملات&nbsp;الغذائية&nbsp;التي&nbsp;تحتوي&nbsp;على&nbsp;الكالسيوم&nbsp;والمغنيسيوم&nbsp;والألمنيوم&nbsp;أو&nbsp;الحديد&nbsp;(أقراص&nbsp;دیدائوزین&nbsp;(العقاقير&nbsp;المضادة&nbsp;للفيروساتالمستخدمة&nbsp;في</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">علاج&nbsp;فيروس&nbsp;نقص&nbsp;المناعة&nbsp;البشرية))</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">إذا&nbsp;كانت&nbsp;هذه&nbsp;الأدوية&nbsp;ضرورية،&nbsp;تناول&nbsp;سيبروفارم&nbsp;نحو&nbsp;ساعتين&nbsp;قبل&nbsp;أو&nbsp;في&nbsp;موعد&nbsp;لا&nbsp;يسبق&nbsp;الأربع&nbsp;ساعات&nbsp;من&nbsp;بعدهم.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">تناول&nbsp;سيبروفارم&nbsp;أقراص&nbsp;مع&nbsp;الطعام&nbsp;والشراب</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">إذا&nbsp;كنت&nbsp;تتناول&nbsp;سيبروفارم&nbsp;خلال&nbsp;وجبات&nbsp;الطعام،&nbsp;أحرص&nbsp;على&nbsp;أن&nbsp;لا&nbsp;تأكل&nbsp;أو&nbsp;تشرب&nbsp;أي&nbsp;من&nbsp;منتجات&nbsp;الألبان&nbsp;(مثل&nbsp;الحليب&nbsp;أو&nbsp;اللبن)&nbsp;أوالمشروبات&nbsp;المضاف</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">إليها&nbsp;الكالسيوم.&nbsp;يمكن&nbsp;لهذه&nbsp;أن&nbsp;تؤثر&nbsp;على&nbsp;امتصاص&nbsp;سيبروفارم&nbsp;وبذلك&nbsp;يجب&nbsp;أن&nbsp;تأخذ&nbsp;الأقراص&nbsp;اسما&nbsp;قبل&nbsp;( 1&nbsp;إلى&nbsp;2&nbsp;ساعة)&nbsp;أو&nbsp;على&nbsp;الأقل&nbsp;بعد(4&nbsp;ساعات)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">من&nbsp;تناولك&nbsp;مثل&nbsp;هذه&nbsp;المنتجات</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">الحمل&nbsp;والرضاعة&nbsp;الطبيعية</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">يفضل&nbsp;تجنب&nbsp;استخدام&nbsp;سيبروفارم&nbsp;خلال&nbsp;فترة&nbsp;الحمل.&nbsp;أخبر&nbsp;طبيبك&nbsp;إذا&nbsp;كنت&nbsp;حامل&nbsp;أو&nbsp;تخططين&nbsp;للحمل</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">لا&nbsp;تأخذ&nbsp;أقراص&nbsp;سيبروفارم&nbsp;أثناء&nbsp;الرضاعة&nbsp;لأن&nbsp;سيبروفارم&nbsp;يتم&nbsp;إفرازه&nbsp;في&nbsp;حليب&nbsp;الثدي&nbsp;و&nbsp;يمكن&nbsp;أن&nbsp;يكون&nbsp;ضارة&nbsp;لطفلك.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&nbsp;</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">إسأل&nbsp;طبيبك&nbsp;أو&nbsp;الصيدلي&nbsp;للحصول&nbsp;على&nbsp;المشورة&nbsp;قبل&nbsp;استخدام&nbsp;أي&nbsp;دواء&nbsp;آخر.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">القيادة&nbsp;واستخدام&nbsp;الآلات</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">قد&nbsp;يجعلك&nbsp;سيبروفارم&nbsp;تشعر&nbsp;بأنك&nbsp;في&nbsp;حالة&nbsp;انتباه&nbsp;أقل.&nbsp;يمكن&nbsp;أن&nbsp;تصاب&nbsp;ببعض&nbsp;الأعراض&nbsp;الجانبية&nbsp;العصبية.&nbsp;ولذلك،&nbsp;تأكد&nbsp;من&nbsp;أنك&nbsp;من&nbsp;استجابتك ل&nbsp;سيبروفارم</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">قبل&nbsp;قيادة&nbsp;السيارة&nbsp;أو&nbsp;تشغيل&nbsp;الآلات.&nbsp;إذا&nbsp;كنت&nbsp;غير&nbsp;متأكد،&nbsp;راجع&nbsp;طبيبك</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">دائما&nbsp;تناول&nbsp;سيبروفارم&nbsp;أقراص&nbsp;تماما&nbsp;كما&nbsp;أخبرك&nbsp;طبيبك.&nbsp;راجع&nbsp;طبيبك&nbsp;أو&nbsp;الصيدلي&nbsp;إذا&nbsp;كنت&nbsp;غير&nbsp;متأكد</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">تناول&nbsp;الأقراص&nbsp;تماما&nbsp;كما&nbsp;أخبرك&nbsp;طبيبك.&nbsp;ينبغي&nbsp;دائما&nbsp;أن&nbsp;تؤخذ&nbsp;الأقراص&nbsp;مع&nbsp;الكثير&nbsp;من&nbsp;الماء،&nbsp;وهذا&nbsp;سوف&nbsp;يساعد&nbsp;على&nbsp;منع&nbsp;تشكيل&nbsp;بلوراتصغيرة&nbsp;في</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">البول&nbsp;(بيلة&nbsp;البلورات)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">يمكنك&nbsp;تناول&nbsp;الأقراص&nbsp;في&nbsp;أوقات&nbsp;الوجبات&nbsp;أو&nbsp;بين&nbsp;الوجبات.&nbsp;و&nbsp;أي&nbsp;كالسيوم&nbsp;تأخذه&nbsp;كجزء&nbsp;من&nbsp;الوجبة&nbsp;لا&nbsp;يؤثر&nbsp;تأثيرا&nbsp;خطيرا&nbsp;على&nbsp;الامتصاص.&nbsp;ومعذلك،&nbsp;لا&nbsp;تأخذ</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">أقراص&nbsp;سيبروفارم&nbsp;مع&nbsp;منتجات&nbsp;الألبان&nbsp;مثل&nbsp;الحليب&nbsp;أو&nbsp;اللبن&nbsp;أو&nbsp;مع&nbsp;عصائر&nbsp;الفاكهة&nbsp;المدعمة&nbsp;(مثل&nbsp;عصير&nbsp;البرتقال&nbsp;المدعم&nbsp;بالكالسيوم)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">أخبر&nbsp;طبيبك&nbsp;إذا&nbsp;كنت&nbsp;تعاني&nbsp;من&nbsp;مشاكل&nbsp;في&nbsp;الكلى&nbsp;لأنك&nbsp;قد&nbsp;تحتاج&nbsp;لتعديل&nbsp;الجرعة</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">سوف&nbsp;تعتمد عتك&nbsp;على&nbsp;نوع&nbsp;وشدة&nbsp;العدوى،&nbsp;العمر،&nbsp;الوزن،&nbsp;وظائف&nbsp;الكلى&nbsp;طبيبك&nbsp;سوف&nbsp;يحدد&nbsp;أفضل&nbsp;جرعة&nbsp;لك.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">الكبار</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">الجرعة&nbsp;المعتادة&nbsp;للبالغين&nbsp;ما&nbsp;بين&nbsp;100 - 750&nbsp;ملغم&nbsp;مرتين&nbsp;يوميا&nbsp;في&nbsp;التهابات&nbsp;الجهاز&nbsp;التنفسي&nbsp;الجرعة&nbsp;المعتادة&nbsp;هي&nbsp;500 - 750&nbsp;ملغم&nbsp;مرتين&nbsp;يوميافي&nbsp;التهابات</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">المثانة&nbsp;والكلى،&nbsp;الجرعة&nbsp;المعتادة&nbsp;هي&nbsp;250 - 500&nbsp;ملغم&nbsp;مرتين&nbsp;يوميا&nbsp;في&nbsp;السيلان،&nbsp;الجرعة&nbsp;المعتادة&nbsp;هي&nbsp;250 - 500&nbsp;ملغم&nbsp;جرعة&nbsp;واحدة&nbsp;فيالالتهابات</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">المعدية&nbsp;المعوية،&nbsp;الجرعة&nbsp;المعتادة&nbsp;هي&nbsp;500&nbsp;ملغم&nbsp;مرتين&nbsp;يوميا&nbsp;في&nbsp;التهابات&nbsp;داخل&nbsp;البطن،&nbsp;و&nbsp;التهابات&nbsp;الجلد&nbsp;و&nbsp;التهابات&nbsp;الأنسجة&nbsp;الرخوة&nbsp;والعظاموالمفاصل،</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">وانخفاض&nbsp;العدلات&nbsp;(خلايا&nbsp;الدم&nbsp;البيضاء)&nbsp;،&nbsp;الجرعة&nbsp;المعتادة&nbsp;500 - 750&nbsp;ملغم&nbsp;مرتين&nbsp;يوميا&nbsp;في&nbsp;الالتهابات&nbsp;التي&nbsp;تسببها&nbsp;البكتيريا&nbsp;التيسريةالسحائية&nbsp;الجرعة</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">المعتادة&nbsp;هي&nbsp;500&nbsp;ملغم&nbsp;في&nbsp;جرعة&nbsp;واحدة.&nbsp;التعرض&nbsp;لاستنشاق&nbsp;الجمرة&nbsp;الخبيثة&nbsp;الجرعة&nbsp;المعتادة&nbsp;500&nbsp;ملغم&nbsp;مرتين&nbsp;يوميا۔</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">المرضى&nbsp;المسنين</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">طبيبك&nbsp;سوف&nbsp;يقرر&nbsp;الجرعة.&nbsp;قد&nbsp;تكون&nbsp;أقل&nbsp;من&nbsp;الجرعة&nbsp;المعتادة&nbsp;للبالغين&nbsp;تبعا&nbsp;لشدة&nbsp;الإصابة&nbsp;الخاصة&nbsp;بك&nbsp;و&nbsp;وظائف&nbsp;الكلى&nbsp;عندك</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">مشاكل&nbsp;في&nbsp;الكلى&nbsp;/&nbsp;الكبد</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">طبيبك&nbsp;سوف&nbsp;يقرر&nbsp;الجرعة&nbsp;اعتمادا&nbsp;على&nbsp;وظائف&nbsp;الكلى&nbsp;و&nbsp;الكبد،&nbsp;هناك&nbsp;حاجة&nbsp;إلى&nbsp;تعليمات&nbsp;خاصة&nbsp;للجرعات&nbsp;إذا&nbsp;كنت&nbsp;تقوم&nbsp;بغسيل&nbsp;كلى&nbsp;أوCAPD (الغسيل</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">البريتوني&nbsp;المستمر&nbsp;المتنقل)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">الأطفال&nbsp;والمراهقين</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">لا&nbsp;ينصح&nbsp;باستخدام&nbsp;أقراص&nbsp;سيبروفارم&nbsp;بشكل&nbsp;عام&nbsp;للأطفال.&nbsp;ولكن&nbsp;في&nbsp;بعض&nbsp;الحالات&nbsp;العلاج&nbsp;مع&nbsp;هذه&nbsp;الأقراص&nbsp;هو&nbsp;الأفضل&nbsp;وطبيبك&nbsp;قد&nbsp;يقررعلاج&nbsp;طفلك&nbsp;بهذا</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">الدواء&nbsp;خاصة&nbsp;بالنسبة&nbsp;للالتهابات&nbsp;المذكورة&nbsp;أدناه.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">التليف&nbsp;الكيسي&nbsp;الجرعة&nbsp;المعتادة&nbsp;هي&nbsp;حجز&nbsp;20&nbsp;ملغم&nbsp;كغم&nbsp;من&nbsp;وزن&nbsp;الجسم&nbsp;مرتين&nbsp;يوميا&nbsp;مع&nbsp;الجرعة&nbsp;اليومية&nbsp;القصوى&nbsp;750&nbsp;ملغم</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">التهابات&nbsp;المسالك&nbsp;البولية&nbsp;المعقدة&nbsp;و&nbsp;التهاب&nbsp;الحويضة&nbsp;و&nbsp;الكلية&nbsp;الجرعة&nbsp;المعتادة&nbsp;هي&nbsp;من&nbsp;10&nbsp;إلى&nbsp;20&nbsp;ملغم&nbsp;كغم&nbsp;من&nbsp;وزن&nbsp;الجسم&nbsp;مرتين&nbsp;يوميا&nbsp;بحدأقصى</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">50&nbsp;ملغم&nbsp;لكل&nbsp;جرعة</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">التعرض&nbsp;لاستنشاق&nbsp;الجمرة&nbsp;الخبيثة&nbsp;الجرعة&nbsp;المعتادة&nbsp;هي&nbsp;من&nbsp;10&nbsp;إلى&nbsp;15&nbsp;ملغم&nbsp;كغم&nbsp;من&nbsp;وزن&nbsp;الجسم&nbsp;مرتين&nbsp;يوميا&nbsp;بحد&nbsp;أقصى&nbsp;500&nbsp;ملغم&nbsp;لكلجرعة</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">إصابات&nbsp;خطيرة&nbsp;أخري&nbsp;الجرعة&nbsp;المعتادة&nbsp;هي&nbsp;حجز&nbsp;20&nbsp;ملغم&nbsp;كغم&nbsp;من&nbsp;وزن&nbsp;الجسم&nbsp;مرتين&nbsp;يوميا&nbsp;بحد&nbsp;أقصى&nbsp;50&nbsp;ملغم&nbsp;لكل&nbsp;مة</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">من&nbsp;المهم&nbsp;جدا&nbsp;أن&nbsp;تتبع&nbsp;تعليمات&nbsp;الطبيب&nbsp;بخصوص&nbsp;عدد&nbsp;أقراص&nbsp;سيپروفارم-&nbsp;كيفية&nbsp;أخذها&nbsp;و&nbsp;الفترة&nbsp;التي&nbsp;يجب&nbsp;أن&nbsp;تستمر&nbsp;فيها&nbsp;بتناول&nbsp;الأقراصالمدة&nbsp;الطبيعية</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">للعلاج&nbsp;ما&nbsp;بين&nbsp;5&nbsp;إلى&nbsp;21&nbsp;يوما&nbsp;(&nbsp;على&nbsp;الرغم&nbsp;أنها&nbsp;قد&nbsp;تكون&nbsp;أطول&nbsp;من&nbsp;ذلك)،&nbsp;تبعا&nbsp;لنوع&nbsp;و&nbsp;شدة&nbsp;الإصابة</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">إذا&nbsp;أخذت&nbsp;سيبروفارم أقراص&nbsp;أكثر&nbsp;مما&nbsp;يجب</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">إذا&nbsp;كنت&nbsp;أنت&nbsp;أو&nbsp;أي&nbsp;شخص&nbsp;آخر&nbsp;قد&nbsp;تناول&nbsp;العديد&nbsp;من&nbsp;هذه&nbsp;الأقراص&nbsp;معأ،&nbsp;أو&nbsp;تعتقد&nbsp;أن&nbsp;أي&nbsp;طفل&nbsp;تناول&nbsp;أي&nbsp;من&nbsp;هذه&nbsp;الأقراص،&nbsp;راجع&nbsp;طبيبك&nbsp;أوالصيدلي&nbsp;أو&nbsp;قسم</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">الطوارئ&nbsp;في&nbsp;المستشفى&nbsp;فورا.&nbsp;خذ&nbsp;الاقراص&nbsp;المتبقية&nbsp;معك،&nbsp;و&nbsp;علية&nbsp;الدواء&nbsp;والتشرة&nbsp;و&nbsp;بذلك&nbsp;يسهل&nbsp;التعرف&nbsp;على&nbsp;الأقراص</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">إذا&nbsp;نسيت&nbsp;أن&nbsp;تأخذ&nbsp;سيبروفارم أقراص</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">إذا&nbsp;نسيت&nbsp;أن&nbsp;تأخذ&nbsp;الجرعة،&nbsp;تناولها&nbsp;حالما&nbsp;تتذكر.&nbsp;إذا&nbsp;كان&nbsp;الوقت&nbsp;قريب&nbsp;لتناول&nbsp;الجرعة&nbsp;التالية،&nbsp;لا&nbsp;تأخذ&nbsp;الجرعة&nbsp;المنسية&nbsp;و&nbsp;ارجع&nbsp;على&nbsp;نظامكالسابق&nbsp;فقط&nbsp;لا</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">تأخذ&nbsp;عة&nbsp;مضاعفة&nbsp;لتعويض&nbsp;الجرعة&nbsp;المنسية.&nbsp;تأكد&nbsp;من&nbsp;إنهاء&nbsp;دورة&nbsp;العلاج&nbsp;بأكملها۔</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">إذا&nbsp;توقفت&nbsp;عن&nbsp;تناول&nbsp;سيبروفارم أقراص</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">من&nbsp;المهم&nbsp;إنهاء&nbsp;دورة&nbsp;العلاج&nbsp;كاملة&nbsp;حتى&nbsp;لو&nbsp;بدأت&nbsp;تشعر&nbsp;بتحسن&nbsp;بعد&nbsp;بضعة&nbsp;أيام.&nbsp;إذا&nbsp;توقفت&nbsp;عن&nbsp;تناول&nbsp;هذا&nbsp;الدواء&nbsp;قبل&nbsp;إنهاء&nbsp;العلاج&nbsp;قد&nbsp;لا&nbsp;تكونالعدوى&nbsp;قد</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">شفيت&nbsp;تماما&nbsp;وأعراضها&nbsp;قد&nbsp;تعود&nbsp;أو&nbsp;تزداد&nbsp;سوءا.&nbsp;بالإضافة&nbsp;إلى&nbsp;أنك&nbsp;قد&nbsp;تعاني&nbsp;من&nbsp;مقاومة&nbsp;للمضادات&nbsp;الحيوية.&nbsp;إذا&nbsp;كان&nbsp;لديك&nbsp;أي&nbsp;أسئلة&nbsp;أخرىعن&nbsp;استخدام&nbsp;هذا</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">الدواء،&nbsp;إسأل&nbsp;طبيبك&nbsp;أو&nbsp;الصيدلي.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">مثل&nbsp;باقي&nbsp;الأدوية&nbsp;قد&nbsp;يتسبب&nbsp;سيبروفلوكساسين&nbsp;بآثار&nbsp;جانبية،&nbsp;وإن&nbsp;لم&nbsp;يكن&nbsp;الجميع&nbsp;يعاني&nbsp;منها.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">حوالي&nbsp;5-14 %&nbsp;من&nbsp;المرضى&nbsp;يعانون&nbsp;من&nbsp;الآثار&nbsp;الجانبية&nbsp;والآثار&nbsp;الجانبية&nbsp;الأكثر&nbsp;شيوعا&nbsp;تشمل&nbsp;القناة&nbsp;الهضمية&nbsp;والجهاز&nbsp;العصبي</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">إذا&nbsp;عانيت&nbsp;من&nbsp;أي&nbsp;من&nbsp;الأعراض&nbsp;التالية&nbsp;بعد&nbsp;تناولك&nbsp;للاقراص&nbsp;بفترة&nbsp;قريبة،&nbsp;توقف&nbsp;ن&nbsp;تناولها&nbsp;وأخبر&nbsp;طبيبك&nbsp;فورا.&nbsp;هذا&nbsp;النوع&nbsp;من&nbsp;ردود&nbsp;الفعل&nbsp;نادر&nbsp;وقديعني</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">أنك&nbsp;تعاني&nbsp;من&nbsp;الحساسية&nbsp;للأقراص:</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&bull;&nbsp;الطفح&nbsp;الجلدي،&nbsp;الحكة،&nbsp;الطفح&nbsp;الجلدي&nbsp;العقدي،&nbsp;الحمی،&nbsp;بقع&nbsp;حمراء&nbsp;صغيرة&nbsp;على&nbsp;الجسم،&nbsp;زيادة&nbsp;الحساسية&nbsp;لأشعة&nbsp;الشمس&nbsp;أو&nbsp;ردود&nbsp;فعلنادرة&nbsp;جدا&nbsp;و</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">شديدة&nbsp;تصيب&nbsp;الجلد&nbsp;مثل&nbsp;يثور&nbsp;كبيرة&nbsp;مليئة&nbsp;بالسوائل،&nbsp;تقشير،&nbsp;قروح&nbsp;وتقرح.&nbsp;يمكن&nbsp;أن&nbsp;يحدث&nbsp;تقرح&nbsp;أيضا&nbsp;في&nbsp;الفم&nbsp;والحلق،&nbsp;وحول&nbsp;منطقة&nbsp;الشرج والأعضاء</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">التناسلية&nbsp;و&nbsp;على&nbsp;سطح&nbsp;العينين</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">:&nbsp;صفير&nbsp;مفاجئ&nbsp;أو&nbsp;ضيق&nbsp;في&nbsp;الصدر.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">و&nbsp;تورم&nbsp;الجفون&nbsp;والوجه&nbsp;و&nbsp;الشفاه&nbsp;أو&nbsp;الأوعية&nbsp;الدموية&nbsp;في&nbsp;الجلد.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">:&nbsp;غثيان&nbsp;وصداع</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">ينبغي&nbsp;أيضا&nbsp;إخبار&nbsp;الطبيب&nbsp;على&nbsp;الفور&nbsp;والتوقف&nbsp;عن&nbsp;تناول&nbsp;الأقراص&nbsp;إذا&nbsp;لاحظت:</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">.&nbsp;ألم&nbsp;أو&nbsp;التهاب&nbsp;في&nbsp;الأوتار.&nbsp;يحدث&nbsp;هذا&nbsp;التأثير&nbsp;في&nbsp;حالات&nbsp;معزولة&nbsp;إذا&nbsp;واجهت&nbsp;هذه&nbsp;الأعراض&nbsp;عليك&nbsp;التوقف&nbsp;عن&nbsp;تناول&nbsp;الأقراص،&nbsp;أرح&nbsp;العضو(الطرف)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">المصاب&nbsp;و&nbsp;راجع&nbsp;طبيبك&nbsp;فورا۔</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&bull;&nbsp;إسهال&nbsp;شديد&nbsp;مصاحب&nbsp;لنزيف&nbsp;أو&nbsp;مخاط.&nbsp;هذا&nbsp;التأثير&nbsp;يصيب&nbsp;أقل&nbsp;من&nbsp;واحد&nbsp;في&nbsp;الألف&nbsp;ولكن&nbsp;أكثر&nbsp;من&nbsp;واحد&nbsp;في&nbsp;العشرة&nbsp;آلاف&nbsp;شخص.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">:&nbsp;الشعور&nbsp;برغبة&nbsp;إيذاء&nbsp;نفسك&nbsp;جسدية&nbsp;و&nbsp;هذا&nbsp;يحدث&nbsp;فقط&nbsp;في&nbsp;حالات&nbsp;نادرة.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">الآثار&nbsp;الجانبية&nbsp;الأخرى&nbsp;المحتمل&nbsp;حدوثها،&nbsp;مدرجة&nbsp;أدناه</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">شائعة&nbsp;(تؤثر&nbsp;على&nbsp;1&nbsp;إلى&nbsp;10&nbsp;مستخدمين&nbsp;من&nbsp;أصل&nbsp;100&nbsp;مستخدم):</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">:&nbsp;الغثيان&nbsp;والإسهال.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&bull;&nbsp;آلام&nbsp;في&nbsp;المفاصل&nbsp;عند&nbsp;الأطفال.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">غير&nbsp;شائعة&nbsp;(تؤثر&nbsp;على&nbsp;1&nbsp;إلى&nbsp;10&nbsp;مستخدمين&nbsp;من&nbsp;أصل&nbsp;1000&nbsp;مستخدم):</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">:&nbsp;العدوى&nbsp;الفطرية&nbsp;المفرطة</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&bull;&nbsp;تركيز&nbsp;عال&nbsp;من&nbsp;الحمضات،&nbsp;وهو&nbsp;نوع&nbsp;من&nbsp;خلايا&nbsp;الدم&nbsp;البيضاء</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">و&nbsp;فقدان&nbsp;الشهية&nbsp;(فقدان&nbsp;الشهية)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&bull;&nbsp;فرط&nbsp;النشاط&nbsp;أو&nbsp;التحريض</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">:&nbsp;الصداع،&nbsp;الدوخة،&nbsp;مشاكل&nbsp;النوم،&nbsp;اضطرابات&nbsp;التذوق.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">التقيؤ&nbsp;وآلام&nbsp;البطن&nbsp;و&nbsp;مشاكل&nbsp;في&nbsp;الجهاز&nbsp;الهضمي&nbsp;مثل&nbsp;اضطراب&nbsp;المعدة&nbsp;(عسر&nbsp;الهضم&nbsp;حرقة)&nbsp;،&nbsp;أو&nbsp;الغازات</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">وزيادة&nbsp;كميات&nbsp;بعض&nbsp;المواد&nbsp;في&nbsp;الدم&nbsp;(الترانساسمیناسات&nbsp;و&nbsp;/&nbsp;أو&nbsp;البيليروبين)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">:&nbsp;طفح&nbsp;جلدي،&nbsp;حكة&nbsp;أو&nbsp;الطفح&nbsp;الجلدي&nbsp;العقدي.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">و&nbsp;ضعف&nbsp;وظائف&nbsp;الكلى</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">.&nbsp;آلام&nbsp;في&nbsp;العضلات&nbsp;والعظام،&nbsp;والشعور&nbsp;بالإعياء)&nbsp;الوهن)&nbsp;،&nbsp;أو&nbsp;الحمى</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">وزيادة&nbsp;الفوسفانير&nbsp;القلوبة&nbsp;في&nbsp;الدم&nbsp;(مادة&nbsp;معينة&nbsp;في&nbsp;الدم)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">نادرة&nbsp;(تؤثر&nbsp;على&nbsp;1&nbsp;إلى&nbsp;10&nbsp;مستخدمين&nbsp;من&nbsp;أصل&nbsp;10000&nbsp;مستخدم)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">و&nbsp;التهاب&nbsp;الأمعاء&nbsp;(التهاب&nbsp;القولون)&nbsp;مرتبط&nbsp;بتعاطي&nbsp;المضادات&nbsp;الحيوية&nbsp;(يمكن&nbsp;أن&nbsp;تكون&nbsp;قاتلة&nbsp;في&nbsp;حالات&nbsp;نادرة&nbsp;جدا) (انظر&nbsp;البند&nbsp;2&nbsp;اتخذاحتياطات&nbsp;خاصة</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">مع&nbsp;سيبروفارم&nbsp;أقراص)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">التغييرات&nbsp;في&nbsp;تعداد&nbsp;الدم&nbsp;(الكريات&nbsp;البيض،&nbsp;زيادة&nbsp;عدد&nbsp;الكريات&nbsp;البيضاء،&nbsp;قلة&nbsp;العدلات&nbsp;وفقر&nbsp;الدم)،&nbsp;زيادة&nbsp;أو&nbsp;نقصان&nbsp;كميات&nbsp;عامل&nbsp;التخثرالدموية</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&bull;&nbsp;الحساسية</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">،&nbsp;تورم&nbsp;(وذمة)،&nbsp;أو&nbsp;تورم&nbsp;سريع&nbsp;للجلد&nbsp;والأغشية&nbsp;المخاطية&nbsp;(وذمة&nbsp;وعائية)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&bull;&nbsp;زيادة&nbsp;السكر&nbsp;في&nbsp;الدم&nbsp;(ارتفاع&nbsp;سكر&nbsp;الدم)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&bull;&nbsp;تشویش،&nbsp;ارتباك،&nbsp;قلق،&nbsp;أحلام&nbsp;غريبة،&nbsp;اكتئاب&nbsp;(مما&nbsp;قد&nbsp;يؤدي&nbsp;إلى&nbsp;الأفكار&nbsp;الانتحارية،&nbsp;محاولات&nbsp;الانتحار&nbsp;أو&nbsp;الانتحار&nbsp;الكامل)،&nbsp;أو&nbsp;الهلوسة.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">:&nbsp;وخز،&nbsp;وحساسية&nbsp;غير&nbsp;عادية&nbsp;لمنبهات&nbsp;الحواس،&nbsp;انخفاض&nbsp;حساسية&nbsp;الجلد،&nbsp;ارتعاش،&nbsp;النوبات&nbsp;المرضية&nbsp;(انظر&nbsp;البند&nbsp;2:&nbsp;اتخذ&nbsp;احتياطات&nbsp;خاصةمع</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">سيبروفارمة&nbsp;أقراص)&nbsp;،&nbsp;أو&nbsp;الدوخة</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&bull;&nbsp;مشاكل&nbsp;في&nbsp;البصر&nbsp;بما&nbsp;في&nbsp;ذلك&nbsp;الرؤية&nbsp;المزدوجة</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">و&nbsp;طنين&nbsp;الأذن،&nbsp;وفقدان&nbsp;السمع،&nbsp;ضعف&nbsp;السمع</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">سرعة&nbsp;ضربات&nbsp;القلب&nbsp;(عدم&nbsp;انتظام&nbsp;دقات&nbsp;القلب)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&bull;&nbsp;توسيع&nbsp;الأوعية&nbsp;الدموية&nbsp;(توسع&nbsp;الأوعية)&nbsp;،&nbsp;انخفاض&nbsp;ضغط&nbsp;الدم،&nbsp;أو&nbsp;الإغماء</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">:&nbsp;ضيق&nbsp;في&nbsp;التنفس،&nbsp;بما&nbsp;في&nbsp;ذلك&nbsp;أعراض&nbsp;الربو</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">و&nbsp;اضطرابات&nbsp;الكبد،&nbsp;اليرقان&nbsp;(اليرقان&nbsp;الركودي)&nbsp;،&nbsp;أو&nbsp;التهاب&nbsp;الكبد</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&bull;&nbsp;الحساسية&nbsp;للضوء&nbsp;(انظر&nbsp;البند&nbsp;2:&nbsp;اتخذ&nbsp;احتياطات&nbsp;خاصة&nbsp;مع&nbsp;سيبروفارمة&nbsp;أقراص)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">:&nbsp;ألم&nbsp;في&nbsp;العضلات،&nbsp;التهاب&nbsp;المفاصل،&nbsp;زيادة&nbsp;قوة&nbsp;العضلات،&nbsp;أو&nbsp;تشنج</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">.&nbsp;فشل&nbsp;الكلى،&nbsp;والدم&nbsp;أو&nbsp;البلورات&nbsp;في&nbsp;البول&nbsp;(انظر&nbsp;البند&nbsp;2:&nbsp;اتخذ&nbsp;احتياطات&nbsp;خاصة&nbsp;مع&nbsp;سيبروفارم&nbsp;أقراص)&nbsp;التهاب&nbsp;المسالك&nbsp;البولية</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">:&nbsp;احتباس&nbsp;السوائل&nbsp;أو&nbsp;التعرق&nbsp;المفرط</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">زيادة&nbsp;مستويات&nbsp;انزيم&nbsp;الأميليز</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">نادرة&nbsp;جدا&nbsp;(تؤثر&nbsp;على&nbsp;أقل&nbsp;من&nbsp;1&nbsp;مستخدم&nbsp;من&nbsp;أصل&nbsp;10000&nbsp;مستخدم):</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&nbsp;</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">:&nbsp;الصداع&nbsp;النصفي،&nbsp;عدم&nbsp;القدرة&nbsp;على&nbsp;التركيز،&nbsp;والمشي&nbsp;غير&nbsp;المتزن&nbsp;(اضطراب&nbsp;بالمشي)،&nbsp;اضطراب&nbsp;في&nbsp;حاسة&nbsp;الشم&nbsp;(اضطرابات&nbsp;حاسة&nbsp;الشم)،الضغط</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">على&nbsp;الدماغ&nbsp;(الضغط&nbsp;داخل&nbsp;الجمجمة)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&bull;&nbsp;نوع&nbsp;خاص&nbsp;من&nbsp;انخفاض&nbsp;عدد&nbsp;خلايا&nbsp;الدم&nbsp;((فقر&nbsp;الدم&nbsp;الانحلالي) -&nbsp;وهو&nbsp;شكل&nbsp;من&nbsp;أشكال&nbsp;فقر&nbsp;الدم&nbsp;بسبب&nbsp;تحطيم&nbsp;خلايا&nbsp;الدم&nbsp;الحمراء)،&nbsp;وقديحدث&nbsp;مع&nbsp;البرقان،</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">وانخفاض&nbsp;خطير&nbsp;في&nbsp;نوع&nbsp;من&nbsp;خلايا&nbsp;الدم&nbsp;البيضاء&nbsp;(ندرة&nbsp;المحببات)،&nbsp;انخفاض&nbsp;في&nbsp;عدد&nbsp;خلايا&nbsp;الدم&nbsp;الحمراء&nbsp;والبيضاء&nbsp;و&nbsp;الصفائح&nbsp;الدموية&nbsp;(قلةالكريات</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">الشاملة)،&nbsp;والتي&nbsp;قد&nbsp;تكون&nbsp;قاتلة&nbsp;ونخاع&nbsp;العظام&nbsp;والاكتئاب،&nbsp;والتي&nbsp;قد&nbsp;تكون&nbsp;قاتله&nbsp;أيضا&nbsp;(انظر&nbsp;البند&nbsp;2:&nbsp;اتخذ&nbsp;احتياطات&nbsp;خاصة&nbsp;مع&nbsp;سيبروفارمأقراص)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&bull;&nbsp;ردود&nbsp;فعل&nbsp;شديدة&nbsp;الحساسية&nbsp;(رد&nbsp;فعل&nbsp;تحسسي&nbsp;أو&nbsp;صدة&nbsp;الحساسية،&nbsp;والتي&nbsp;يمكن&nbsp;أن&nbsp;تكون&nbsp;قائلة&nbsp;-&nbsp;داء&nbsp;البصل) (انظر&nbsp;البند&nbsp;2&nbsp;اتخذاحتياطات&nbsp;خاصة</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">مع&nbsp;سيبروفارم&nbsp;أقراص)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&bull;&nbsp;الاضطرابات&nbsp;العقلية&nbsp;(ردود&nbsp;الفعل&nbsp;الذهانية&nbsp;مما&nbsp;قد&nbsp;يؤدي&nbsp;إلى&nbsp;الأفكار&nbsp;الانتحارية،&nbsp;ومحاولات&nbsp;الانتحار&nbsp;أو&nbsp;الانتحار&nbsp;الكامل) (انظر&nbsp;البند&nbsp;2:&nbsp;اتخذاحتياطات</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">خاصة&nbsp;مع&nbsp;سيبروفارما&nbsp;أقراص)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">التشوهات&nbsp;الألوان&nbsp;البصرية</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">التهاب&nbsp;في&nbsp;جدار&nbsp;الأوعية&nbsp;الدموية&nbsp;(الأوعية&nbsp;الدموية&nbsp;)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">التهاب&nbsp;البنكرياس</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">نقط&nbsp;نزيف&nbsp;صغيره&nbsp;بحجم&nbsp;أثر&nbsp;الدبوس،&nbsp;تحت&nbsp;الجلد&nbsp;(petechiaae(1)&nbsp;،&nbsp;هيجان&nbsp;الجلد&nbsp;أو&nbsp;الطفح&nbsp;الجلدي&nbsp;بانواعه&nbsp;(على&nbsp;سبيل&nbsp;المثال،&nbsp;يمتاز&nbsp;بهستيفن</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">جونسون&nbsp;قاتلة&nbsp;أو&nbsp;انحلال&nbsp;البشرة&nbsp;السمي)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">.&nbsp;ضعف&nbsp;العضلات،&nbsp;والتهاب&nbsp;الأوتار&nbsp;وتمزق&nbsp;الأوتار&nbsp;-&nbsp;خصوصا&nbsp;في&nbsp;وتر&nbsp;كبير&nbsp;في&nbsp;الجزء&nbsp;الخلفي&nbsp;من&nbsp;الكاحل&nbsp;(وتر&nbsp;العرقوب) (انظر&nbsp;البند&nbsp;2:&nbsp;اتخذ</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&nbsp;</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">احتياطات&nbsp;خاصة&nbsp;مع&nbsp;سيبروفارمة&nbsp;أقراص)&nbsp;تفاقم&nbsp;أعراض&nbsp;الوهن&nbsp;العضلي&nbsp;الوبيل&nbsp;(انظر&nbsp;البند&nbsp;2:&nbsp;اتخذ&nbsp;احتياطات&nbsp;خاصة&nbsp;مع&nbsp;سيبروفارمةأقراص)</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">التكرار&nbsp;غير&nbsp;معروف&nbsp;(لا&nbsp;يمكن&nbsp;تقديرها&nbsp;من&nbsp;البيانات&nbsp;المتاحة</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&bull;&nbsp;الاضطرابات&nbsp;المرتبطة&nbsp;بالجهاز&nbsp;العصبي&nbsp;مثل&nbsp;الألم،&nbsp;وحرق،&nbsp;وخز،&nbsp;وخدر&nbsp;و/&nbsp;أو&nbsp;ضعف&nbsp;في&nbsp;الأطراف.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">سرعة&nbsp;غير&nbsp;طبيعية&nbsp;في&nbsp;ضربات&nbsp;القلب،&nbsp;عدم&nbsp;انتظام&nbsp;في&nbsp;ضربات&nbsp;القلب&nbsp;و&nbsp;مهددة&nbsp;للحياة،&nbsp;تغيير&nbsp;في&nbsp;ضربات&nbsp;القلب&nbsp;(تسمى&nbsp;إطالة&nbsp;فترة&nbsp;QT،&nbsp;تظهرفي</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">تخطيط&nbsp;القلب،&nbsp;والنشاط&nbsp;الكهربائي&nbsp;للقلب)&nbsp;تهدد</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">&bull;&nbsp;الطفح&nbsp;البثري</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">:&nbsp;التأثير&nbsp;على&nbsp;تجلط&nbsp;الدم&nbsp;(في&nbsp;المرضى&nbsp;الذين&nbsp;عولجوا&nbsp;بمضادات&nbsp;فيتامين&nbsp;K)</p><p style="margin-left:0cm; margin-right:.05pt; text-align:right" dir="RTL">إذا&nbsp;تطورت&nbsp;أي&nbsp;من&nbsp;الآثار&nbsp;الجانبية&nbsp;لتصبح&nbsp;أكثر&nbsp;سوءا،&nbsp;أو&nbsp;إذا&nbsp;لاحظت&nbsp;أي&nbsp;آثار&nbsp;جانبية&nbsp;غير&nbsp;المذكورة&nbsp;في&nbsp;هذه&nbsp;النشرة،&nbsp;يرجي&nbsp;إخبار&nbsp;الطبيب&nbsp;أوالصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">يحفظ&nbsp;بعيدا&nbsp;عن&nbsp;متناول&nbsp;الأطفال&nbsp;و&nbsp;نظر&nbsp;هم</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">لا&nbsp;تستخدم&nbsp;الأقراص&nbsp;بعد&nbsp;تاريخ&nbsp;انتهاء&nbsp;الصلاحية&nbsp;(EXP)&nbsp;المذكور&nbsp;على&nbsp;الشريط&nbsp;و&nbsp;العلبة&nbsp;الخارجية</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">تاريخ&nbsp;الانتهاء&nbsp;يشير&nbsp;إلى&nbsp;اليوم&nbsp;الأخير&nbsp;من&nbsp;ذلك&nbsp;الشهر</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">سيبروفارم أقراص:&nbsp;يحفظ&nbsp;بدرجة&nbsp;حرارة&nbsp;دون&nbsp;30&nbsp;م.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">يجب&nbsp;أن&nbsp;لا&nbsp;يتم&nbsp;التخلص&nbsp;من&nbsp;الأدوية&nbsp;عن&nbsp;طريق&nbsp;مياه&nbsp;الصرف&nbsp;الصحي&nbsp;أو&nbsp;النفايات&nbsp;المنزلية&nbsp;اسأل&nbsp;الصيدلي&nbsp;عن&nbsp;كيفية&nbsp;التخلص&nbsp;من&nbsp;الأدوية&nbsp;التيلم&nbsp;تعد&nbsp;مطلوبة</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">وسوف&nbsp;تساعد&nbsp;هذه&nbsp;التدابير&nbsp;في&nbsp;حماية&nbsp;البيئة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">المادة&nbsp;الفعالة&nbsp;:&nbsp;سيبروفلوكساسين&nbsp;هيدروكلوريد.</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">المكونات&nbsp;الأخرى&nbsp;هي&nbsp;جليكوليت&nbsp;نشا&nbsp;الصوديوم،&nbsp;بوفيدون&nbsp;ك،&nbsp;ميكرو&nbsp;کریستالين&nbsp;سيليلوز&nbsp;فابكل&nbsp;PH،&nbsp;تلك،&nbsp;سغنيسيوم&nbsp;ستيريت،&nbsp;أو&nbsp;بادريأبيض،&nbsp;PEG.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">أقراص&nbsp;سيبروفارم&nbsp;250&nbsp;ملغم&nbsp;المغلفة&nbsp;غشائيا&nbsp;بيضاء،&nbsp;دائرية،&nbsp;قليلة&nbsp;التحدب،&nbsp;عليها&nbsp;خط&nbsp;يسمح&nbsp;بكسرها&nbsp;لنصفين،&nbsp;محفور&nbsp;عليها&nbsp;PhI على&nbsp;الوجه الثاني،</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">موجودة&nbsp;في&nbsp;شريط&nbsp;من&nbsp;الألومنيوم&nbsp;/PVDC،&nbsp;المعدة&nbsp;للاستخدام&nbsp;عن&nbsp;طريق&nbsp;الفم</p><p style="margin-left:0cm; margin-right:0cm; text-align:right" dir="RTL">حجم&nbsp;العبوة: 10&nbsp;أقراص</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>&nbsp;</p><p style="margin-left:192.3pt; margin-right:0cm; text-indent:-7.05pt" dir="RTL">الشركة الدولية للدواء عمان - األردن</p><p>00962 - 6 - 5158890 / 5157893 :الهاتف</p><p>00962 - 6 - 5154753 :فاكس</p><p dir="RTL">البريد اإللكتروني: marketing@pic-jo.com</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تم تنقيح هذه النشرة في 01/2019
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Cipropharm® (Ciprofloxacin hydrochloride 250mg F/C tablets).
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each tablet contains 250 mg of Ciprofloxacin (hydrochloride).

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Cipropharm® 250mg are White, round, shallow convex, scored on one face and engraved with PhI on the other, presented in PVDC /Alu blisters, intended for oral use.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:left">Cipropharm&reg; is indicated for the treatment of the following infections (see sections 4.4 and 5.1). Special attention should be paid to available information on resistance to Cipropharm&reg; before commencing therapy.<br />Consideration should be given to official guidance on the appropriate use of antibacterial agents.<br />Adults<br />&bull; Lower Respiratory tract infections due to Gram-negative bacteria<br />- pneumonia<br />- exacerbations of chronic obstructive pulmonary disease<br />- broncho-pulmonary infections in cystic fibrosis or in bronchiectasis<br />&bull; Chronic suppurative otitis media<br />&bull; Acute exacerbation of chronic sinusitis especially if these are caused by Gram-negative bacteria<br />&bull; Urinary tract infections<br />&bull; Genital tract infections<br />- gonococcal uretritis and cervicitis due to susceptible Neisseria gonorrhoeae<br />- epididymo-orchitis including cases due to susceptible Neisseria gonorrhoeae<br />- pelvic inflammatory disease including cases due to susceptible Neisseria gonorrhoeae<br />&bull; Infections of the gastro-intestinal tract (e.g. travellers&#39; diarrhoea)<br />&bull; Intra-abdominal infections<br />&bull; Infections of the skin and soft tissue caused by Gram-negative bacteria<br />&bull; Malignant external otitis<br />&bull; Infections of the bones and joints<br />&bull; Prophylaxis of invasive infections due to Neisseria meningitidis<br />&bull; Inhalation anthrax (post-exposure prophylaxis and curative treatment)<br />Cipropharm&reg; may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.<br />Children and adolescents<br />&bull; Broncho-pulmonary infections in cystic fibrosis caused by Pseudomonas aeruginosa<br />&bull; Complicated urinary tract infections and pyelonephritis<br />&bull; Inhalation anthrax (post-exposure prophylaxis and curative treatment)<br />Cipropharm&reg; may also be used to treat severe infections in children and adolescents when this is considered to be necessary.<br />Treatment should be initiated only by physicians who are experienced in the treatment of cystic fibrosis and/or severe infections in children and adolescents&nbsp; (see sections 4.4 and 5.1).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:21.05pt; margin-right:21.95pt; text-align:left">The dosage is determined by the indication, the severity and the site of the infection, the susceptibility to <strong>Cipropharm<sup>&reg;</sup> </strong>of the causative organism(s), the renal function of the patient and, in children and adolescents the body weight. The duration of treatment depends on the severity of the illness and on the clinical and bacteriological course.</p><p style="margin-left:21.05pt; margin-right:21.85pt; text-align:left">Treatment of infections due to certain bacteria (e.g. <em>Pseudomonas aeruginosa</em>, <em>Acinetobacter </em>or <em>Staphylococci) </em>may require higher <strong>Cipropharm<sup>&reg;</sup> </strong>doses and co-administration with other appropriate antibacterial agents.</p><p style="margin-left:21.05pt; margin-right:21.6pt; text-align:left">Treatment of some infections (e.g. pelvic inflammatory disease, intra- abdominal infections, infections in neutropenic patients and infections of bones and joints) may require co-administration with other appropriate antibacterial agents depending on the pathogens involved.</p><p style="margin-left:21.05pt; margin-right:0cm; text-align:left"><strong><u>Adults</u></strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="height:102.1pt; vertical-align:top; width:168.45pt" colspan="2"><p style="margin-left:3.05pt; margin-right:0cm; text-align:left"><strong>Indications</strong></p></td><td style="height:102.1pt; vertical-align:top; width:109.1pt"><p style="margin-left:3.1pt; margin-right:0cm; text-align:left"><strong>Daily dose in mg</strong></p></td><td style="height:102.1pt; vertical-align:top; width:112.75pt"><p style="margin-left:2.75pt; margin-right:12.45pt; text-align:left"><strong>Total duration of treatment (potentially including initial parenteral treatment with Cipropharm<sup>&reg;</sup>)</strong></p></td></tr><tr><td style="height:47.45pt; vertical-align:top; width:168.45pt" colspan="2"><p style="margin-left:3.05pt; margin-right:46.15pt; text-align:left">Infections of the lower respiratory tract</p></td><td style="height:47.45pt; vertical-align:top; width:109.1pt"><p style="margin-left:3.1pt; margin-right:4.4pt; text-align:left">500 mg twice daily to 750 mg twice daily</p></td><td style="height:47.45pt; vertical-align:top; width:112.75pt"><p style="margin-left:2.75pt; margin-right:0cm; text-align:left">7 to 14 days</p></td></tr><tr><td style="height:61.15pt; vertical-align:top; width:81.5pt" rowspan="3"><p style="margin-left:3.05pt; margin-right:11.2pt; text-align:left">Infections of the upper respiratory tract</p></td><td style="height:61.15pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; margin-right:12.55pt; text-align:left">Acute exacerbation of chronic sinusitis</p></td><td style="height:61.15pt; vertical-align:top; width:109.1pt"><p style="margin-left:3.1pt; margin-right:4.4pt; text-align:left">500 mg twice daily to 750 mg twice daily</p></td><td style="height:61.15pt; vertical-align:top; width:112.75pt"><p style="margin-left:2.75pt; margin-right:0cm; text-align:left">7 to 14 days</p></td></tr><tr><td style="height:47.45pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; margin-right:19.25pt; text-align:left">Chronic suppurative otitis media</p></td><td style="height:47.45pt; vertical-align:top; width:109.1pt"><p style="margin-left:3.1pt; margin-right:4.4pt; text-align:left">500 mg twice daily to 750 mg twice daily</p></td><td style="height:47.45pt; vertical-align:top; width:112.75pt"><p style="margin-left:2.75pt; margin-right:0cm; text-align:left">7 to 14 days</p></td></tr><tr><td style="height:33.5pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; margin-right:10.6pt; text-align:left">Malignant external otitis</p></td><td style="height:33.5pt; vertical-align:top; width:109.1pt"><p style="margin-left:3.1pt; margin-right:0cm; text-align:left">750 mg twice daily</p></td><td style="height:33.5pt; vertical-align:top; width:112.75pt"><p style="margin-left:2.75pt; margin-right:25.05pt; text-align:left">28 days up to 3 months</p></td></tr><tr><td style="height:47.1pt; vertical-align:top; width:81.5pt" rowspan="3"><p style="margin-left:3.05pt; margin-right:10.6pt; text-align:left">Urinary tract infections</p></td><td style="height:47.1pt; vertical-align:top; width:86.95pt" rowspan="2"><p style="margin-left:3.15pt; margin-right:1.9pt; text-align:left">Uncomplicated cystitis</p></td><td style="height:47.1pt; vertical-align:top; width:109.1pt"><p style="margin-left:3.1pt; margin-right:4.4pt; text-align:left">250 mg twice daily to 500 mg twice daily</p></td><td style="height:47.1pt; vertical-align:top; width:112.75pt"><p style="margin-left:2.75pt; margin-right:0cm; text-align:left">3 days</p></td></tr><tr><td style="height:32.75pt; vertical-align:top; width:221.85pt" colspan="2"><p style="margin-left:3.1pt; margin-right:27.45pt; text-align:left">In pre-menopausal women, 500 mg single dose may be used</p></td></tr><tr><td style="height:60.4pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; margin-right:1.9pt; text-align:left">Complicated cystitis, Uncomplicated pyelonephritis</p></td><td style="height:60.4pt; vertical-align:top; width:109.1pt"><p style="margin-left:3.1pt; margin-right:0cm; text-align:left">500 mg twice daily</p></td><td style="height:60.4pt; vertical-align:top; width:112.75pt"><p style="margin-left:2.75pt; margin-right:0cm; text-align:left">7 days</p></td></tr></tbody></table><p style="text-align:left">&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="height:116.3pt; vertical-align:top; width:81.5pt" rowspan="2"><p style="text-align:left">&nbsp;</p></td><td style="height:116.3pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; margin-right:7.25pt; text-align:left">Complicated pyelonephritis</p></td><td style="height:116.3pt; vertical-align:top; width:109.1pt"><p style="margin-left:3.1pt; margin-right:4.4pt; text-align:left">500 mg twice daily to 750 mg twice daily</p></td><td style="height:116.3pt; vertical-align:top; width:112.75pt"><p style="margin-left:2.75pt; margin-right:10.4pt; text-align:left">at least 10 days, it can be continued for longer than 21 days in some specific circumstances (such as abscesses)</p></td></tr><tr><td style="height:47.45pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; margin-right:0cm; text-align:left">Prostatitis</p></td><td style="height:47.45pt; vertical-align:top; width:109.1pt"><p style="margin-left:3.1pt; margin-right:4.4pt; text-align:left">500 mg twice daily to 750 mg twice daily</p></td><td style="height:47.45pt; vertical-align:top; width:112.75pt"><p style="margin-left:2.75pt; margin-right:0cm; text-align:left">2 to 4 weeks</p><p style="margin-left:2.75pt; margin-right:23.05pt; text-align:left">(acute) to 4 to 6 weeks (chronic)</p></td></tr><tr><td style="height:47.35pt; vertical-align:top; width:81.5pt" rowspan="2"><p style="margin-left:3.05pt; margin-right:11.25pt; text-align:left">Genital tract infections</p></td><td style="height:47.35pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; margin-right:18.7pt; text-align:left">Gonococcal uretritis and cervicitis</p></td><td style="height:47.35pt; vertical-align:top; width:109.1pt"><p style="margin-left:3.1pt; margin-right:2.35pt; text-align:left">500 mg as a single dose</p></td><td style="height:47.35pt; vertical-align:top; width:112.75pt"><p style="margin-left:2.75pt; margin-right:0cm; text-align:left">1 day (single dose)</p></td></tr><tr><td style="height:75.05pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; margin-right:12.6pt; text-align:left">Epididymo- orchitis and pelvic inflammatory diseases</p></td><td style="height:75.05pt; vertical-align:top; width:109.1pt"><p style="margin-left:3.1pt; margin-right:4.4pt; text-align:left">500 mg twice daily to 750 mg twice daily</p></td><td style="height:75.05pt; vertical-align:top; width:112.75pt"><p style="margin-left:2.75pt; margin-right:0cm; text-align:left">at least 14 days</p></td></tr><tr><td style="height:16.7pt; vertical-align:top; width:81.5pt"><p style="margin-left:3.05pt; margin-right:0cm; text-align:left">Infections of</p></td><td style="height:16.7pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; margin-right:0cm; text-align:left">Diarrhoea</p></td><td style="height:16.7pt; vertical-align:top; width:109.1pt"><p style="margin-left:3.1pt; margin-right:0cm; text-align:left">500 mg twice daily</p></td><td style="height:16.7pt; vertical-align:top; width:112.75pt"><p style="margin-left:2.75pt; margin-right:0cm; text-align:left">1 day</p></td></tr><tr><td style="height:13.8pt; vertical-align:top; width:81.5pt"><p style="margin-left:3.05pt; text-align:left">the gastro-</p></td><td style="height:13.8pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; text-align:left">caused by</p></td><td style="height:13.8pt; vertical-align:top; width:109.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:13.8pt; vertical-align:top; width:112.75pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:13.75pt; vertical-align:top; width:81.5pt"><p style="margin-left:3.05pt; text-align:left">intestinal tract</p></td><td style="height:13.75pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; text-align:left">bacterial</p></td><td style="height:13.75pt; vertical-align:top; width:109.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:13.75pt; vertical-align:top; width:112.75pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:13.8pt; vertical-align:top; width:81.5pt"><p style="margin-left:3.05pt; text-align:left">and intra-</p></td><td style="height:13.8pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; text-align:left">pathogens</p></td><td style="height:13.8pt; vertical-align:top; width:109.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:13.8pt; vertical-align:top; width:112.75pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:13.75pt; vertical-align:top; width:81.5pt"><p style="margin-left:3.05pt; text-align:left">abdominal</p></td><td style="height:13.75pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; text-align:left">including</p></td><td style="height:13.75pt; vertical-align:top; width:109.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:13.75pt; vertical-align:top; width:112.75pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:13.85pt; vertical-align:top; width:81.5pt"><p style="margin-left:3.05pt; text-align:left">infections</p></td><td style="height:13.85pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; text-align:left"><em>Shigella </em>spp.</p></td><td style="height:13.85pt; vertical-align:top; width:109.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:13.85pt; vertical-align:top; width:112.75pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:13.7pt; vertical-align:top; width:81.5pt"><p style="text-align:left">&nbsp;</p></td><td style="height:13.7pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; text-align:left">other than</p></td><td style="height:13.7pt; vertical-align:top; width:109.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:13.7pt; vertical-align:top; width:112.75pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:13.7pt; vertical-align:top; width:81.5pt"><p style="text-align:left">&nbsp;</p></td><td style="height:13.7pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; text-align:left"><em>Shigella</em></p></td><td style="height:13.7pt; vertical-align:top; width:109.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:13.7pt; vertical-align:top; width:112.75pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:13.85pt; vertical-align:top; width:81.5pt"><p style="text-align:left">&nbsp;</p></td><td style="height:13.85pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; text-align:left"><em>dysenteriae</em></p></td><td style="height:13.85pt; vertical-align:top; width:109.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:13.85pt; vertical-align:top; width:112.75pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:13.85pt; vertical-align:top; width:81.5pt"><p style="text-align:left">&nbsp;</p></td><td style="height:13.85pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; text-align:left">type 1 and</p></td><td style="height:13.85pt; vertical-align:top; width:109.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:13.85pt; vertical-align:top; width:112.75pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:13.75pt; vertical-align:top; width:81.5pt"><p style="text-align:left">&nbsp;</p></td><td style="height:13.75pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; text-align:left">empirical</p></td><td style="height:13.75pt; vertical-align:top; width:109.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:13.75pt; vertical-align:top; width:112.75pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:13.8pt; vertical-align:top; width:81.5pt"><p style="text-align:left">&nbsp;</p></td><td style="height:13.8pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; text-align:left">treatment of</p></td><td style="height:13.8pt; vertical-align:top; width:109.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:13.8pt; vertical-align:top; width:112.75pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:13.8pt; vertical-align:top; width:81.5pt"><p style="text-align:left">&nbsp;</p></td><td style="height:13.8pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; text-align:left">severe</p></td><td style="height:13.8pt; vertical-align:top; width:109.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:13.8pt; vertical-align:top; width:112.75pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:13.75pt; vertical-align:top; width:81.5pt"><p style="text-align:left">&nbsp;</p></td><td style="height:13.75pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; text-align:left">travellers&#39;</p></td><td style="height:13.75pt; vertical-align:top; width:109.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:13.75pt; vertical-align:top; width:112.75pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:16.75pt; vertical-align:top; width:81.5pt"><p style="text-align:left">&nbsp;</p></td><td style="height:16.75pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; text-align:left">diarrhoea</p></td><td style="height:16.75pt; vertical-align:top; width:109.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:16.75pt; vertical-align:top; width:112.75pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:16.75pt; vertical-align:top; width:81.5pt"><p style="text-align:left">&nbsp;</p></td><td style="height:16.75pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; margin-right:0cm; text-align:left">Diarrhoea</p></td><td style="height:16.75pt; vertical-align:top; width:109.1pt"><p style="margin-left:3.1pt; margin-right:0cm; text-align:left">500 mg twice daily</p></td><td style="height:16.75pt; vertical-align:top; width:112.75pt"><p style="margin-left:2.75pt; margin-right:0cm; text-align:left">5 days</p></td></tr><tr><td style="height:13.75pt; vertical-align:top; width:81.5pt"><p style="text-align:left">&nbsp;</p></td><td style="height:13.75pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; text-align:left">caused by</p></td><td style="height:13.75pt; vertical-align:top; width:109.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:13.75pt; vertical-align:top; width:112.75pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:13.7pt; vertical-align:top; width:81.5pt"><p style="text-align:left">&nbsp;</p></td><td style="height:13.7pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; text-align:left"><em>Shigella</em></p></td><td style="height:13.7pt; vertical-align:top; width:109.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:13.7pt; vertical-align:top; width:112.75pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:13.85pt; vertical-align:top; width:81.5pt"><p style="text-align:left">&nbsp;</p></td><td style="height:13.85pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; text-align:left"><em>dysenteriae</em></p></td><td style="height:13.85pt; vertical-align:top; width:109.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:13.85pt; vertical-align:top; width:112.75pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:16.95pt; vertical-align:top; width:81.5pt"><p style="text-align:left">&nbsp;</p></td><td style="height:16.95pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; text-align:left">type 1</p></td><td style="height:16.95pt; vertical-align:top; width:109.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:16.95pt; vertical-align:top; width:112.75pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:16.7pt; vertical-align:top; width:81.5pt"><p style="text-align:left">&nbsp;</p></td><td style="height:16.7pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; margin-right:0cm; text-align:left">Diarrhoea</p></td><td style="height:16.7pt; vertical-align:top; width:109.1pt"><p style="margin-left:3.1pt; margin-right:0cm; text-align:left">500 mg twice daily</p></td><td style="height:16.7pt; vertical-align:top; width:112.75pt"><p style="margin-left:2.75pt; margin-right:0cm; text-align:left">3 days</p></td></tr><tr><td style="height:13.7pt; vertical-align:top; width:81.5pt"><p style="text-align:left">&nbsp;</p></td><td style="height:13.7pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; text-align:left">caused by</p></td><td style="height:13.7pt; vertical-align:top; width:109.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:13.7pt; vertical-align:top; width:112.75pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:11.95pt; vertical-align:top; width:81.5pt"><p style="text-align:left">&nbsp;</p></td><td style="height:11.95pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; text-align:left"><em>Vibrio</em></p></td><td style="height:11.95pt; vertical-align:top; width:109.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:11.95pt; vertical-align:top; width:112.75pt"><p style="text-align:left">&nbsp;</p></td></tr></tbody></table><p style="text-align:left">&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="height:19.7pt; vertical-align:top; width:81.5pt" rowspan="3"><p style="text-align:left">&nbsp;</p></td><td style="height:19.7pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; margin-right:0cm; text-align:left"><em>cholerae</em></p></td><td style="height:19.7pt; vertical-align:top; width:109.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:19.7pt; vertical-align:top; width:112.75pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:19.85pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; margin-right:0cm; text-align:left">Typhoid fever</p></td><td style="height:19.85pt; vertical-align:top; width:109.1pt"><p style="margin-left:3.1pt; margin-right:0cm; text-align:left">500 mg twice daily</p></td><td style="height:19.85pt; vertical-align:top; width:112.75pt"><p style="margin-left:2.75pt; margin-right:0cm; text-align:left">7 days</p></td></tr><tr><td style="height:88.7pt; vertical-align:top; width:86.95pt"><p style="margin-left:3.15pt; margin-right:7.2pt; text-align:left">Intra- abdominal infections due to Gram- negative bacteria</p></td><td style="height:88.7pt; vertical-align:top; width:109.1pt"><p style="margin-left:3.1pt; margin-right:4.4pt; text-align:left">500 mg twice daily to 750 mg twice daily</p></td><td style="height:88.7pt; vertical-align:top; width:112.75pt"><p style="margin-left:2.75pt; margin-right:0cm; text-align:left">5 to 14 days</p></td></tr><tr><td style="height:47.45pt; vertical-align:top; width:168.45pt" colspan="2"><p style="margin-left:3.05pt; margin-right:7.45pt; text-align:left">Infections of the skin and soft tissue</p></td><td style="height:47.45pt; vertical-align:top; width:109.1pt"><p style="margin-left:3.1pt; margin-right:4.4pt; text-align:left">500 mg twice daily to 750 mg twice daily</p></td><td style="height:47.45pt; vertical-align:top; width:112.75pt"><p style="margin-left:2.75pt; margin-right:0cm; text-align:left">7 to 14 days</p></td></tr><tr><td style="height:47.35pt; vertical-align:top; width:168.45pt" colspan="2"><p style="margin-left:3.05pt; margin-right:0cm; text-align:left">Bone and joint infections</p></td><td style="height:47.35pt; vertical-align:top; width:109.1pt"><p style="margin-left:3.1pt; margin-right:4.4pt; text-align:left">500 mg twice daily to 750 mg twice daily</p></td><td style="height:47.35pt; vertical-align:top; width:112.75pt"><p style="margin-left:2.75pt; margin-right:0cm; text-align:left">max. of 3 months</p></td></tr><tr><td style="height:116.45pt; vertical-align:top; width:168.45pt" colspan="2"><p style="margin-left:3.05pt; margin-right:5.45pt; text-align:left">Neutropenic patients with fever that is suspected to be due to a bacterial infection <strong>Cipropharm<sup>&reg;</sup> </strong>should be co- administered with appropriate antibacterial agent(s) in accordance to official guidance.</p></td><td style="height:116.45pt; vertical-align:top; width:109.1pt"><p style="margin-left:3.1pt; margin-right:4.4pt; text-align:left">500 mg twice daily to 750 mg twice daily</p></td><td style="height:116.45pt; vertical-align:top; width:112.75pt"><p style="margin-left:2.75pt; margin-right:7.7pt; text-align:left">Therapy should be continued over the entire period of neutropenia</p></td></tr><tr><td style="height:47.35pt; vertical-align:top; width:168.45pt" colspan="2"><p style="margin-left:3.05pt; margin-right:22.15pt; text-align:left">Prophylaxis of invasive infections due to <em>Neisseria meningitidis</em></p></td><td style="height:47.35pt; vertical-align:top; width:109.1pt"><p style="margin-left:3.1pt; margin-right:2.35pt; text-align:left">500 mg as a single dose</p></td><td style="height:47.35pt; vertical-align:top; width:112.75pt"><p style="margin-left:2.75pt; margin-right:0cm; text-align:left">1 day (single dose)</p></td></tr><tr><td style="height:143.65pt; vertical-align:top; width:168.45pt" colspan="2"><p style="margin-left:3.05pt; margin-right:3.45pt; text-align:left">Inhalation anthrax post- exposure prophylaxis and curative treatment for persons able to receive treatment by oral route when clinically appropriate.</p><p style="margin-left:3.05pt; margin-right:10.8pt; text-align:left">Drug administration should begin as soon as possible after suspected or confirmed exposure.</p></td><td style="height:143.65pt; vertical-align:top; width:109.1pt"><p style="margin-left:3.1pt; margin-right:0cm; text-align:left">500 mg twice daily</p></td><td style="height:143.65pt; vertical-align:top; width:112.75pt"><p style="margin-left:2.75pt; margin-right:13.75pt; text-align:left">60 days from the confirmation of <em>Bacillus anthracis </em>exposure</p></td></tr></tbody></table><p style="margin-left:21.05pt; margin-right:0cm; text-align:left"><strong><u>Children and adolescents</u></strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="border-color:#9f9f9f; height:74.15pt; vertical-align:top; width:97.4pt"><p style="margin-left:3.05pt; margin-right:0cm; text-align:left"><strong>Indications</strong></p></td><td style="height:74.15pt; vertical-align:top; width:195.35pt"><p style="margin-left:2.9pt; margin-right:0cm; text-align:left"><strong>Daily dose in mg</strong></p></td><td style="height:74.15pt; vertical-align:top; width:97.4pt"><p style="margin-left:3.15pt; margin-right:2.4pt; text-align:left"><strong>Total&nbsp;&nbsp;&nbsp; duration of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; treatment (potentially including initial parenteral</strong></p></td></tr></tbody></table><p style="text-align:left">&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="height:33.1pt; vertical-align:top; width:97.4pt"><p style="text-align:left">&nbsp;</p></td><td style="height:33.1pt; vertical-align:top; width:195.35pt"><p style="text-align:left">&nbsp;</p></td><td style="height:33.1pt; vertical-align:top; width:97.4pt"><p style="margin-left:3.15pt; margin-right:2.35pt; text-align:left"><strong>treatment&nbsp;&nbsp; with Cipropharm<sup>&reg;</sup>)</strong></p></td></tr><tr><td style="height:47.45pt; vertical-align:top; width:97.4pt"><p style="margin-left:3.05pt; margin-right:0cm; text-align:left">Cystic fibrosis</p></td><td style="height:47.45pt; vertical-align:top; width:195.35pt"><p style="margin-left:2.9pt; margin-right:2.8pt; text-align:left">20 mg/kg body weight twice daily with a maximum of 750 mg per dose.</p></td><td style="height:47.45pt; vertical-align:top; width:97.4pt"><p style="margin-left:3.15pt; margin-right:0cm; text-align:left">10 to 14 days</p></td></tr><tr><td style="height:61.1pt; vertical-align:top; width:97.4pt"><p style="margin-left:3.05pt; margin-right:17.4pt; text-align:left">Complicated urinary tract infections and pyelonephritis</p></td><td style="height:61.1pt; vertical-align:top; width:195.35pt"><p style="margin-left:2.9pt; margin-right:2.8pt; text-align:left">10 mg/kg body weight twice daily to 20 mg/kg body weight twice daily with a maximum of 750 mg per dose.</p></td><td style="height:61.1pt; vertical-align:top; width:97.4pt"><p style="margin-left:3.15pt; margin-right:0cm; text-align:left">10 to 21 days</p></td></tr><tr><td style="height:268.3pt; vertical-align:top; width:97.4pt"><p style="margin-left:3.05pt; margin-right:2.25pt; text-align:left">Inhalation anthrax post- exposure prophylaxis and curative treatment for persons able to receive treatment by oral route when clinically appropriate.</p><p style="margin-left:3.05pt; margin-right:2.05pt; text-align:left">Drug administration should begin as soon as possible after suspected or confirmed exposure.</p></td><td style="height:268.3pt; vertical-align:top; width:195.35pt"><p style="margin-left:2.9pt; margin-right:2.8pt; text-align:left">10 mg/kg body weight twice daily to 15 mg/kg body weight twice daily with a maximum of 500 mg per dose.</p></td><td style="height:268.3pt; vertical-align:top; width:97.4pt"><p style="margin-left:3.15pt; margin-right:2.5pt; text-align:left">60 days from the confirmation&nbsp;&nbsp;&nbsp; of <em>Bacillus anthracis </em>exposure</p></td></tr><tr><td style="height:46.9pt; vertical-align:top; width:97.4pt"><p style="margin-left:3.05pt; margin-right:22.1pt; text-align:left">Other severe infections</p></td><td style="height:46.9pt; vertical-align:top; width:195.35pt"><p style="margin-left:2.9pt; margin-right:2.8pt; text-align:left">20 mg/kg body weight twice daily with a maximum of 750 mg per dose.</p></td><td style="height:46.9pt; vertical-align:top; width:97.4pt"><p style="margin-left:3.15pt; margin-right:1.65pt; text-align:left">According to the type of infections</p></td></tr></tbody></table><p style="margin-left:21.05pt; text-align:left"><strong><u>Geriatric patients</u></strong></p><p style="margin-right:22.35pt; text-align:left">Geriatric patients should receive a dose selected according to the severity of the infection and the patient&#39;s creatinine clearance.</p><p style="margin-left:21.05pt; text-align:left"><strong><u>Renal and hepatic impairment</u></strong></p><p style="margin-left:21.05pt; margin-right:22.35pt; text-align:left">Recommended starting and maintenance doses for patients with impaired renal function:</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="height:33.2pt; vertical-align:top; width:132.55pt"><p style="margin-left:3.05pt; margin-right:7.2pt; text-align:left"><strong>Creatinine Clearance [mL/min/1.73 m&sup2;]</strong></p></td><td style="height:33.2pt; vertical-align:top; width:128.9pt"><p style="margin-left:2.9pt; margin-right:23.35pt; text-align:left"><strong>Serum Creatinine [&micro;mol/L]</strong></p></td><td style="height:33.2pt; vertical-align:top; width:128.65pt"><p style="margin-left:2.9pt; margin-right:66.15pt; text-align:left"><strong>Oral Dose [mg]</strong></p></td></tr><tr><td style="height:19.85pt; vertical-align:top; width:132.55pt"><p style="margin-left:3.05pt; margin-right:0cm; text-align:left">&gt; 60</p></td><td style="height:19.85pt; vertical-align:top; width:128.9pt"><p style="margin-left:2.9pt; margin-right:0cm; text-align:left">&lt; 124</p></td><td style="height:19.85pt; vertical-align:top; width:128.65pt"><p style="margin-left:2.9pt; margin-right:0cm; text-align:left">See Usual Dosage.</p></td></tr><tr><td style="height:33.1pt; vertical-align:top; width:132.55pt"><p style="margin-left:3.05pt; margin-right:0cm; text-align:left">30-60</p></td><td style="height:33.1pt; vertical-align:top; width:128.9pt"><p style="margin-left:2.9pt; margin-right:0cm; text-align:left">124 to 168</p></td><td style="height:33.1pt; vertical-align:top; width:128.65pt"><p style="margin-left:2.9pt; margin-right:3.75pt; text-align:left">250-500 mg every 12 h</p></td></tr></tbody></table><p style="text-align:left">&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="height:33.1pt; vertical-align:top; width:132.55pt"><p style="margin-left:3.05pt; margin-right:0cm; text-align:left"><u>&lt;</u>30</p></td><td style="height:33.1pt; vertical-align:top; width:128.9pt"><p style="margin-left:2.9pt; margin-right:0cm; text-align:left">&gt;169</p></td><td style="height:33.1pt; vertical-align:top; width:128.65pt"><p style="margin-left:2.9pt; margin-right:3.75pt; text-align:left">250-500 mg every 24 h</p></td></tr><tr><td style="height:47.45pt; vertical-align:top; width:132.55pt"><p style="margin-left:3.05pt; margin-right:0cm; text-align:left">Patients&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; on</p><p style="margin-left:3.05pt; text-align:left">haemodialysis</p></td><td style="height:47.45pt; vertical-align:top; width:128.9pt"><p style="margin-left:2.9pt; margin-right:0cm; text-align:left">&gt;169</p></td><td style="height:47.45pt; vertical-align:top; width:128.65pt"><p style="margin-left:2.9pt; margin-right:3.75pt; text-align:left">250-500 mg every 24 h</p><p style="margin-left:2.9pt; text-align:left">(after dialysis)</p></td></tr><tr><td style="height:33.2pt; vertical-align:top; width:132.55pt"><p style="margin-left:3.05pt; margin-right:7.2pt; text-align:left">Patients on peritoneal dialysis</p></td><td style="height:33.2pt; vertical-align:top; width:128.9pt"><p style="margin-left:2.9pt; margin-right:0cm; text-align:left">&gt;169</p></td><td style="height:33.2pt; vertical-align:top; width:128.65pt"><p style="margin-left:2.9pt; margin-right:3.75pt; text-align:left">250-500 mg every 24 h</p></td></tr></tbody></table><p style="margin-right:22.35pt; text-align:left">In patients with impaired liver function, no dose adjustment is required. Dosing in children with impaired renal and/or hepatic function has not been studied.</p><p style="margin-left:21.05pt; text-align:left"><strong><u>Method of administration</u></strong></p><p style="margin-right:21.8pt; text-align:left">Tablets are to be swallowed unchewed with fluid. They can be taken independent of mealtimes. If taken on an empty stomach, the active substance is absorbed more rapidly. Ciprofloxacin tablets should not be taken with dairy products (e.g. milk, yoghurt) or mineral-fortified fruit -juice (e.g. calcium-fortified orange juice) (see section 4.5).</p><p style="margin-right:22.05pt; text-align:left">In severe cases or if the patient is unable to take tablets (e.g. patients on enteral nutrition), it is recommended to commence therapy with intravenous ciprofloxacin until a switch to oral administration is possible.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance, to other quinolones or to any of the excipients (see section 6.1).
Concomitant administration of ciprofloxacin and tizanidine (see section 4.5).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:left">Disabling and Potentially Irreversible Serious Adverse Reactions Including Tendinitis and Tendon Rupture, Peripheral Neuropathy, and Central Nervous System Effects<br />Fluoroquinolones, including ciprofloxacin, have been associated with disabling and potentially irreversible serious adverse reactions from different body systems that can occur together in the same patient. Commonly seen adverse reactions include tendinitis, tendon rupture, arthralgia, myalgia, peripheral neuropathy, and central nervous system effects (hallucinations, anxiety, depression, insomnia, severe headaches, and confusion). These reactions can occur within hours to weeks after starting Cipropharm&reg;. Patients of any age or without pre-existing risk factors have experienced these adverse reactions.<br />Discontinue Cipropharm&reg;, immediately at the first signs or symptoms of any serious adverse reaction. In addition, avoid the use of fluoroquinolones, including Cipropharm&reg;, in patients who have experienced any of these serious adverse reactions associated with fluoroquinolones.<br />Streptococcal Infections (including Streptococcus pneumoniae)<br />Ciprofloxacin is not recommended for the treatment of streptococcal infections due to inadequate efficacy.<br />Severe infections and mixed infections with Gram-positive and anaerobic pathogens<br />Ciprofloxacin monotherapy is not suited for treatment of severe infections and infections that might be due to Gram-positive or anaerobic pathogens. In such infections ciprofloxacin must be co-administered with other appropriate antibacterial agents.<br />Genital tract infections<br />Gonococcal uretritis, cervicitis, epididymo-orchitis and pelvic inflammatory diseases may be caused by fluoroquinolone-resistant Neisseria gonorrhoeae isolates.<br />Therefore, ciprofloxacin should be administered for the treatment of gonococcal uretritis or cervicitis only if ciprofloxacin-resistant Neisseria gonorrhoeae can be excluded.<br />For epididymo-orchitis and pelvic inflammatory diseases, empirical ciprofloxacin should only be considered in combination with another appropriate antibacterial agent (e.g. a cephalosporin) unless ciprofloxacin-resistant Neisseria gonorrhoeae can be excluded based on local prevalence data. If clinical improvement is not achieved after 3 days of treatment, the therapy should be reconsidered.<br />Urinary tract infections<br />Resistance to fluoroquinolones of Escherichia coli&ndash; the most common pathogen involved in urinary tract infections &ndash; varies across the European Union. Prescribers are advised to take into account the local prevalence of resistance in Escherichia coli to fluoroquinolones.<br />The single dose of ciprofloxacin is expected to be associated with lower efficacy than with the longer treatment duration. This is all the more to be taken into account as regards the increasing resistance level of Escherichia coli to quinolones.<br />Intra-abdominal infections<br />There are limited data on the efficacy of ciprofloxacin in the treatment of post-surgical intra-abdominal infections.<br />Travellers&#39; diarrhoea<br />The choice of ciprofloxacin should take into account information on resistance to ciprofloxacin in relevant pathogens in the countries visited.<br />Infections of the bones and joints<br />Ciprofloxacin should be used in combination with other antimicrobial agents depending on the results of the microbiological documentation.<br />Inhalational anthrax<br />Use in humans is based on in-vitro susceptibility data and on animal experimental data together with limited human data. Treating physicians should refer to national and/or international consensus documents regarding the treatment of anthrax.<br />Children and adolescents<br />The use of ciprofloxacin in children and adolescents should follow available official guidance. Ciprofloxacin treatment should be initiated only by physicians who are experienced in the treatment of cystic fibrosis and/or severe infections in children and adolescents.<br />Ciprofloxacin has been shown to cause arthropathy in weight-bearing joints of immature animals. Safety data from a randomised double-blind study on ciprofloxacin use in children (ciprofloxacin: n=335, mean age = 6.3 years; comparators: n=349, mean age = 6.2 years; age range = 1 to 17 years) revealed an incidence of suspected drug-related arthropathy (discerned from joint-related clinical signs and symptoms) by Day +42 of 7.2% and 4.6%. Respectively, an incidence of drug-related arthropathy by 1-year follow-up was 9.0% and 5.7%. The increase of suspected drug-related arthropathy cases over time was not statistically significant between groups. Treatment should be initiated only after a careful benefit/risk evaluation, due to possible adverse events related to joints and/or surrounding tissue.<br />Broncho-pulmonary infections in cystic fibrosis<br />Clinical trials have included children and adolescents aged 5-17 years. More limited experience is available in treating children between 1 and 5 years of age.<br />Complicated urinary tract infections and pyelonephritis<br />Ciprofloxacin treatment of urinary tract infections should be considered when other treatments cannot be used, and should be based on the results of the microbiological documentation.<br />Clinical trials have included children and adolescents aged 1-17 years.<br />Other specific severe infections<br />Other severe infections in accordance with official guidance, or after careful benefit-risk evaluation when other treatments cannot be used, or after failure to conventional therapy and when the microbiological documentation can justify a ciprofloxacin use.<br />The use of ciprofloxacin for specific severe infections other than those mentioned above has not been evaluated in clinical trials and the clinical experience is limited. Consequently, caution is advised when treating patients with these infections.<br />Hypersensitivity<br />Hypersensitivity and allergic reactions, including anaphylaxis and anaphylactoid reactions, may occur following a single dose (see section 4.8) and may be life-threatening. If such reaction occurs, ciprofloxacin should be discontinued and an adequate medical treatment is required.<br />Musculoskeletal System<br />Ciprofloxacin should generally not be used in patients with a history of tendon disease/disorder related to quinolone treatment. Nevertheless, in very rare instances, after microbiological documentation of the causative organism and evaluation of the risk/benefit balance, ciprofloxacin may be prescribed to these patients for the treatment of certain severe infections, particularly in the event of failure of the standard therapy or bacterial resistance, where the microbiological data may justify the use of ciprofloxacin.<br />Tendinitis and tendon rupture (especially Achilles tendon), sometimes bilateral, may occur with ciprofloxacin, even within the first 48 hours of treatment. Inflammation and ruptures of tendon may occur even up to several months after discontinuation of ciprofloxacin therapy. The risk of tendinopathy may be increased in elderly patients or in patients concomitantly treated with<br />corticosteroids (see section 4.8). At any sign of tendinitis (e.g. painful swelling, inflammation), ciprofloxacin treatment should be discontinued. Care should be taken to keep the affected limb at rest.<br />Ciprofloxacin should be used with caution in patients with myasthenia gravis (see section 4.8).<br />Photosensitivity<br />Ciprofloxacin has been shown to cause photosensitivity reactions. Patients taking ciprofloxacin should be advised to avoid direct exposure to either extensive sunlight or UV irradiation during treatment (see section 4.8).<br />Central Nervous System<br />Ciprofloxacin like other quinolones are known to trigger seizures or lower the seizure threshold. Cases of status epilepticus have been reported. Ciprofloxacin should be used with caution in patients with CNS disorders which may be predisposed to seizure. If seizures occur ciprofloxacin should be discontinued (see section 4.8). Psychiatric reactions may occur even after first administration of ciprofloxacin. In rare cases, depression or psychosis can progress to suicidal ideations/thoughts culminating in attempted suicide or completed suicide. In the occurrence of such cases, ciprofloxacin should be discontinued.<br />Cases of polyneuropathy (based on neurological symptoms such as pain, burning, sensory disturbances or muscle weakness, alone or in combination) have been reported in patients receiving ciprofloxacin. Ciprofloxacin should be discontinued in patients experiencing symptoms of neuropathy, including pain; burning, tingling, numbness, and/or weakness in order to prevent the development of an irreversible condition (see section 4.8).<br />Vision disorders<br />If vision becomes impaired or any effects on the eyes are experienced, an eye specialist should be consulted immediately.<br />Cardiac disorders<br />Caution should be taken when using fluoroquinolones, including ciprofloxacin, in patients with known risk factors for prolongation of the QT interval such as, for example:<br />- congenital long QT syndrome<br />- concomitant use of drugs that are known to prolong the QT interval (e.g. Class IA and III anti-arrhythmics, tricyclic antidepressants, macrolides, antipsychotics)<br />- uncorrected electrolyte imbalance (e.g. hypokalaemia, hypomagnesaemia)<br />- cardiac disease (e.g. heart failure, myocardial infarction, bradycardia)<br />Elderly patients and women may be more sensitive to QTc-prolonging medications. Therefore, caution should be taken when using fluoroquinolones, including ciprofloxacin, in these populations.<br />(See section 4.2 Geriatric patients, section 4.5, section 4.8, and section 4.9).<br />Hypoglycaemia<br />As with other quinolones, hypoglycaemia has been reported most often in diabetic patients, predominantly in the elderly population. In all diabetic patients, careful monitoring of blood glucose is recommended (see section 4.8).<br />Gastrointestinal System<br />The occurrence of severe and persistent diarrhoea during or after treatment (including several weeks after treatment) may indicate an antibiotic-associated colitis (life-threatening with possible fatal outcome), requiring immediate treatment (see section 4.8). In such cases, ciprofloxacin should immediately be discontinued, and an appropriate therapy initiated. Anti-peristaltic drugs are contraindicated in this situation.<br />Renal and urinary system<br />Crystalluria related to the use of ciprofloxacin has been reported (see section 4.8). Patients receiving ciprofloxacin should be well hydrated and excessive alkalinity of the urine should be avoided.<br />Impaired renal function<br />Since ciprofloxacin is largely excreted unchanged via renal pathway dose adjustment is needed in patients with impaired renal function as described in section 4.2 to avoid an increase in adverse drug reactions due to accumulation of ciprofloxacin.<br />Hepatobiliary system<br />Cases of hepatic necrosis and life-threatening hepatic failure have been reported with ciprofloxacin (see section 4.8). In the event of any signs and symptoms of hepatic disease (such as anorexia, jaundice, dark urine, pruritus, or tender abdomen), treatment should be discontinued.<br />Glucose-6-phosphate dehydrogenase deficiency<br />Haemolytic reactions have been reported with ciprofloxacin in patients with glucose-6-phosphate dehydrogenase deficiency. Ciprofloxacin should be avoided in these patients unless the potential benefit is considered to outweigh the possible risk. In this case,potential occurrence of haemolysis should be monitored.<br />Resistance<br />During or following a course of treatment with ciprofloxacin bacteria that demonstrate resistance to ciprofloxacin may be isolated, with or without a clinically apparent superinfection. There may be a particular risk of selecting for ciprofloxacin-resistant bacteria during extended durations of treatment and when treating nosocomial infections and/or infections caused by Staphylococcus and Pseudomonas species.<br />Cytochrome P450<br />Ciprofloxacin inhibits CYP1A2 and thus may cause increased serum concentration of concomitantly administered substances metabolised by this enzyme (e.g. theophylline, clozapine, olanzapine, ropinirole, tizanidine, duloxetine). Co-administration of ciprofloxacin and tizanidine is contra-indicated. Therefore, patients taking these substances concomitantly with ciprofloxacin should be monitored closely for clinical signs of overdose, and determination of serum concentrations (e.g. of theophylline) may be necessary (see section 4.5).<br />Methotrexate<br />The concomitant use of ciprofloxacin with methotrexate is not recommended (see section 4.5).<br />Interaction with tests<br />The in-vitro activity of ciprofloxacin against Mycobacterium tuberculosis might give falsenegative bacteriological test results in specimens from patients currently taking ciprofloxacin.<br />Epidemiologic studies report an increased risk of aortic aneurysm and dissection after intake of fluoroquinolones, particularly in the older population.<br />Therefore, fluoroquinolones should only be used after careful benefit-risk assessment and after consideration of other therapeutic options in patients with positive family history of aneurysm disease, or in patients diagnosed with pre-existing aortic aneurysm and/or aortic dissection, or in presence of other risk factors or conditions predisposing for aortic aneurysm and dissection (e.g. Marfan syndrome, vascular Ehlers-Danlos syndrome, Takayasu arteritis, giant cell arteritis, Behcet&#39;s disease, hypertension, known atherosclerosis).<br />In case of sudden abdominal, chest or back pain, patients should be advised to immediately consult a physician in an emergency department.<br />Psychiatric Adverse Reactions<br />Fluoroquinolones, including ciprofloxacin, have been associated with an increased risk of psychiatric adverse reactions, including: toxic psychosis, psychotic reactions progressing to suicidal ideations/thoughts, hallucinations, or paranoia; depression, or self-injurious behavior such as attempted or completed suicide; anxiety, agitation, or nervousness; confusion, delirium, disorientation, or disturbances in attention; insomnia or nightmares; memory impairment. These reactions may occur following the first dose. Advise patients receiving Cipropharm&reg; to inform their healthcare provider immediately if these reactions occur, discontinue the drug, and institute appropriate care.<br />Blood Glucose Disturbances<br />Fluoroquinolones, including ciprofloxacin, have been associated with disturbances of blood glucose, including symptomatic hyperglycemia and hypoglycemia, usually in diabetic patients receiving concomitant treatment with an oral hypoglycemic agent (for example, glyburide) or with insulin. In these patients, careful monitoring of blood glucose is recommended. Severe cases of hypoglycemia resulting in coma or death have been reported. If a hypoglycemic reaction occurs in a patient being treated with cipropharm&reg;, discontinue cipropharm&reg; and initiate appropriate therapy immediately.<br />Because fluoroquinolones have been associated with serious adverse reactions reserve fluoroquinolones for use in patients who have no alternative treatment options for the following indications:<br /> Acute bacterial exacerbation of chronic bronchitis<br /> uncomplicated urinary tract infection<br /> Acute bacterial sinusitis</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:left">Effects of other products on ciprofloxacin:<br />Drugs known to prolong QT interval<br />Ciprofloxacin, like other fluoroquinolones, should be used with caution in patients receiving drugs known to prolong the QT interval (e.g. Class IA and III anti-arrhythmics, tricyclic antidepressants, macrolides, antipsychotics) (see section 4.4).<br />Chelation complex formation<br />The simultaneous administration of ciprofloxacin (oral) and multivalent cation-containing drugs and mineral supplements (e.g. calcium, magnesium, aluminium, iron), polymeric phosphate binders (e.g. sevelamer), sucralfate or antacids, and highly buffered drugs (e.g. didanosine tablets) containing magnesium, aluminium, or calcium reduces the absorption of ciprofloxacin. Consequently, ciprofloxacin should be administered either 1-2 hours before or at least 4 hours after these preparations. The restriction does not apply to antacids belonging to the class of H2 receptor blockers.<br />Food and Dairy products:<br />Dietary calcium as part of a meal does not significantly affect absorption. However, the concurrent administration of dairy products or mineral-fortified drinks alone (e.g. milk, yoghurt, calcium-fortified orange juice) with ciprofloxacin should be avoided because absorption of ciprofloxacin may be reduced.<br />Probenecid<br />Probenecid interferes with renal secretion of ciprofloxacin. Co-administration of probenecid and ciprofloxacin increases ciprofloxacin serum concentrations.<br />Metoclopramide<br />Metoclopramide accelerates the absorption of ciprofloxacin (oral) resulting in a shorter time to reach maximum plasma concentrations. No effect was seen on the bioavailability of ciprofloxacin.<br />Omeprazole<br />Concomitant administration of ciprofloxacin and omeprazole containing medicinal products results in a slight reduction of Cmax and AUC of ciprofloxacin.<br />Effects of ciprofloxacin on other medicinal products:<br />Tizanidine<br />Tizanidine must not be administered together with ciprofloxacin (see section 4.3). In a clinical study with healthy subjects, there was an increase in serum tizanidine concentration (Cmax increase: 7-fold, range: 4 to 21-fold; AUC increase: 10-fold, range: 6 to 24-fold) when given concomitantly with ciprofloxacin. Increased serum tizanidine concentration is associated with a potentiated hypotensive and sedative effect.<br />Methotrexate<br />Renal tubular transport of methotrexate may be inhibited by concomitant administration of ciprofloxacin, potentially leading to increased plasma levels of methotrexate and increased risk of methotrexate-associated toxic reactions. The concomitant use is not recommended (see section 4.4).<br />Theophylline<br />Concurrent administration of ciprofloxacin and theophylline can cause an undesirable increase in serum theophylline concentration. This can lead to theophylline-induced side effects that may rarely be life threatening or fatal. During the combination, serum theophylline concentrations should be checked and the theophylline dose reduced as necessary (see section 4.4).<br />Other xanthine derivatives<br />On concurrent administration of ciprofloxacin and caffeine or pentoxifylline (oxpentifylline), raised serum concentrations of these xanthine derivatives were reported.<br />Cyclosporin<br />A transient rise in the concentration of serum creatinine was observed when ciprofloxacin and cyclosporin containing medicinal products were administered simultaneously. Therefore, it is frequently (twice a week) necessary to control the serum creatinine concentrations in these patients.<br />Vitamin K antagonists<br />Simultaneous administration of ciprofloxacin with a vitamin K antagonist may augment its anti-coagulant effects. The risk may vary with the underlying infection, age and general status of the patient so that the contribution of ciprofloxacin to the increase in INR (international normalised ratio) is difficult to assess. The INR should be monitored frequently during and shortly after co-administration of ciprofloxacin with a vitamin K antagonist (e.g., warfarin, acenocoumarol, phenprocoumon, or fluindione).<br />Glibenclamide<br />In particular cases, concurrent administration of ciprofloxacin and glibenclamide containing medicinal products can intensify the action of glibenclamide (hypoglycaemia).<br />Mexiletine<br />Simultaneous administration of ciprofloxacin and mexiletine can lead to increased plasma concentrations of mexiletine.<br />Phenytoin<br />Simultaneous administration of ciprofloxacin and phenytoin may result in increased or reduced serum levels of phenytoin such that monitoring of drug levels is recommended.<br />Duloxetine<br />In clinical studies, it was demonstrated that concomitant use of duloxetine with strong inhibitors of the CYP450 1A2 isozyme such as fluvoxamine, may result in an increase of AUC and Cmax of duloxetine. Although no clinical data are available on a possible interaction with ciprofloxacin, similar effects can be expected upon concomitant administration (see section 4.4).<br />Ropinirole<br />It was shown in a clinical study that concomitant use of ropinirole with ciprofloxacin, a moderate inhibitor of the CYP450 1A2 isozyme, results in an increase of Cmax and AUC of ropinirole by 60% and 84%, respectively. Monitoring of ropinirole-related side effects and dose adjustment as appropriate is recommended during and shortly after co-administration with<br />ciprofloxacin (see section 4.4).<br />Lidocaine<br />It was demonstrated in healthy subjects that concomitant use of lidocaine containing medicinal products with ciprofloxacin, a moderate inhibitor of CYP450 1A2 isozyme, reduces clearance of intravenous lidocaine by 22%. Although lidocaine treatment was well tolerated, a possible interaction with ciprofloxacin associated with side effects may occur upon concomitant administration.<br />Clozapine<br />Following concomitant administration of 250 mg ciprofloxacin with clozapine for 7 days, serum concentrations of clozapine and N-desmethylclozapine were increased by 29% and 31%, respectively. Clinical surveillance and appropriate adjustment of clozapine dosage during and shortly after co-administration with ciprofloxacin are advised (see section 4.4).<br />Sildenafil<br />Cmax and AUC of sildenafil were increased approximately twofold in healthy subjects after an oral dose of 50 mg given concomitantly with 500 mg ciprofloxacin. Therefore, caution should be used prescribing ciprofloxacin concomitantly with sildenafil taking into consideration the risks and the benefits.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:left">Pregnancy:<br />The data that are available on administration of ciprofloxacin to pregnant women indicates no malformative or feto/neonatal toxicity of ciprofloxacin. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity. In juvenile and prenatal animals exposed to quinolones, effects on immature cartilage have been observed, thus, it cannot be excluded that the drug could cause damage to articular cartilage in the human immature organism / foetus (see section 5.3).<br />As a precautionary measure, it is preferable to avoid the use of ciprofloxacin during pregnancy.<br />Lactation<br />Ciprofloxacin is excreted in breast milk. Due to the potential risk of articular damage, ciprofloxacin should not be used during breast-feeding.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:left">Due to its neurological effects, ciprofloxacin may affect reaction time. Thus, the ability to drive or to operate machinery may be impaired.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:14.25pt; margin-right:0cm; text-align:left">The most commonly reported adverse drug reactions (ADRs) are nausea and diarrhoea.</p><p style="margin-left:14.25pt; text-align:left">ADRs derived from clinical studies and post-marketing surveillance with ciprofloxacin (oral, intravenous, and sequential therapy) sorted by categories of</p><p style="text-align:left">&nbsp;</p><p style="margin-left:14.25pt; margin-right:0cm; text-align:left">frequency are listed below. The frequency analysis takes into account data from both oral and intravenous administration of ciprofloxacin.</p><p style="text-align:left"><!--[if !supportMisalignedColumns]--></p><p style="text-align:left"><!--[endif]--></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="height:102.1pt; vertical-align:top; width:77.9pt" colspan="2"><p style="margin-left:2.95pt; margin-right:6.7pt; text-align:left"><strong>System Organ Class</strong></p></td><td style="height:102.1pt; vertical-align:top; width:48.25pt"><p style="margin-left:2.9pt; margin-right:4.75pt; text-align:left"><strong>Comm on</strong></p><p style="margin-left:2.9pt; margin-right:2.1pt; text-align:left">&ge;1/100 to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &lt;</p><p style="margin-left:2.9pt; text-align:left">1/10</p></td><td style="height:102.1pt; vertical-align:top; width:69.95pt"><p style="margin-left:2.95pt; margin-right:5.05pt; text-align:left"><strong>Uncommo n</strong></p><p style="margin-left:2.95pt; text-align:left">&ge;1/1 000 to</p><p style="margin-left:2.95pt; text-align:left">&lt; 1/100</p></td><td style="height:102.1pt; vertical-align:top; width:84.4pt" colspan="2"><p style="margin-left:2.95pt; margin-right:0cm; text-align:left"><strong>Rare</strong></p><p style="margin-left:2.95pt; text-align:left">&ge;1/10 000 to</p><p style="margin-left:2.95pt; text-align:left">&lt; 1/1 000</p></td><td style="height:102.1pt; vertical-align:top; width:73.15pt" colspan="2"><p style="margin-left:2.8pt; margin-right:0cm; text-align:left"><strong>Very Rare</strong></p><p style="margin-left:2.8pt; text-align:left">&lt; 1/10 000</p></td><td style="height:102.1pt; vertical-align:top; width:70.85pt"><p style="margin-left:2.75pt; margin-right:2.6pt; text-align:left"><strong>Frequency not known </strong>(cannot&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; be estimated from available data)</p></td></tr><tr><td style="height:102.65pt; vertical-align:top; width:77.9pt" colspan="2"><p style="margin-left:2.95pt; margin-right:4.7pt; text-align:left"><strong>Infections and Infestations</strong></p></td><td style="height:102.65pt; vertical-align:top; width:48.25pt"><p style="text-align:left">&nbsp;</p></td><td style="height:102.65pt; vertical-align:top; width:69.95pt"><p style="margin-left:2.95pt; margin-right:2.35pt; text-align:left">Mycotic superinfecti ons</p></td><td style="height:102.65pt; vertical-align:top; width:84.4pt" colspan="2"><p style="margin-left:2.95pt; margin-right:2.3pt; text-align:left">Antibiotic associated colitis&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (very</p><p style="margin-left:2.95pt; margin-right:2.2pt; text-align:left">rarely with possible fatal outcome) (see section 4.4)</p></td><td style="height:102.65pt; vertical-align:top; width:73.15pt" colspan="2"><p style="text-align:left">&nbsp;</p></td><td style="height:102.65pt; vertical-align:top; width:70.85pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:15.95pt; vertical-align:top; width:44.75pt"><p style="margin-left:2.95pt; margin-right:0cm; text-align:left"><strong>Blood</strong></p></td><td style="height:15.95pt; vertical-align:top; width:33.15pt"><p style="margin-left:8.25pt; margin-right:0cm; text-align:left"><strong>and</strong></p></td><td style="height:15.95pt; vertical-align:top; width:48.25pt" rowspan="12"><p style="text-align:left">&nbsp;</p></td><td style="height:15.95pt; vertical-align:top; width:69.95pt"><p style="margin-left:2.95pt; margin-right:0cm; text-align:left">Eosinophili</p></td><td style="height:15.95pt; vertical-align:top; width:84.4pt" colspan="2"><p style="margin-left:2.95pt; margin-right:0cm; text-align:left">Leukopenia</p></td><td style="height:15.95pt; vertical-align:top; width:73.15pt" colspan="2"><p style="margin-left:2.8pt; margin-right:0cm; text-align:left">Haemolytic</p></td><td style="height:15.95pt; vertical-align:top; width:70.85pt" rowspan="12"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:12.3pt; vertical-align:top; width:77.9pt" colspan="2"><p style="margin-left:2.95pt; text-align:left"><strong>Lymphatic</strong></p></td><td style="height:12.3pt; vertical-align:top; width:69.95pt"><p style="margin-left:2.95pt; text-align:left">a</p></td><td style="height:12.3pt; vertical-align:top; width:84.4pt" colspan="2"><p style="margin-left:2.95pt; text-align:left">Anaemia</p></td><td style="height:12.3pt; vertical-align:top; width:73.15pt" colspan="2"><p style="margin-left:2.8pt; text-align:left">anaemia</p></td></tr><tr><td style="height:12.3pt; vertical-align:top; width:77.9pt" colspan="2"><p style="margin-left:2.95pt; text-align:left"><strong>System</strong></p></td><td style="height:12.3pt; vertical-align:top; width:69.95pt"><p style="text-align:left">&nbsp;</p></td><td style="height:12.3pt; vertical-align:top; width:84.4pt" colspan="2"><p style="margin-left:2.95pt; text-align:left">Neutropenia</p></td><td style="height:12.3pt; vertical-align:top; width:73.15pt" colspan="2"><p style="margin-left:2.8pt; text-align:left">Agranulocyt</p></td></tr><tr><td style="height:12.25pt; vertical-align:top; width:77.9pt" colspan="2"><p style="margin-left:2.95pt; text-align:left"><strong>Disorders</strong></p></td><td style="height:12.25pt; vertical-align:top; width:69.95pt"><p style="text-align:left">&nbsp;</p></td><td style="height:12.25pt; vertical-align:top; width:84.4pt" colspan="2"><p style="margin-left:2.95pt; text-align:left">Leukocytosis</p></td><td style="height:12.25pt; vertical-align:top; width:73.15pt" colspan="2"><p style="margin-left:2.8pt; text-align:left">osis</p></td></tr><tr><td style="height:12.3pt; vertical-align:top; width:77.9pt" colspan="2"><p style="text-align:left">&nbsp;</p></td><td style="height:12.3pt; vertical-align:top; width:69.95pt"><p style="text-align:left">&nbsp;</p></td><td style="height:12.3pt; vertical-align:top; width:84.4pt" colspan="2"><p style="margin-left:2.95pt; text-align:left">Thrombocytop</p></td><td style="height:12.3pt; vertical-align:top; width:73.15pt" colspan="2"><p style="margin-left:2.8pt; text-align:left">Pancytopen</p></td></tr><tr><td style="height:12.25pt; vertical-align:top; width:77.9pt" colspan="2"><p style="text-align:left">&nbsp;</p></td><td style="height:12.25pt; vertical-align:top; width:69.95pt"><p style="text-align:left">&nbsp;</p></td><td style="height:12.25pt; vertical-align:top; width:84.4pt" colspan="2"><p style="margin-left:2.95pt; text-align:left">enia</p></td><td style="height:12.25pt; vertical-align:top; width:25.1pt"><p style="margin-left:2.8pt; text-align:left">ia</p></td><td style="height:12.25pt; vertical-align:top; width:48.05pt"><p style="margin-right:2.3pt; text-align:left">(life-</p></td></tr><tr><td style="height:12.3pt; vertical-align:top; width:77.9pt" colspan="2"><p style="text-align:left">&nbsp;</p></td><td style="height:12.3pt; vertical-align:top; width:69.95pt"><p style="text-align:left">&nbsp;</p></td><td style="height:12.3pt; vertical-align:top; width:84.4pt" colspan="2"><p style="margin-left:2.95pt; text-align:left">Thrombocytae</p></td><td style="height:12.3pt; vertical-align:top; width:73.15pt" colspan="2"><p style="margin-left:2.8pt; text-align:left">threatening)</p></td></tr><tr><td style="height:12.3pt; vertical-align:top; width:77.9pt" colspan="2"><p style="text-align:left">&nbsp;</p></td><td style="height:12.3pt; vertical-align:top; width:69.95pt"><p style="text-align:left">&nbsp;</p></td><td style="height:12.3pt; vertical-align:top; width:84.4pt" colspan="2"><p style="margin-left:2.95pt; text-align:left">mia</p></td><td style="height:12.3pt; vertical-align:top; width:73.15pt" colspan="2"><p style="margin-left:2.8pt; text-align:left">Bone</p></td></tr><tr><td style="height:12.3pt; vertical-align:top; width:77.9pt" colspan="2"><p style="text-align:left">&nbsp;</p></td><td style="height:12.3pt; vertical-align:top; width:69.95pt"><p style="text-align:left">&nbsp;</p></td><td style="height:12.3pt; vertical-align:top; width:84.4pt" colspan="2"><p style="text-align:left">&nbsp;</p></td><td style="height:12.3pt; vertical-align:top; width:73.15pt" colspan="2"><p style="margin-left:2.8pt; text-align:left">marrow</p></td></tr><tr><td style="height:12.3pt; vertical-align:top; width:77.9pt" colspan="2"><p style="text-align:left">&nbsp;</p></td><td style="height:12.3pt; vertical-align:top; width:69.95pt"><p style="text-align:left">&nbsp;</p></td><td style="height:12.3pt; vertical-align:top; width:84.4pt" colspan="2"><p style="text-align:left">&nbsp;</p></td><td style="height:12.3pt; vertical-align:top; width:73.15pt" colspan="2"><p style="margin-left:2.8pt; text-align:left">depression</p></td></tr><tr><td style="height:12.25pt; vertical-align:top; width:77.9pt" colspan="2"><p style="text-align:left">&nbsp;</p></td><td style="height:12.25pt; vertical-align:top; width:69.95pt"><p style="text-align:left">&nbsp;</p></td><td style="height:12.25pt; vertical-align:top; width:84.4pt" colspan="2"><p style="text-align:left">&nbsp;</p></td><td style="height:12.25pt; vertical-align:top; width:73.15pt" colspan="2"><p style="margin-left:2.8pt; text-align:left">(life-</p></td></tr><tr><td style="height:16.0pt; vertical-align:top; width:77.9pt" colspan="2"><p style="text-align:left">&nbsp;</p></td><td style="height:16.0pt; vertical-align:top; width:69.95pt"><p style="text-align:left">&nbsp;</p></td><td style="height:16.0pt; vertical-align:top; width:84.4pt" colspan="2"><p style="text-align:left">&nbsp;</p></td><td style="height:16.0pt; vertical-align:top; width:73.15pt" colspan="2"><p style="margin-left:2.8pt; text-align:left">threatening)</p></td></tr><tr><td style="height:15.95pt; vertical-align:top; width:77.9pt" colspan="2"><p style="margin-left:2.95pt; margin-right:0cm; text-align:left"><strong>Immune</strong></p></td><td style="height:15.95pt; vertical-align:top; width:48.25pt" rowspan="11"><p style="text-align:left">&nbsp;</p></td><td style="height:15.95pt; vertical-align:top; width:69.95pt" rowspan="11"><p style="text-align:left">&nbsp;</p></td><td style="height:15.95pt; vertical-align:top; width:84.4pt" colspan="2"><p style="margin-left:2.95pt; margin-right:0cm; text-align:left">Allergic</p></td><td style="height:15.95pt; vertical-align:top; width:73.15pt" colspan="2"><p style="margin-left:2.8pt; margin-right:0cm; text-align:left">Anaphylacti</p></td><td style="height:15.95pt; vertical-align:top; width:70.85pt" rowspan="11"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:12.25pt; vertical-align:top; width:77.9pt" colspan="2"><p style="margin-left:2.95pt; text-align:left"><strong>System</strong></p></td><td style="height:12.25pt; vertical-align:top; width:84.4pt" colspan="2"><p style="margin-left:2.95pt; text-align:left">reaction</p></td><td style="height:12.25pt; vertical-align:top; width:73.15pt" colspan="2"><p style="margin-left:2.8pt; text-align:left">c reaction</p></td></tr><tr><td style="height:12.25pt; vertical-align:top; width:77.9pt" colspan="2"><p style="margin-left:2.95pt; text-align:left"><strong>Disorders</strong></p></td><td style="height:12.25pt; vertical-align:top; width:84.4pt" colspan="2"><p style="margin-left:2.95pt; text-align:left">Allergic</p></td><td style="height:12.25pt; vertical-align:top; width:73.15pt" colspan="2"><p style="margin-left:2.8pt; text-align:left">Anaphylacti</p></td></tr><tr><td style="height:12.3pt; vertical-align:top; width:77.9pt" colspan="2"><p style="text-align:left">&nbsp;</p></td><td style="height:12.3pt; vertical-align:top; width:61.85pt"><p style="margin-left:2.95pt; text-align:left">oedema</p></td><td style="height:12.3pt; vertical-align:top; width:22.55pt"><p style="margin-right:2.25pt; text-align:left">/</p></td><td style="height:12.3pt; vertical-align:top; width:25.1pt"><p style="margin-left:2.8pt; text-align:left">c</p></td><td style="height:12.3pt; vertical-align:top; width:48.05pt"><p style="margin-right:2.35pt; text-align:left">shock</p></td></tr><tr><td style="height:12.25pt; vertical-align:top; width:77.9pt" colspan="2"><p style="text-align:left">&nbsp;</p></td><td style="height:12.25pt; vertical-align:top; width:84.4pt" colspan="2"><p style="margin-left:2.95pt; text-align:left">angiooedema</p></td><td style="height:12.25pt; vertical-align:top; width:73.15pt" colspan="2"><p style="margin-left:2.8pt; text-align:left">(life-</p></td></tr><tr><td style="height:12.3pt; vertical-align:top; width:77.9pt" colspan="2"><p style="text-align:left">&nbsp;</p></td><td style="height:12.3pt; vertical-align:top; width:84.4pt" colspan="2"><p style="text-align:left">&nbsp;</p></td><td style="height:12.3pt; vertical-align:top; width:73.15pt" colspan="2"><p style="margin-left:2.8pt; text-align:left">threatening)</p></td></tr><tr><td style="height:12.3pt; vertical-align:top; width:77.9pt" colspan="2"><p style="text-align:left">&nbsp;</p></td><td style="height:12.3pt; vertical-align:top; width:84.4pt" colspan="2"><p style="text-align:left">&nbsp;</p></td><td style="height:12.3pt; vertical-align:top; width:73.15pt" colspan="2"><p style="margin-left:2.8pt; text-align:left">(see section</p></td></tr><tr><td style="height:12.3pt; vertical-align:top; width:77.9pt" colspan="2"><p style="text-align:left">&nbsp;</p></td><td style="height:12.3pt; vertical-align:top; width:84.4pt" colspan="2"><p style="text-align:left">&nbsp;</p></td><td style="height:12.3pt; vertical-align:top; width:73.15pt" colspan="2"><p style="margin-left:2.8pt; text-align:left">4.4)</p></td></tr><tr><td style="height:12.3pt; vertical-align:top; width:77.9pt" colspan="2"><p style="text-align:left">&nbsp;</p></td><td style="height:12.3pt; vertical-align:top; width:84.4pt" colspan="2"><p style="text-align:left">&nbsp;</p></td><td style="height:12.3pt; vertical-align:top; width:73.15pt" colspan="2"><p style="margin-left:2.8pt; text-align:left">Serum</p></td></tr><tr><td style="height:12.3pt; vertical-align:top; width:77.9pt" colspan="2"><p style="text-align:left">&nbsp;</p></td><td style="height:12.3pt; vertical-align:top; width:84.4pt" colspan="2"><p style="text-align:left">&nbsp;</p></td><td style="height:12.3pt; vertical-align:top; width:73.15pt" colspan="2"><p style="margin-left:2.8pt; text-align:left">sickness-</p></td></tr><tr><td style="height:16.15pt; vertical-align:top; width:77.9pt" colspan="2"><p style="text-align:left">&nbsp;</p></td><td style="height:16.15pt; vertical-align:top; width:84.4pt" colspan="2"><p style="text-align:left">&nbsp;</p></td><td style="height:16.15pt; vertical-align:top; width:73.15pt" colspan="2"><p style="margin-left:2.8pt; text-align:left">like reaction</p></td></tr><tr><td style="height:15.6pt; vertical-align:top; width:77.9pt" colspan="2"><p style="margin-left:2.95pt; margin-right:0cm; text-align:left"><strong>Metabolism</strong></p></td><td style="height:15.6pt; vertical-align:top; width:48.25pt" rowspan="4"><p style="text-align:left">&nbsp;</p></td><td style="height:15.6pt; vertical-align:top; width:69.95pt"><p style="margin-left:2.95pt; margin-right:0cm; text-align:left">Decreased</p></td><td style="height:15.6pt; vertical-align:top; width:84.4pt" colspan="2"><p style="margin-left:2.95pt; margin-right:0cm; text-align:left">Hyperglycaem</p></td><td style="height:15.6pt; vertical-align:top; width:73.15pt" rowspan="4" colspan="2"><p style="text-align:left">&nbsp;</p></td><td style="height:15.6pt; vertical-align:top; width:70.85pt" rowspan="4"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:11.5pt; vertical-align:top; width:77.9pt" colspan="2"><p style="margin-left:2.95pt; text-align:left"><strong>and</strong></p></td><td style="height:11.5pt; vertical-align:top; width:69.95pt"><p style="margin-left:2.95pt; text-align:left">appetite,</p></td><td style="height:11.5pt; vertical-align:top; width:84.4pt" colspan="2"><p style="margin-left:2.95pt; text-align:left">ia</p></td></tr><tr><td style="height:11.5pt; vertical-align:top; width:77.9pt" colspan="2"><p style="margin-left:2.95pt; text-align:left"><strong>Nutrition</strong></p></td><td style="height:11.5pt; vertical-align:top; width:69.95pt"><p style="margin-left:2.95pt; text-align:left">Anorexia</p></td><td style="height:11.5pt; vertical-align:top; width:84.4pt" colspan="2"><p style="margin-left:2.95pt; text-align:left">Hypoglycaemi</p></td></tr><tr><td style="height:10.75pt; vertical-align:top; width:77.9pt" colspan="2"><p style="margin-left:2.95pt; text-align:left"><strong>Disorders</strong></p></td><td style="height:10.75pt; vertical-align:top; width:69.95pt"><p style="text-align:left">&nbsp;</p></td><td style="height:10.75pt; vertical-align:top; width:84.4pt" colspan="2"><p style="margin-left:2.95pt; text-align:left">a (see section</p></td></tr><tr><td style="text-align:left">&nbsp;</td><td style="text-align:left">&nbsp;</td><td style="text-align:left">&nbsp;</td><td style="text-align:left">&nbsp;</td><td style="text-align:left">&nbsp;</td><td style="text-align:left">&nbsp;</td><td style="text-align:left">&nbsp;</td><td style="text-align:left">&nbsp;</td><td style="text-align:left">&nbsp;</td></tr></tbody></table><p style="text-align:left">&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="height:19.3pt; vertical-align:top; width:77.95pt"><p style="text-align:left">&nbsp;</p></td><td style="height:19.3pt; vertical-align:top; width:48.3pt"><p style="text-align:left">&nbsp;</p></td><td style="height:19.3pt; vertical-align:top; width:70.0pt"><p style="text-align:left">&nbsp;</p></td><td style="height:19.3pt; vertical-align:top; width:84.4pt"><p style="margin-left:2.8pt; margin-right:0cm; text-align:left">4.4)</p></td><td style="height:19.3pt; vertical-align:top; width:73.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:19.3pt; vertical-align:top; width:70.85pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:268.25pt; vertical-align:top; width:77.95pt"><p style="margin-left:2.95pt; margin-right:8.05pt; text-align:left"><strong>Psychiatric Disorders</strong></p></td><td style="height:268.25pt; vertical-align:top; width:48.3pt"><p style="text-align:left">&nbsp;</p></td><td style="height:268.25pt; vertical-align:top; width:70.0pt"><p style="margin-left:2.85pt; margin-right:2.5pt; text-align:left">Psychomot or hyperactivit y / agitation</p></td><td style="height:268.25pt; vertical-align:top; width:84.4pt"><p style="margin-left:2.8pt; margin-right:2.3pt; text-align:left">Confusion and disorientation Anxiety reaction Abnormal dreams Depression (potentially culminating in suicidal ideations/thou ghts&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; or</p><p style="margin-left:2.8pt; margin-right:2.4pt; text-align:left">suicide attempts&nbsp;&nbsp; and completed suicide)&nbsp;&nbsp;&nbsp; (see section 4.4) Hallucinations</p></td><td style="height:268.25pt; vertical-align:top; width:73.1pt"><p style="margin-left:2.65pt; margin-right:2.45pt; text-align:left">Psychotic reactions (potentially culminating in&nbsp;&nbsp;&nbsp;&nbsp; suicidal ideations/ thoughts or suicide attempts and completed suicide) (see section 4.4)</p></td><td style="height:268.25pt; vertical-align:top; width:70.85pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:171.55pt; vertical-align:top; width:77.95pt"><p style="margin-left:2.95pt; margin-right:16.1pt; text-align:left"><strong>Nervous System Disorders</strong></p></td><td style="height:171.55pt; vertical-align:top; width:48.3pt"><p style="text-align:left">&nbsp;</p></td><td style="height:171.55pt; vertical-align:top; width:70.0pt"><p style="margin-left:2.85pt; margin-right:9.15pt; text-align:left">Headache Dizziness Sleep disorders Taste disorders</p></td><td style="height:171.55pt; vertical-align:top; width:84.4pt"><p style="margin-left:2.8pt; margin-right:2.35pt; text-align:left">Par-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and Dysaesthesia Hypoaesthesi a</p><p style="margin-left:2.8pt; margin-right:2.4pt; text-align:left">Tremor Seizures (including status epilepticus see&nbsp;&nbsp;&nbsp;&nbsp; section 4.4)</p><p style="margin-left:2.8pt; text-align:left">Vertigo</p></td><td style="height:171.55pt; vertical-align:top; width:73.1pt"><p style="margin-left:2.65pt; margin-right:1.8pt; text-align:left">Migraine Disturbed coordination Gait disturbance Olfactory nerve disorders Intracranial hypertensio n</p></td><td style="height:171.55pt; vertical-align:top; width:70.85pt"><p style="margin-left:2.65pt; margin-right:4.05pt; text-align:left">Peripheral neuropathy (see section 4.4)</p></td></tr><tr><td style="height:47.45pt; vertical-align:top; width:77.95pt"><p style="margin-left:2.95pt; margin-right:16.1pt; text-align:left"><strong>Eye Disorders</strong></p></td><td style="height:47.45pt; vertical-align:top; width:48.3pt"><p style="text-align:left">&nbsp;</p></td><td style="height:47.45pt; vertical-align:top; width:70.0pt"><p style="text-align:left">&nbsp;</p></td><td style="height:47.45pt; vertical-align:top; width:84.4pt"><p style="margin-left:2.8pt; margin-right:5.6pt; text-align:left">Visual disturbances (e.g. diplopia)</p></td><td style="height:47.45pt; vertical-align:top; width:73.1pt"><p style="margin-left:2.65pt; margin-right:12.5pt; text-align:left">Visual colour distortions</p></td><td style="height:47.45pt; vertical-align:top; width:70.85pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:61.15pt; vertical-align:top; width:77.95pt"><p style="margin-left:2.95pt; margin-right:2.2pt; text-align:left"><strong>Ear&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and Labyrinth Disorders</strong></p></td><td style="height:61.15pt; vertical-align:top; width:48.3pt"><p style="text-align:left">&nbsp;</p></td><td style="height:61.15pt; vertical-align:top; width:70.0pt"><p style="text-align:left">&nbsp;</p></td><td style="height:61.15pt; vertical-align:top; width:84.4pt"><p style="margin-left:2.8pt; margin-right:0cm; text-align:left">Tinnitus Hearing loss / Hearing impaired</p></td><td style="height:61.15pt; vertical-align:top; width:73.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:61.15pt; vertical-align:top; width:70.85pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:56.25pt; vertical-align:top; width:77.95pt"><p style="margin-left:2.95pt; margin-right:16.1pt; text-align:left"><strong>Cardiac Disorders</strong></p></td><td style="height:56.25pt; vertical-align:top; width:48.3pt"><p style="text-align:left">&nbsp;</p></td><td style="height:56.25pt; vertical-align:top; width:70.0pt"><p style="text-align:left">&nbsp;</p></td><td style="height:56.25pt; vertical-align:top; width:84.4pt"><p style="margin-left:2.8pt; margin-right:0cm; text-align:left">Tachycardia</p></td><td style="height:56.25pt; vertical-align:top; width:73.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:56.25pt; vertical-align:top; width:70.85pt"><p style="margin-left:2.65pt; margin-right:2.65pt; text-align:left">Ventricular arrhythmiaa nd torsades de&nbsp;&nbsp; pointes</p></td></tr></tbody></table><p style="text-align:left">&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="height:184.95pt; vertical-align:top; width:77.95pt"><p style="text-align:left">&nbsp;</p></td><td style="height:184.95pt; vertical-align:top; width:48.3pt"><p style="text-align:left">&nbsp;</p></td><td style="height:184.95pt; vertical-align:top; width:70.0pt"><p style="text-align:left">&nbsp;</p></td><td style="height:184.95pt; vertical-align:top; width:84.4pt"><p style="text-align:left">&nbsp;</p></td><td style="height:184.95pt; vertical-align:top; width:73.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:184.95pt; vertical-align:top; width:70.85pt"><p style="margin-left:2.65pt; margin-right:2.75pt; text-align:left">(reported predominan tly&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; in</p><p style="margin-left:2.65pt; margin-right:2.85pt; text-align:left">patients with&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; risk</p><p style="margin-left:2.65pt; margin-right:2.6pt; text-align:left">factors&nbsp;&nbsp;&nbsp; for QT</p><p style="margin-left:2.65pt; margin-right:2.6pt; text-align:left">prolongatio n), ECG QT</p><p style="margin-left:2.65pt; margin-right:2.7pt; text-align:left">prolonged (see section &nbsp;4.4</p><p style="margin-left:2.65pt; text-align:left">and 4.9)</p></td></tr><tr><td style="height:47.45pt; vertical-align:top; width:77.95pt"><p style="margin-left:2.95pt; margin-right:16.1pt; text-align:left"><strong>Vascular Disorders</strong></p></td><td style="height:47.45pt; vertical-align:top; width:48.3pt"><p style="text-align:left">&nbsp;</p></td><td style="height:47.45pt; vertical-align:top; width:70.0pt"><p style="text-align:left">&nbsp;</p></td><td style="height:47.45pt; vertical-align:top; width:84.4pt"><p style="margin-left:2.8pt; margin-right:2.95pt; text-align:left">Vasodilatation Hypotension Syncope</p></td><td style="height:47.45pt; vertical-align:top; width:73.1pt"><p style="margin-left:2.65pt; margin-right:0cm; text-align:left">Vasculitis</p></td><td style="height:47.45pt; vertical-align:top; width:70.85pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:74.9pt; vertical-align:top; width:77.95pt"><p style="margin-left:2.95pt; margin-right:2.1pt; text-align:left"><strong>Respiratory, Thoracic and Mediastinal Disorders</strong></p></td><td style="height:74.9pt; vertical-align:top; width:48.3pt"><p style="text-align:left">&nbsp;</p></td><td style="height:74.9pt; vertical-align:top; width:70.0pt"><p style="text-align:left">&nbsp;</p></td><td style="height:74.9pt; vertical-align:top; width:84.4pt"><p style="margin-left:2.8pt; margin-right:25.2pt; text-align:left">Dyspnoea (including asthmatic condition)</p></td><td style="height:74.9pt; vertical-align:top; width:73.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:74.9pt; vertical-align:top; width:70.85pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:116.45pt; vertical-align:top; width:77.95pt"><p style="margin-left:2.95pt; margin-right:5.4pt; text-align:left"><strong>Gastrointes tinal Disorders</strong></p></td><td style="height:116.45pt; vertical-align:top; width:48.3pt"><p style="margin-left:2.85pt; margin-right:2.85pt; text-align:left">Nause a Diarrho ea</p></td><td style="height:116.45pt; vertical-align:top; width:70.0pt"><p style="margin-left:2.85pt; margin-right:8.8pt; text-align:left">Vomiting Gastro- intestinal and abdominal pains Dyspepsia Flatulence</p></td><td style="height:116.45pt; vertical-align:top; width:84.4pt"><p style="margin-left:2.8pt; margin-right:2.45pt; text-align:left; text-indent:3.35pt">Antibiotic associated colitis&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (very</p><p style="margin-left:2.8pt; margin-right:2.35pt; text-align:left">rarely with possible fatal outcome) (see section 4.4)</p></td><td style="height:116.45pt; vertical-align:top; width:73.1pt"><p style="margin-left:2.65pt; margin-right:0cm; text-align:left">Pancreatitis</p></td><td style="height:116.45pt; vertical-align:top; width:70.85pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:130.15pt; vertical-align:top; width:77.95pt"><p style="margin-left:2.95pt; margin-right:2.75pt; text-align:left"><strong>Hepatobiliar y Disorders</strong></p></td><td style="height:130.15pt; vertical-align:top; width:48.3pt"><p style="text-align:left">&nbsp;</p></td><td style="height:130.15pt; vertical-align:top; width:70.0pt"><p style="margin-left:2.85pt; margin-right:2.5pt; text-align:left">Increase in transamina ses Increased bilirubin</p></td><td style="height:130.15pt; vertical-align:top; width:84.4pt"><p style="margin-left:2.8pt; margin-right:18.95pt; text-align:left">Hepatic impairment Cholestatic icterus Hepatitis</p></td><td style="height:130.15pt; vertical-align:top; width:73.1pt"><p style="margin-left:2.65pt; margin-right:2.4pt; text-align:left">Liver necrosis (very rarely progressing to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; life-</p><p style="margin-left:2.65pt; margin-right:1.8pt; text-align:left">threatening hepatic failure) (see section 4.4)</p></td><td style="height:130.15pt; vertical-align:top; width:70.85pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:70.05pt; vertical-align:top; width:77.95pt"><p style="margin-left:2.95pt; margin-right:2.2pt; text-align:left"><strong>Skin and Subcutaneo us Tissue Disorders</strong></p></td><td style="height:70.05pt; vertical-align:top; width:48.3pt"><p style="text-align:left">&nbsp;</p></td><td style="height:70.05pt; vertical-align:top; width:70.0pt"><p style="margin-left:2.85pt; margin-right:19.2pt; text-align:left">Rash Pruritus Urticaria</p></td><td style="height:70.05pt; vertical-align:top; width:84.4pt"><p style="margin-left:2.8pt; margin-right:2.35pt; text-align:left">Photosensitivi ty reactions (see section 4.4)</p></td><td style="height:70.05pt; vertical-align:top; width:73.1pt"><p style="margin-left:2.65pt; margin-right:11.15pt; text-align:left">Petechiae Erythema multiforme Erythema nodosum</p></td><td style="height:70.05pt; vertical-align:top; width:70.85pt"><p style="margin-left:2.65pt; margin-right:2.6pt; text-align:left">Acute generalised exanthemat ous pustulosis</p></td></tr></tbody></table><p style="text-align:left">&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="height:171.1pt; vertical-align:top; width:77.95pt"><p style="text-align:left">&nbsp;</p></td><td style="height:171.1pt; vertical-align:top; width:48.3pt"><p style="text-align:left">&nbsp;</p></td><td style="height:171.1pt; vertical-align:top; width:70.0pt"><p style="text-align:left">&nbsp;</p></td><td style="height:171.1pt; vertical-align:top; width:84.4pt"><p style="text-align:left">&nbsp;</p></td><td style="height:171.1pt; vertical-align:top; width:73.1pt"><p style="margin-left:2.65pt; margin-right:4pt; text-align:left">Stevens- Johnson syndrome (potentially life- threatening) Toxic epidermal necrolysis (potentially life- threatening)</p></td><td style="height:171.1pt; vertical-align:top; width:70.85pt"><p style="margin-left:2.65pt; margin-right:0cm; text-align:left">(AGEP)</p></td></tr><tr><td style="height:240.7pt; vertical-align:top; width:77.95pt"><p style="margin-left:2.95pt; margin-right:2.2pt; text-align:left"><strong>Musculo- skeletal, Connective Tissue&nbsp;&nbsp; and Bone Disorders</strong></p></td><td style="height:240.7pt; vertical-align:top; width:48.3pt"><p style="text-align:left">&nbsp;</p></td><td style="height:240.7pt; vertical-align:top; width:70.0pt"><p style="margin-left:2.85pt; margin-right:2.3pt; text-align:left">Musculo- skeletal pain&nbsp;&nbsp;&nbsp; (e.g. extremity pain,&nbsp;&nbsp; back pain, chest pain) Arthralgia</p></td><td style="height:240.7pt; vertical-align:top; width:84.4pt"><p style="margin-left:2.8pt; margin-right:2.4pt; text-align:left">Myalgia Arthritis Increased muscle&nbsp;&nbsp;&nbsp; tone and cramping</p></td><td style="height:240.7pt; vertical-align:top; width:73.1pt"><p style="margin-left:2.65pt; margin-right:3.15pt; text-align:left">Muscular weakness Tendinitis Tendon rupture (predomina ntly Achilles tendon) (see section 4.4)</p><p style="margin-left:2.65pt; margin-right:2.6pt; text-align:left">Exacerbatio n&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; of</p><p style="margin-left:2.65pt; margin-right:2.6pt; text-align:left">symptoms of myasthenia gravis&nbsp;&nbsp; (see section 4.4)</p></td><td style="height:240.7pt; vertical-align:top; width:70.85pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:102.5pt; vertical-align:top; width:77.95pt"><p style="margin-left:2.95pt; margin-right:2.2pt; text-align:left"><strong>Renal&nbsp;&nbsp;&nbsp;&nbsp; and Urinary Disorders</strong></p></td><td style="height:102.5pt; vertical-align:top; width:48.3pt"><p style="text-align:left">&nbsp;</p></td><td style="height:102.5pt; vertical-align:top; width:70.0pt"><p style="margin-left:2.85pt; margin-right:4.55pt; text-align:left">Renal impairment</p></td><td style="height:102.5pt; vertical-align:top; width:84.4pt"><p style="margin-left:2.8pt; margin-right:2.4pt; text-align:left">Renal failure Haematuria Crystalluria (see&nbsp;&nbsp;&nbsp; section 4.4)</p><p style="margin-left:2.8pt; margin-right:2.95pt; text-align:left">Tubulointerstit ial nephritis</p></td><td style="height:102.5pt; vertical-align:top; width:73.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:102.5pt; vertical-align:top; width:70.85pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:88.85pt; vertical-align:top; width:77.95pt"><p style="margin-left:2.95pt; margin-right:2.35pt; text-align:left"><strong>General Disorders and Administrati on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Site Conditions</strong></p></td><td style="height:88.85pt; vertical-align:top; width:48.3pt"><p style="text-align:left">&nbsp;</p></td><td style="height:88.85pt; vertical-align:top; width:70.0pt"><p style="margin-left:2.85pt; margin-right:17.2pt; text-align:left">Asthenia Fever</p></td><td style="height:88.85pt; vertical-align:top; width:84.4pt"><p style="margin-left:2.8pt; margin-right:2.95pt; text-align:left">Oedema Sweating (hyperhidrosis</p><p style="margin-left:2.8pt; text-align:left">)</p></td><td style="height:88.85pt; vertical-align:top; width:73.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:88.85pt; vertical-align:top; width:70.85pt"><p style="text-align:left">&nbsp;</p></td></tr><tr><td style="height:14.85pt; vertical-align:top; width:77.95pt"><p style="margin-left:2.95pt; margin-right:0cm; text-align:left"><strong>Investigatio</strong></p></td><td style="height:14.85pt; vertical-align:top; width:48.3pt"><p style="text-align:left">&nbsp;</p></td><td style="height:14.85pt; vertical-align:top; width:70.0pt"><p style="margin-left:2.85pt; margin-right:0cm; text-align:left">Increase in</p></td><td style="height:14.85pt; vertical-align:top; width:84.4pt"><p style="margin-left:2.8pt; margin-right:0cm; text-align:left">Increased</p></td><td style="height:14.85pt; vertical-align:top; width:73.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:14.85pt; vertical-align:top; width:70.85pt"><p style="margin-left:2.65pt; margin-right:0cm; text-align:left">Internationa</p></td></tr></tbody></table><p style="text-align:left">&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="border-color:#9f9f9f; height:129.4pt; vertical-align:top; width:77.95pt"><p style="margin-left:2.95pt; margin-right:0cm; text-align:left"><strong>ns</strong></p></td><td style="border-color:#9f9f9f; height:129.4pt; vertical-align:top; width:48.3pt"><p style="text-align:left">&nbsp;</p></td><td style="border-color:#9f9f9f; height:129.4pt; vertical-align:top; width:70.0pt"><p style="margin-left:2.85pt; margin-right:1.8pt; text-align:left">blood alkaline phosphatas e</p></td><td style="border-color:#9f9f9f; height:129.4pt; vertical-align:top; width:84.4pt"><p style="margin-left:2.8pt; margin-right:0cm; text-align:left">amylase</p></td><td style="border-color:#9f9f9f; height:129.4pt; vertical-align:top; width:73.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:129.4pt; vertical-align:top; width:70.85pt"><p style="margin-left:2.65pt; margin-right:2.7pt; text-align:left">l normalised ratio increased (in patients treated with Vitamin&nbsp;&nbsp;&nbsp;&nbsp; K antagonists</p><p style="margin-left:2.65pt; margin-right:0cm; text-align:left">)</p></td></tr></tbody></table><p style="margin-left:14.25pt; text-align:left"><em><u>Paediatric patients</u></em></p><p style="margin-left:14.25pt; margin-right:15.25pt; text-align:left">The incidence of arthropathy, mentioned above, is referring to data collected in studies with adults. In children, arthropathy is reported to occur commonly (see section 4.4).</p><p style="margin-left:0cm; margin-right:0cm; text-align:left">&nbsp;</p><p style="text-align:left">To report any side effect(s):</p><p style="margin-left:47pt; text-align:left; text-indent:-18.05pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><strong>Saudi Arabia:</strong></p><p style="margin-left:46.15pt; margin-right:50.75pt; text-align:left; text-indent:-1.8pt">The National Pharmacovigilance and Drug Safety Center (NPC) Fax: +966-11-205-7662</p><p style="margin-left:46.15pt; margin-right:0cm; text-align:left">Call NPC at +966-11-2038222, Exts: 2317-2356-2340.</p><p style="margin-left:46.15pt; margin-right:0cm; text-align:left">Reporting hotline: 19999</p><p style="margin-left:46.15pt; margin-right:244.45pt; text-align:left">E-mail: <u>npc.drug@sfda.gov.sa</u> Website: <u>www.sfda.gov.sa/npc</u></p><p style="margin-left:46.15pt; margin-right:243.95pt; text-align:left; text-indent:-17.2pt"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]--><strong>United Arab of Emirates: </strong>P.O. Box: 1853, Tel: 80011111 Email: pv@moh.gov.ae</p><p style="margin-left:46.15pt; margin-right:145.3pt; text-align:left">Drug Department, Ministry of Health &amp; Prevention Dubai-UAE.</p><p style="text-align:left"><!--[if !supportLists]-->&middot;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Other GCC States:</p><p style="text-align:left">Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:left">An overdose of 12 g has been reported to lead to mild symptoms of toxicity. An acute overdose of 16 g has been reported to cause acute renal failure.<br />Symptoms in overdose consist of dizziness, tremor, headache, tiredness, seizures, hallucinations, confusion, abdominal discomfort, renal and hepatic impairment as well as crystalluria and haematuria. Reversible renal toxicity has been reported.<br />Apart from routine emergency measures, e.g. ventricular emptying followed by medical carbon it is recommended to monitor renal function, including urinary pH and acidify, if required, to prevent crystalluria. Patients should be kept well hydrated.<br />Calcium or magnesium containing antacids may theoretically reduce the absorption of ciprofloxacin in overdoses<br />Only a small quantity of ciprofloxacin (&lt;10%) is eliminated by haemodialysis<br />or peritoneal dialysis.<br />In the event of overdose, symptomatic treatment should be implemented. ECG monitoring should be undertaken, because of the possibility of QT interval prolongation.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:20.35pt; margin-right:21.55pt; text-align:left">Pharmacotherapeutic group:Quinolone Antibacterials, fluoroquinolones,ATC code: J 01 MA 02</p><p style="margin-left:20.35pt; text-align:left"><em><u>Mechanism of action:</u></em></p><p style="margin-left:20.35pt; margin-right:21.2pt; text-align:left">As a fluoroquinolone antibacterial agent, the bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA- gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.</p><p style="margin-left:20.35pt; text-align:left"><em><u>PK/PD relationship:</u></em></p><p style="margin-left:20.35pt; margin-right:21.5pt; text-align:left">Efficacy mainly depends on the relation between the maximum concentration in serum (C<sub>max</sub>) and the minimum inhibitory concentration (MIC) of ciprofloxacin for a bacterial pathogen and the relation between the area under the curve (AUC) and the MIC.</p><p style="margin-left:20.35pt; text-align:left"><em><u>Mechanism of resistance:</u></em></p><p style="margin-left:20.35pt; margin-right:21.25pt; text-align:left">In-vitro resistance to ciprofloxacin can be acquired through a stepwise process by target site mutations in both DNA gyrase and topoisomerase IV. The degree of cross-resistance between ciprofloxacin and other fluoroquinolones that results is variable. Single mutations may not result in clinical resistance, but multiple mutations generally result in clinical resistance to many or all active substances within the class.</p><p style="margin-left:20.35pt; margin-right:21.25pt; text-align:left">Impermeability&nbsp;&nbsp; and/or&nbsp;&nbsp; active&nbsp;&nbsp; substance&nbsp;&nbsp; efflux&nbsp;&nbsp; pump &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; mechanisms of resistance may have a variable effect on susceptibility to fluoroquinolones, which depends on the physiochemical properties of the various active substances within the class and the affinity of transport systems for each active substance. All in-vitro mechanisms of resistance are commonly observed in clinical isolates. Resistance mechanisms that inactivate other antibiotics&nbsp;&nbsp;&nbsp; such&nbsp;&nbsp;&nbsp; as&nbsp;&nbsp; permeation&nbsp;&nbsp; barriers&nbsp;&nbsp; (common&nbsp;&nbsp; in &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pseudomonas aeruginosa) and efflux mechanisms may affect susceptibility to ciprofloxacin. Plasmid-mediated resistance encoded by qnr-genes has been reported.</p><p style="margin-left:20.35pt; text-align:left"><em><u>Spectrum of antibacterial activity:</u></em></p><p style="margin-left:20.35pt; margin-right:0cm; text-align:left">Breakpoints separate susceptible strains from strains with intermediate susceptibility and the latter from resistant strains:</p><p style="margin-left:20.35pt; margin-right:0cm; text-align:left"><em><u>EUCAST Recommendations</u></em></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="height:19.4pt; vertical-align:top; width:133.05pt"><p style="margin-left:3.05pt; margin-right:0cm; text-align:left"><strong>Microorganisms</strong></p></td><td style="height:19.4pt; vertical-align:top; width:129.4pt"><p style="margin-left:2.85pt; margin-right:0cm; text-align:left"><strong>Susceptible</strong></p></td><td style="height:19.4pt; vertical-align:top; width:129.15pt"><p style="margin-left:2.75pt; margin-right:0cm; text-align:left"><strong>Resistant</strong></p></td></tr><tr><td style="height:19.85pt; vertical-align:top; width:133.05pt"><p style="margin-left:3.05pt; margin-right:0cm; text-align:left"><em>Enterobacteriaceae</em></p></td><td style="height:19.85pt; vertical-align:top; width:129.4pt"><p style="margin-left:2.85pt; margin-right:0cm; text-align:left">S &le;0.5 mg/L</p></td><td style="height:19.85pt; vertical-align:top; width:129.15pt"><p style="margin-left:2.75pt; margin-right:0cm; text-align:left">R &gt; 1 mg/L</p></td></tr><tr><td style="height:19.7pt; vertical-align:top; width:133.05pt"><p style="margin-left:3.05pt; margin-right:0cm; text-align:left"><em>Pseudomonas </em>spp</p></td><td style="height:19.7pt; vertical-align:top; width:129.4pt"><p style="margin-left:2.85pt; margin-right:0cm; text-align:left">S &le;0.5 mg/L</p></td><td style="height:19.7pt; vertical-align:top; width:129.15pt"><p style="margin-left:2.75pt; margin-right:0cm; text-align:left">R &gt; 1 mg/L</p></td></tr><tr><td style="height:19.4pt; vertical-align:top; width:133.05pt"><p style="margin-left:3.05pt; margin-right:0cm; text-align:left"><em>Acinetobacter </em>spp</p></td><td style="height:19.4pt; vertical-align:top; width:129.4pt"><p style="margin-left:2.85pt; margin-right:0cm; text-align:left">S &le;1 mg/L</p></td><td style="height:19.4pt; vertical-align:top; width:129.15pt"><p style="margin-left:2.75pt; margin-right:0cm; text-align:left">R &gt; 1 mg/L</p></td></tr></tbody></table><p style="text-align:left">&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="height:19.3pt; vertical-align:top; width:133.05pt"><p style="margin-left:3.05pt; margin-right:0cm; text-align:left"><em>Staphylococcus </em>spp.<sup>1</sup></p></td><td style="height:19.3pt; vertical-align:top; width:129.4pt"><p style="margin-left:2.85pt; margin-right:0cm; text-align:left">S &le;1 mg/L</p></td><td style="height:19.3pt; vertical-align:top; width:129.15pt"><p style="margin-left:2.75pt; margin-right:0cm; text-align:left">R &gt; 1 mg/L</p></td></tr><tr><td style="height:47.45pt; vertical-align:top; width:133.05pt"><p style="margin-left:3.05pt; margin-right:2.25pt; text-align:left"><em>Haemophilus influenzae&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>and <em>Moraxella catarrhalis</em></p></td><td style="height:47.45pt; vertical-align:top; width:129.4pt"><p style="margin-left:2.85pt; margin-right:0cm; text-align:left">S &le;0.5 mg/L</p></td><td style="height:47.45pt; vertical-align:top; width:129.15pt"><p style="margin-left:2.75pt; margin-right:0cm; text-align:left">R &gt; 0.5 mg/L</p></td></tr><tr><td style="height:19.7pt; vertical-align:top; width:133.05pt"><p style="margin-left:3.05pt; margin-right:0cm; text-align:left"><em>Neisseria gonorrhoeae</em></p></td><td style="height:19.7pt; vertical-align:top; width:129.4pt"><p style="margin-left:2.85pt; margin-right:0cm; text-align:left">S &le;0.03 mg/L</p></td><td style="height:19.7pt; vertical-align:top; width:129.15pt"><p style="margin-left:2.75pt; margin-right:0cm; text-align:left">R &gt; 0.06 mg/L</p></td></tr><tr><td style="height:19.85pt; vertical-align:top; width:133.05pt"><p style="margin-left:3.05pt; margin-right:0cm; text-align:left"><em>Neisseria meningitidis</em></p></td><td style="height:19.85pt; vertical-align:top; width:129.4pt"><p style="margin-left:2.85pt; margin-right:0cm; text-align:left">S &le;0.03 mg/L</p></td><td style="height:19.85pt; vertical-align:top; width:129.15pt"><p style="margin-left:2.75pt; margin-right:0cm; text-align:left">R &gt; 0.06 mg/L</p></td></tr><tr><td style="height:33.5pt; vertical-align:top; width:133.05pt"><p style="margin-left:3.05pt; margin-right:19.7pt; text-align:left">Non-species-related breakpoints<strong>*</strong></p></td><td style="height:33.5pt; vertical-align:top; width:129.4pt"><p style="margin-left:2.85pt; margin-right:0cm; text-align:left">S &le;0.5 mg/L</p></td><td style="height:33.5pt; vertical-align:top; width:129.15pt"><p style="margin-left:2.75pt; margin-right:0cm; text-align:left">R &gt; 1 mg/L</p></td></tr><tr><td style="height:102.25pt; vertical-align:top; width:391.6pt" colspan="3"><p style="margin-left:3.05pt; margin-right:2.65pt; text-align:left">1 <em>Staphylococcus </em>spp. - breakpoints for ciprofloxacin relate to high dose therapy.</p><p style="margin-left:3.05pt; margin-right:2.65pt; text-align:left">* Non-species-related breakpoints have been determined mainly on the basis of PK/PD data and are independent of MIC distributions of specific species. They are for use only for species that have not been given a species-specific breakpoint and not for those species where susceptibility testing is not recommended.</p></td></tr></tbody></table><p style="margin-left:20.35pt; margin-right:21.2pt; text-align:left">The prevalence of acquired resistance may vary geographically and with time for selected species and local information on resistance is desirable, particularly when treating severe infections. As necessary, expert advice should be sought when the local prevalence of resistance is such that the utility of the agent in at least some types of infections is questionable.</p><p style="margin-left:20.35pt; text-align:left">Groupings of relevant species according to ciprofloxacin susceptibility (for</p><p style="margin-left:20.35pt; margin-right:0cm; text-align:left"><em>Streptococcus </em>species see section 4.4)</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="height:19.4pt; vertical-align:top; width:412.2pt"><p style="margin-left:3.05pt; margin-right:0cm; text-align:left"><strong>COMMONLY SUSCEPTIBLE SPECIES</strong></p></td></tr><tr><td style="height:33.5pt; vertical-align:top; width:412.2pt"><p style="margin-left:3.05pt; margin-right:0cm; text-align:left"><u>Aerobic Gram-positive micro-organisms</u></p><p style="margin-left:3.05pt; text-align:left"><em>Bacillus anthracis </em>(1)</p></td></tr><tr><td style="height:212.65pt; vertical-align:top; width:412.2pt"><p style="margin-left:3.05pt; margin-right:0cm; text-align:left"><u>Aerobic Gram-negative micro-organisms</u></p><p style="margin-left:3.05pt; text-align:left"><em>Aeromonas </em>spp.</p><p style="margin-left:3.05pt; margin-right:293.9pt; text-align:left"><em>Brucella </em>spp. <em>Citrobacter koseri Francisella tularensis Haemophilus ducreyi</em></p><p style="margin-left:3.05pt; margin-right:273.9pt; text-align:left"><em>Haemophilus influenzae* Legionella </em>spp.</p><p style="margin-left:3.05pt; margin-right:290.8pt; text-align:left"><em>Moraxella catarrhalis* Neisseria meningitidis Pasteurella </em>spp.</p><p style="margin-left:3.05pt; margin-right:316.55pt; text-align:left"><em>Salmonella </em>spp.<em>* Shigella </em>spp.<em>* Vibrio </em>spp.</p><p style="margin-left:3.05pt; text-align:left"><em>Yersinia pestis</em></p></td></tr></tbody></table><p style="text-align:left">&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="height:33.1pt; vertical-align:top; width:412.2pt"><p style="margin-left:3.05pt; margin-right:0cm; text-align:left"><u>Anaerobic micro-organisms</u></p><p style="margin-left:3.05pt; text-align:left"><em>Mobiluncus</em></p></td></tr><tr><td style="height:75.05pt; vertical-align:top; width:412.2pt"><p style="margin-left:3.05pt; margin-right:251.9pt; text-align:left"><u>Other micro-organisms</u> <em>Chlamydia trachomatis </em>($) <em>Chlamydia pneumoniae </em>($) <em>Mycoplasma hominis </em>($) <em>Mycoplasma pneumoniae </em>($)</p></td></tr><tr><td style="height:19.7pt; vertical-align:top; width:412.2pt"><p style="margin-left:3.05pt; margin-right:0cm; text-align:left"><strong>SPECIES FOR WHICH ACQUIRED RESISTANCE MAY BE A PROBLEM</strong></p></td></tr><tr><td style="height:47.45pt; vertical-align:top; width:412.2pt"><p style="margin-left:3.05pt; margin-right:195.9pt; text-align:left"><u>Aerobic Gram-positive micro-organisms</u> <em>Enterococcus faecalis </em>($) <em>Staphylococcus </em>spp. *(2)</p></td></tr><tr><td style="height:254.35pt; vertical-align:top; width:412.2pt"><p style="margin-left:3.05pt; margin-right:0cm; text-align:left"><u>Aerobic Gram-negative micro-organisms</u></p><p style="margin-left:3.05pt; margin-right:271.2pt; text-align:left"><em>Acinetobacter baumannii<sup>+</sup> Burkholderia cepacia<sup>+</sup> * Campylobacter </em>spp.<em><sup>+</sup> * Citrobacter freundii* Enterobacter aerogenes Enterobacter cloacae* Escherichia coli* Klebsiella oxytoca Klebsiella pneumoniae* Morganella morganii* Neisseria gonorrhoeae* Proteus mirabilis* Proteus vulgaris* Providencia </em>spp.</p><p style="margin-left:3.05pt; margin-right:263.4pt; text-align:left"><em>Pseudomonas aeruginosa* Pseudomonas fluorescens Serratia marcescens*</em></p></td></tr><tr><td style="height:47.45pt; vertical-align:top; width:412.2pt"><p style="margin-left:3.05pt; margin-right:0cm; text-align:left"><u>Anaerobic micro-organisms</u></p><p style="margin-left:3.05pt; text-align:left"><em>Peptostreptococcus </em>spp.</p><p style="margin-left:3.05pt; text-align:left"><em>Propionibacterium acnes</em></p></td></tr><tr><td style="height:19.7pt; vertical-align:top; width:412.2pt"><p style="margin-left:3.05pt; margin-right:0cm; text-align:left"><strong>INHERENTLY RESISTANT ORGANISMS</strong></p></td></tr><tr><td style="height:61.25pt; vertical-align:top; width:412.2pt"><p style="margin-left:3.05pt; margin-right:0cm; text-align:left"><u>Aerobic Gram-positive micro-organisms</u></p><p style="margin-left:3.05pt; margin-right:279.9pt; text-align:left"><em>Actinomyces Enteroccus faecium Listeria monocytogenes</em></p></td></tr><tr><td style="height:33.5pt; vertical-align:top; width:412.2pt"><p style="margin-left:3.05pt; margin-right:0cm; text-align:left"><u>Aerobic Gram-negative micro-organisms</u></p><p style="margin-left:3.05pt; text-align:left"><em>Stenotrophomonas maltophilia</em></p></td></tr><tr><td style="height:33.2pt; vertical-align:top; width:412.2pt"><p style="margin-left:3.05pt; margin-right:0cm; text-align:left"><u>Anaerobic micro-organisms</u></p><p style="margin-left:3.05pt; text-align:left"><em>Excepted as listed above</em></p></td></tr></tbody></table><p style="text-align:left">&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="height:46.9pt; vertical-align:top; width:412.2pt"><p style="margin-left:3.05pt; margin-right:278.15pt; text-align:left"><u>Other micro-organisms</u> <em>Mycoplasma genitalium Ureaplasma urealitycum</em></p></td></tr><tr><td style="height:281.65pt; vertical-align:top; width:412.2pt"><p style="margin-left:3.05pt; margin-right:2.75pt; text-align:left">* Clinical efficacy has been demonstrated for susceptible isolates in approved clinical indications</p><p style="margin-left:3.05pt; text-align:left">+ Resistance rate &ge;50% in one or more EU countries</p><p style="margin-left:3.05pt; margin-right:2.8pt; text-align:left">($): Natural intermediate susceptibility in the absence of acquired mechanism of resistance</p><p style="margin-left:3.05pt; margin-right:2.45pt; text-align:left; text-indent:0cm"><!--[if !supportLists]-->(1)&nbsp; <!--[endif]-->: Studies have been conducted in experimental animal infections due to inhalations of <em>Bacillus anthracis </em>spores; these studies reveal that antibiotics starting early after exposition avoid the occurrence of the disease if the treatment is made up to the decrease of the number of spores in the organism under the infective dose. The recommended use in human subjects is based primarily on <em>in-vitro </em>susceptibility and on animal experimental data together with limited human data. Two-month treatment duration in adults with oral ciprofloxacin given at the following dose, 500 mg bid, is considered as effective to prevent anthrax infection in humans. The treating physician should refer to national and/or international consensus documents regarding treatment of anthrax.</p><p style="margin-left:3.05pt; margin-right:2.45pt; text-align:left; text-indent:0cm"><!--[if !supportLists]-->(2)&nbsp; <!--[endif]-->: Methicillin-resistant <em>S. aureus </em>very commonly express co-resistance to fluoroquinolones. The rate of resistance to methicillin is around 20 to 50% among all staphylococcal species and is usually higher in nosocomial isolates.</p></td></tr></tbody></table><p style="margin-left:0cm; margin-right:0cm; text-align:left">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:left"><u>Absorption</u></p><p style="margin-right:21.8pt; text-align:left">Following oral administration of single doses of 250 mg, 500 mg, and 750 mg of ciprofloxacin tablets, ciprofloxacin is absorbed rapidly and extensively, mainly from the small intestine, reaching maximum serum concentrations 1-2 hours later.</p><p style="margin-right:22pt; text-align:left">Single doses of 100-750 mg produced dose-dependent maximum serum concentrations (C<sub>max</sub>) between 0.56 and 3.7 mg/L. Serum concentrations increase proportionately with doses up to 1000 mg.</p><p style="text-align:left">The absolute bioavailability is approximately 70-80%.</p><p style="margin-right:22pt; text-align:left">A 500 mg oral dose given every 12 hours has been shown to produce an area under the serum concentration-time curve (AUC) equivalent to that produced by an intravenous infusion of 400 mg ciprofloxacin given over 60 minutes every 12 hours.</p><p style="text-align:left"><u>Distribution</u></p><p style="margin-right:21.9pt; text-align:left">Protein binding of ciprofloxacin is low (20-30%). Ciprofloxacin is present in plasma largely in a non-ionised form and has a large steady state distribution volume of 2-3 L/kg body weight. Ciprofloxacin reaches high concentrations in a variety of tissues such as lung (epithelial fluid, alveolar macrophages, biopsy tissue), sinuses, inflamed lesions (cantharides blister fluid), and the urogenital tract (urine, prostate, endometrium) where total concentrations</p><p style="text-align:left">&nbsp;</p><p style="margin-left:21.05pt; margin-right:139pt; text-align:left">exceeding those of plasma concentrations are reached. <u>Metabolism</u></p><p style="margin-right:21.7pt; text-align:left">Low concentrations of four metabolites have been reported, which were identified as: desethyleneciprofloxacin (M 1), sulphociprofloxacin (M 2), oxociprofloxacin (M 3) and formylciprofloxacin (M 4). The metabolites display <em>in-vitro </em>antimicrobial activity but to a lower degree than the parent compound. Ciprofloxacin is known to be a moderate inhibitor of the CYP 450 1A2 iso- enzymes.</p><p style="text-align:left"><u>Elimination</u></p><p style="margin-left:21.05pt; margin-right:21.9pt; text-align:left">Ciprofloxacin is largely excreted unchanged both renally and, to a smaller extent, faecally. The serum elimination half-life in subjects with normal renal function is approximately 4-7 hours.</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="height:19.3pt; vertical-align:top; width:234.1pt"><p style="margin-left:3.05pt; margin-right:0cm; text-align:left"><strong>Excretion of ciprofloxacin (% of dose)</strong></p></td><td style="height:19.3pt; vertical-align:top; width:156.0pt" colspan="2"><p style="margin-left:2.9pt; margin-right:0cm; text-align:left"><strong>Oral administration</strong></p></td></tr><tr><td style="height:19.85pt; vertical-align:top; width:234.1pt"><p style="text-align:left">&nbsp;</p></td><td style="height:19.85pt; vertical-align:top; width:78.1pt"><p style="margin-left:2.9pt; margin-right:0cm; text-align:left"><strong>Urine</strong></p></td><td style="height:19.85pt; vertical-align:top; width:77.9pt"><p style="margin-left:2.9pt; margin-right:0cm; text-align:left"><strong>Faeces</strong></p></td></tr><tr><td style="height:47.1pt; vertical-align:top; width:234.1pt"><p style="margin-left:3.05pt; margin-right:0cm; text-align:left">Ciprofloxacin</p><p style="text-align:left">&nbsp;</p><p style="margin-left:3.05pt; margin-right:0cm; text-align:left">Metabolites (M1- M4)</p></td><td style="height:47.1pt; vertical-align:top; width:78.1pt"><p style="margin-left:2.9pt; margin-right:0cm; text-align:left">44.7</p><p style="text-align:left">&nbsp;</p><p style="margin-left:2.9pt; margin-right:0cm; text-align:left">11.3</p></td><td style="height:47.1pt; vertical-align:top; width:77.9pt"><p style="margin-left:2.9pt; margin-right:0cm; text-align:left">25.0</p><p style="text-align:left">&nbsp;</p><p style="margin-left:2.9pt; margin-right:0cm; text-align:left">7.5</p></td></tr></tbody></table><p style="margin-left:21.05pt; margin-right:22.15pt; text-align:left">Renal clearance is between 180-300 mL/kg/h and the total body clearance is between 480-600 mL/kg/h. Ciprofloxacin undergoes both glomerular filtration and tubular secretion. Severely impaired renal function leads to increased half-lives of ciprofloxacin of up to 12 h.</p><p style="margin-right:21.75pt; text-align:left">Non-renal clearance of ciprofloxacin is mainly due to active trans-intestinal secretion and metabolism. 1% of the dose is excreted via the biliary route. Ciprofloxacin is present in the bile in high concentrations.</p><p style="margin-left:21.05pt; text-align:left"><em><u>Paediatric patients</u></em></p><p style="text-align:left">The pharmacokinetic data in paediatric patients are limited.</p><p style="margin-right:22.1pt; text-align:left">In a study in children C<sub>max</sub> and AUC were not age-dependent (above one year of age). No notable increase in C<sub>max</sub> and AUC upon multiple dosing (10 mg/kg three times daily) was observed.</p><p style="margin-right:21.8pt; text-align:left">In 10 children with severe sepsis C<sub>max</sub> was 6.1 mg/L (range 4.6-8.3 mg/L) after a 1-hour intravenous infusion of 10 mg/kg in children aged less than 1 year compared to 7.2 mg/L (range 4.7-11.8 mg/L) for children between 1 and 5 years of age. The AUC values were 17.4 mg*h/L (range 11.8-32.0 mg*h/L) and 16.5 mg*h/L (range 11.0-23.8 mg*h/L) in the respective age groups.</p><p style="margin-left:21.05pt; margin-right:21.85pt; text-align:left">These values are within the range reported for adults at therapeutic doses. Based on population pharmacokinetic analysis of paediatric patients with various infections, the predicted mean half-life in children is approx. 4-5 hours and the bioavailability of the oral suspension ranges from 50 to 80%.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:left">Non-clinical data reveal no special hazards for humans based on conventional studies of single dose toxicity, repeated dose toxicity, carcinogenic potential, or toxicity to reproduction.<br />Like a number of other quinolones, ciprofloxacin is phototoxic in animals at clinically relevant exposure levels. Data on photomutagenicity/photocarcinogenicity show a weak photomutagenic or phototumorigenic effect of ciprofloxacin in-vitro and in animal experiments. This effect was comparable to that of other gyrase inhibitors.<br />Articular tolerability:<br />As reported for other gyrase inhibitors, ciprofloxacin causes damage to the large weight-bearing joints in immature animals. The extent of the cartilage damage varies according to age, species and dose; the damage can be reduced by taking the weight off the joints. Studies with mature animals (rat, dog) revealed no evidence of cartilage lesions. In a study in young beagle dogs, ciprofloxacin caused severe articular changes at therapeutic doses after two weeks of treatment, which were still observed after 5 months.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:left">Sodium starch glycolate, Povidone K, Microcrystalline cellulose Avicel PH, Talc, Magnesium stearate, Opadry O-YL White, Polyethylene glycol</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:left">None.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36 months.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:left">Store below 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:left">Cipropharm&reg; 250 mg F/C Tablets are packed in PVDC /Alu blisters as primary packaging material and packed in cartoon box as secondary packaging material.<br />Pack size: 10 tablets</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:left">None</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Pharma International Company
Amman - Jordan
Tel: 00962-6-5158890 / 5157893
Fax: 00962-6-5154753
Email: marketing@pic-jo.com

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                06/2019
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>